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Abstract 
 
Phospholipid-based copolymers having zwitterionic phosphorylcholine (PC) group 
provide bioinert nature which has great importance in providing blood compatibility and 
reducing non-specific protein adsorption for application in biomedical science. So, these 
copolymers are important in designing synthetic biopolymer for application in coating 
cardiovascular implant and synthesizing polymeric micelles for drug delivery. Till date, most 
of the research focussed on the fabrication of MPC based amphiphilic copolymer using 
conventional or ready-made hydrophobic monomer such as poly [MPC-co-n-butyl 
methacrylate(BMA) and Cholesterol. The hydrophobic domain in the amphiphilic copolymer 
is one of the essential fundamental domains for hydrophobic drug interaction, encapsulation 
and stable micelle formation which was mainly investigated using BMA as hydrophobic 
moiety. Additionally, the biomaterial used for the cardiovascular application requires 
mechanical strength for sustainability, bio and hemocompatibility through attracting the 
endothelial progenitor cells from circulatory blood. The modification of MPC with focus on 
the above mentioned essential requirements for extending its application has not been studied 
yet. This doctoral research focused on the design of new polymeric biomaterial based on 
‘element block’ concept (proposed by researchers from Japan) with phospholipid MPC and 
element block (polyhedral oligosilsesquioxane (POSS)). The ‘element block’ concept suggests 
the incorporation of inorganic component with domain size at the nano or molecular scale into 
the polymer matrix to produce organic-inorganic polymer hybrids. The structural unit of 
organic-inorganic polymer hybrids consisting of various group of elements is termed as 
“element block”. Design and synthesis of new element blocks and polymerization of those 
blocks with polymeric material creates new copolymer with improved material properties. It is 
well-known that hydrophobic POSS moiety improves the mechanical, surface, thermal 
properties of the polymer. Additionally, the POSS cage structure can be easily modified 
depending on the functional requirement. The element block POSS and MPC based copolymer 
described in this thesis is the first report of combination of POSS and MPC. The research has 
been performed with an objective to explore application of synthesized copolymer as a surface 
coating material for a cardiovascular implant and hydrophobic drug carrier molecules for 
controlled delivery.  
The element block (POSS) was synthesized in laboratory with focus on inducing 
hydrophobicity (vertex R-groups modified with ethyl (C2H5), hexyl (C6H13), octyl (C8H17)) and 
was copolymerized (random and RAFT copolymerization techniques) with phospholipid MPC 
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to achieve the following desired functions a) controlled protein adsorption and cell attachment 
on the surface and b) formation of stable polymeric assembly in an aqueous environment which 
will help in encapsulating the hydrophobic drug and its controlled release.  
The surface modification is essential to attract the endothelial progenitor cells from 
circulatory blood for enhancement of the bio and haemocompatibility of cardiovascular devices. 
Mechanical strength is another essential requirement for graft. The results of the study showed 
that only the C2H5-POSS based MPC random copolymer achieves significant improvement of 
mechanical and thermal properties and also showed protein adsorption and cell attachment on 
the surface. The results suggested that C2H5-POSS moiety is evenly distributed on the polymer 
matrix in nanometer scale and strong interaction with MPC restricted the mobility which results 
in the better Young’s modulus. The observed phenomenon of cell attachment on the surface 
supported that the unique hydration layer of poly MPC which resists the protein adsorption and 
cell adhesion is affected by the incorporation of C2H5-POSS moiety. The obtained results 
suggested the potentiality of the designed C2H5-POSS based MPC random copolymer as a 
coating material. 
Administration of poorly water-soluble drug like paclitaxel (PTX) is a major challenge 
both in the injectable and oral dosage form. So, the next focus was on micellar delivery of PTX 
and its dissolution from the solid dosage form. The designed C2H5-POSS based MPC random 
copolymer (along with PTX and polyvinylpyrrolidone (PVP) only for solid dosage form) 
showed a significant increase in the solubility of paclitaxel in water, and encapsulation of the 
drug inside the micelles also showed controlled drug release. The random copolymers form 
stable association in aqueous environment and their slight anionic surface charge favourable 
for acquiring good blood compatibility. The strong interaction of C2H5-POSS moiety with PTX 
in association effectively control the drug release. After drug loading, the strong hydrophobic 
interaction between PTX and the POSS moiety leads to the shrinkage in hydrodynamic 
diameter which also support the phenomenon of control drug release. The cell viability in PTX 
solubilized C2H5-POSS based MPC random copolymer was found around 87 ± 24 % and 21 ± 
5 % after 24 and 48 h of incubation respectively. The phenomenon suggests that PTX remains 
incorporated into the copolymer association till 24 h. Due to the negligible release of PTX the 
cell viability was not significantly reduced. After 48 h the PTX accumulation inside the cell 
increased which leads to cytotoxicity. In vitro PTX release results also suggested that only 
30 % (cumulative PTX release) of PTX was released in 47 h from PTX-solubilized C2H5-POSS 
based MPC random copolymer. The FITC labelled PTX loaded C2H5-POSS based MPC 
random copolymer was internalized by the cells within 2 h and induced cell death. The results 
suggested that C2H5-POSS based MPC random copolymer play a role for rapid cellular uptake. 
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Based on the findings, it can be inferred that C2H5-POSS based MPC random copolymer shows 
promising characteristics and C2H5-POSS moiety in the copolymer have significant importance 
as hydrphobic monomer for enhancement of drug solubilization and delivery.   
The above study revealed that C2H5-POSS based MPC random copolymer enhanced 
the aqueous solubility of PTX. This promising result encourages for further investigation of 
the role of C2H5-POSS based MPC random copolymer in dissolution of PTX from solid 
formulation. The solid formulation of C2H5-POSS based MPC random copolymer, PVP and 
PTX formed a single-phase homogeneous formulation. The XRD, FT-IR spectroscopy and 
DSC analysis confirmed the presence of PTX in amorphous state. The solid formulation of 
C2H5-POSS based MPC random copolymer, PVP and PTX enhanced the dissolution rate and 
dissolved amount (approximately 90% within 40 min) of PTX without any visible precipitation. 
The presence of the C2H5-POSS based MPC random copolymer prevented the immediate 
recrystallization of amorphous PTX at the water interface. The formulation of C2H5-POSS 
based MPC random copolymer , PVP and PTX would be a promising approach to enhance the 
dissolution of PTX from solid formulation. Hence, the outcome of the two sperate studies 
indicated that the C2H5-POSS based MPC random copolymer could be a good carrier for PTX 
in both liquid and solid dosage form applicable in cancer therapy.  
The RAFT polymerization technique with the focus of achieving POSS and MPC based 
well-defined architecture di-block copolymer which will form 3D supramolecular self-
assembly structures in an aqueous environment was undertaken to study the encapsulation of 
hydrophobic drug and its controlled release. The copolymer formed highly stable small-size 
(26 − 43 𝑛𝑚) micelle in an aqueous environment, suitable for encapsulation of hydrophobic 
drug inside the core. All the micelles were able to encapsulate hydrophobic drugs inside the 
core, the stability of which was dependent on the chemical structure of the drugs: poorly soluble 
drugs bearing long alkyl chains such as α-TP were suitable for the R-POSS core. Also, the 
copolymer micelles were highly internalized by the cell. Cellular uptake of PTX-loaded 
micelles was governed by the PMPC-related cellular uptake phenomena. The excellent results 
pointed out that the C2H5-POSS and C8H17-POSS based MPC di-block copolymer can be a 
potential selective hydrophobic drug carrier.  
The applications of MPC and alkylated POSS based random and di-block copolymers 
were extended to investigate their effect on the stabilization of liposome. The surface of the 
liposomes were modified with copolymers and the stability of copolymer modified liposomes 
were compared with DSPE-PEG-2000 modified liposomes. The stability of random and di-
block modified liposomes were found to increase in 1:1 D-PBS and serum mixed solutions 
after 6 days. The cellular uptake after 6 h was observed to be more in case of random and di-
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block copolymer modified liposome than that in DSPE-PEG-2000 modified liposome. The 
MPC and POSS based random and di-block copolymers could be a good amphiphilic surface 
modifier of liposome for overcoming limitations in liposomal drug delivery. 
This study has been systemically performed starting from the stage of design of element block 
POSS to the investigation of POSS – MPC – based copolymer in application as surface coating 
material and drug delivery system. The research highlights that the element block POSS and 
phospholipid MPC based copolymer have the potential for opening a new path in the area of 
biomedical and pharmaceutical engineering.         
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Abbreviation 
 
The following abbreviations are used in this dissertation 
 
AIBN 𝛼, 𝛼′- Azobisisobutyronitrile 
BCA Bicinchoninic acid 
BMA n-butyl methacrylate 
BSA Bovine serum albumin 
CTA Chain transfer agent 
C2H5-POSS MA Methacrylethyl polyhedral oligomeric silsesquioxane 
C6H13-POSS MA Methacrylhexyl polyhedral oligomeric silsesquioxane 
C8H17-POSS MA Methacryloctyl polyhedral oligomeric silsesquioxane 
DMEM Dulbecco's Modified Eagle Medium 
DP Degree of polymerization 
DSPE-PEG-2000 1, 2-distearoyl-sn-glycero-3-phosphoethanolamine-N-
[amino(polyethylene glycol)-2000] 
EDTA Ethylenediaminetetraacetic acid 
FACS Fluorescence-activated cell sorting 
FITC Fluorescein-4-isothiocyanate 
GPC Gel permeation chromatography 
HPLC High performance liquid chromatography 
Mn Number-average molecular weight 
Mw Weight-average molecular weight 
NMR Nuclear magnetic resonance 
PBS Phosphate buffered solution (saline) 
PEG Polyethylene glycol 
PEO Poly (ethylene oxide) 
THF Tetrahydrofuran 
UV Ultraviolet 
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1-1. Background of the Research: 
Biomaterials have been used since a long time and subsequently increased their 
applications in medical research due to the rapidly growing chronic diseases, traumatic 
accidents, surgical reconstructions and other health-related issues. The extensive research has 
been conducted on biomaterials and has shown an important role of it in medical science, 
especially in the field of tissue engineering and drug delivery applications. In 1960-70, the first 
generation of biomaterials was evolved with the fabrication of biomedical devices that have a 
balance between physical and mechanical properties with minimal cytotoxicity or 
carcinogenicity to living host tissues. The second-generation of biomaterials was a focus on 
the incorporation of bio-activity and resorbable behavior with the use of bioactive glass and 
ceramics material in orthopedic and dental implants. The third-generation of biomaterials was 
focused on to develop stimulating specific cell response for the living tissue. The concept of 
nanotechnology in biomaterial-based devices and drug delivery system help in achieving 
further improvement. Recently, the researchers are focusing on the incorporation of 
architectural nanoscale features in the development of biomaterials to achieve 3D 
microenvironment to mimic native extracellular matrix (ECM)[1-4]. The designing of 
biomaterials for targeted and controlled drug delivery and complex tissue regeneration is still 
a great challenge toward clinical applications. The successful treatment of cancer highly 
depends on the designing of the drug-carrier molecule that can encapsulate drugs and release 
the drug molecules in a controlled manner at the specific site.  
Historically, purified collagen, gelatine, silk, or cotton were natural biomaterials. 
Advancement in polymer chemistry brings first-generation medical polymers which are 
currently used in a wide range of biomedical applications. Selection of appropriate biomaterials 
for a specific application is a key factor of successful implementation. The application of 
biomaterials are as follows[5]: 
a) To support new tissue for growth where cell-cell communication and availability of nutrient, 
growth factors, pharmaceutically active component will be maximized. 
b) To prevent cellular activity where tissue growth is undesirable. 
c) To monitor tissue response like enhancement and inhibition of particular cellular response.  
Chapter 1                                                                                                    General Introduction 
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d) To enhance cell attachment and cellular activation such as fibroblast attachment, 
proliferation and extracellular matrix production for dermis repair. 
e) To inhibit cellular attachment and activation such as platelet attachment to a vascular 
graft. 
f) To prevent biological response such as blocking antibodies against homograft or xenograft 
in the case of organ transplantation. 
The key step of the biomedical application of biomaterials is its accurate processing 
(Figure 1-1). There are nine potential biomedical applications areas have been identified[5]: 
1) Membranes in extracorporeal applications such as oxygenators. 
2) Bioactive material for controlled release delivery systems. 
3) Disposable equipment for blood bags and disposable syringes. 
4) Sutures and adhesives material including biodegradable and nonbiodegradable. 
5) Cardiovascular devices for vascular grafts. 
6) Reconstructive and orthopedic implants material. 
7) Ophthalmic devices material for corneas and contact lenses. 
8) Dental restoration materials including dentures. 
9) Degradable plastic material for commodity products. 
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Figure 1-1. Biomedical applications of biomaterials 
 
This thesis describes the application of polymeric biomaterial in the field of control 
delivery and polymer coating aiming for cardiovascular use. The selection of appropriate 
biomaterials was based on enhancement or inhibition of cellular attachment and cellular 
activity. 
 
1-1. 1. The coating materials for cardiovascular device    
When the natural heart valves or arteries fail to function properly, replacement materials 
are used to correct the functions. The replacement materials are used to restore the flow of 
blood in the body to function properly. The development of polymeric materials as a 
replacement for heart valves and for use in making stents draw great attention[5]. 
Hemocompatibility is an essential requirement of biomaterials used in cardiovascular 
applications as the implants are directly in contact with the blood. So, the material should not 
induce any thrombosis or damage the red blood cells[5,6]. To meet the essential requirement for 
these applications coating of the surface is necessary (Figure 1-2). Natural polymers such as 
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heparin (a polysaccharide) have been used for the coating[5]. The resorbable polymers such as 
polycaprolactone, polyorthoester, and copolymers such as polyglycolic–polylactic acid, 
poly(hydroxybutyrate valerate), poly(ethylene oxide)–poly(butylene terephthalate) have been 
studied in vivo as resorbable coatings material[5,7]. Phosphorylcholine moiety showes to have 
great potential to prevent the thrombus formation on the surface. The nanocomposite polymers, 
bio-functionalized with growth-factor through surface modification, attract the endothelial 
progenitor cells from circulatory blood and enhance the bio- and haemo-compatibility of 
cardiovascular devices. The mechanical strength of the biomaterials is an essential requirement 
of the cardiovascular implant especially for heart valves, which should have properties like 
flexibility, toughness and durability[8].   
 
 
 
Figure 1-2. Essential requirement of cardiovascular coating material 
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1-1. 2. Biomaterials for drug delivery 
Polymeric delivery systems are focus to achieve temporal or spatial control of drug 
delivery. Polymeric vehicles are capable to deliver the drug over an extended period of time 
and to the site of action. Polymeric vehicles can be designed to enhance drug safety, efficacy, 
reduce side-effect and can improve patient compliance. The polymeric vehicles can decrease 
the amount of drug molecule and dosage frequency of the drug[9]. The goals of drug delivery 
(Figure 1-3) are as follows[9,10,11]: 
1. Controlled drug delivery: to control the duration of action of the drug and maintain the drug’s 
level in the human body. 
2. Targeting: to target the drug particular places or cells in the body. 
3. Overcome tissue barriers: to overcome certain tissue barriers such as the lung, skin, or 
intestine. 
4. Overcome cellular barriers: to overcome certain cellular barriers which are important in gene 
therapy. 
 
 
 
Figure 1-3. Goal of polymeric drug delivery 
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Innovations in materials chemistry have initiated the development of delivery system by 
creating new carriers that are biodegradable, biocompatible, targeting, and stimulus-responsive. 
And nanotechnology has helped in realizing the fact that the size and shape of nanoparticles 
(NPs) play an equal role to develop effective particulate for successful drug delivery (Figure 
1-4). The size of the NPs determines the biodistribution. The smaller particles (less than 20 
nm) cleared from circulation via reticuloendothelial system (RES) within a few hours of 
injection, whereas larger ones trapped in the liver and the spleen within minutes[10]. Different 
fabrication techniques such as nanoprecipitation, emulsion-based phase inversion, 
microfluidics-based self-assembly, layer-by-layer synthesis, and nanoimprinting have been 
used to generate particle nano-carrier to deliver a wide range of drugs. Liposome has been the 
most successful candidate of DDS in clinical applications. Most of the FDA approved DDS are 
liposome or lipid-based[10]. 
 
 
 
Figure 1-4. Nanoparticles for drug delivery 
 
Biodegradable polymers are considered as an alternative to lipid-based delivery for their 
improved in vivo stability. The degradability of the polymer could be tuned to control the 
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release of the drug. The polymers, poly (lactic acid) (PLA), poly(glycol acid) (PGA) and their 
copolymers, poly (lactide-co-glycolide) (PLGA) are the most widely used for DDS 
development because of their biodegradability, biocompatibility and ease of processing[10,12,13]. 
Polyanhydride is another class of biodegradable polymers for application in DDS. To overcome 
the undesirable bulk-degrading behavior of polyesters, polyanhydrides are designed to undergo 
surface-degradation. As the different drugs used for various therapies demand the carriers of 
various properties to achieve optimal delivery[10].  
Block copolymers draw great attention of researchers because of their remarkable 
chemical flexibility. The building blocks can be designed in such a way that they could 
assemble to nanostructures in the form of micelles, electrostatic complexes, or polymersomes. 
The stable nanoparticle can be used for passive tumor targeting utilizing the enhanced 
permeability and recognition (EPR) effect[14]. The A-B block type copolymer comprised of 
PEG and poly(aspartic acid) modified by 4-phenyl-1-butanol to enhance the hydrophobicity is 
under phase II clinical investigation with the aim of delivery of paclitaxel (NK105) and 
doxorubicin (NK911)[15]. The amphiphilic block copolymer of PEG-polycation is also of great 
interest due to their ability to condense nucleic acids into their nanosized polyplex with 
protective and biocompatible PEG shell[10].  
The major drawback of polymeric micelles is the stability of micelle in blood stream after 
administration which leads to rapid dissociation and burst release of the drug. Some approaches 
have been taken to address this issue[10]:  
a) Attachment of pendent group to the backbone such as fatty acid, benzyl groups, cholesterol 
to increase the hydrophobicity of the core[16,17,18]. 
b) Introducing hydrogen-bond interaction in the core. For example, amphiphilic PEO-PCL 
based polymer containing urea functional group in the side chain shows improved kinetic 
stability of micelles in the presence of a destabilizing agent[19]. 
 c) Introduction of oppositely charged groups in the micelle core to promote electrostatic 
interactions. For example, PEO with poly (L-lysine) or poly(aspartic acid)[15]. 
d) Crosslinking of the micelle core by thermal or photo-induced polymerization. For example, 
PEO-PLA block copolymers having polymerizable methacryloyl pendant groups at the PLA 
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block can be crosslinked thermally or photochemically during micelle formation. It provides 
stability at high temperature and in an organic solvent[20,21].  
The shell and core of polymeric micelles could also be modified depending on the 
applications. The hydrophilic shell of the micelles can be functionalized with various ligands 
such as antibodies, small organic molecules, carbohydrates, peptides or polymers to target 
binding to cancer cells[10]. The polymeric micelles with cationic surface allow the co-delivery 
such as nucleic acids and small organic drugs. The cationic amphiphilic block copolymers of 
poly(N-methyldietheneamine sebacate) (PMDS) and cholesterol have been studied for 
targeting and drug loading[22]. The cationic block PMDS act as siRNA and plasmid binding 
and the cholesterol pendant group increases the hydrophobicity of the core for efficient drug 
loading[10]. A triblock copolymer of poly (ethylene glycol)-β-poly (ε-caprolactone)-β-poly(2- 
aminoethyl ethylene phosphate) (mPEG-β-PCL-β-PPEEA) have been studied for co-delivery 
of pro-like kinase 1 gene (Plk1) siRNA and paclitaxel[23]. Many co-delivery systems have been 
investigated so far by various groups and the system showed a promising alternative to the 
liposomal co-delivery system for hydrophilic macromolecule and small lipophilic drugs[10].  
The literature review indicated the challenges in the research area of the surface coating 
of implant and drug delivery system. Also, indicated the huge scope to encounter the challenges 
in these research areas. The designing of the biomaterials is key to encounter the challenges. 
In this thesis, I focused on the development of new polymeric material to be applied for the 
surface coating of the implant and for hydrophobic drug delivery.    
 
1-1.3. Concept of “element block” and “element block”-copolymer 
Recently, a new concept of polymer hybrids has been suggested by Chujo et. al. The 
concept is the incorporation of the inorganic component with domain size at the nano or 
molecular scale into the polymer matrix to produce organic-inorganic polymer hybrids. The 
inorganic structural unit consisting of various groups of elements is termed as “element block” 
and the organic-inorganic polymer hybrids is termed as “element block”-copolymer[24]. The 
concept involves the design and synthesis of the new element blocks and polymerization of 
those blocks to create new polymeric materials with improved and desired functional properties 
(Figure 1-5). This bottom-up approach is expected to encourage the creation of new polymeric 
material which cannot be achieved with conventional designing and synthesis process of 
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organic polymeric material. The new element block with a variety of elements can be 
synthesized by different approaches such as an organic, inorganic and organometallic reaction 
and these element blocks can be polymerized by different polymerization techniques. This 
strategy was applied in the current study to develop the new element block based MPC 
copolymer for the biomedical applications[24].  
 
 
 
Figure 1-5. Concept of "element block" copolymer 
 
1-2. Scope of the Research 
The purpose of this study is the investigation of the properties of amphiphilic 
phospholipid copolymer with “element block”-based hydrophobic domain as surface coating 
materials and drug carrier molecules in an aqueous environment. Amphiphilic copolymers can 
be synthesized by copolymerization of hydrophilic and hydrophobic monomers, which form 
aggregates or nanoparticle in an aqueous environment. This amphiphilic copolymer system has 
a great interest in various biomedical applications (drug delivery). Conventional polymer 
aggregate was fabricated with conventional ready-made material. This study was based on the 
design of hydrophobic “element block” monomer for amphiphilic phospholipid-based 
copolymers and systemic research for its different application. The design of the molecules 
was fundamentally different from the conventional polymeric biomaterial and in this study “2-
methacryloyloxyethyl phosphorylcholine (MPC)” was selected as phospholipid-based 
hydrophilic polymer as one of the monomers of the amphiphilic copolymer. The zwitterionic 
water-soluble polymer, 2-methacryloyloxyethyl phosphorylcholine (MPC) polymer (poly 
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MPC) has been used extensively in blood-contacting medical devices for a high level of 
biocompatibility and resistance to protein adsorption. Also, MPC monomer can copolymerize 
with hydrophobic monomers, and the obtained amphiphilic copolymers have been considered 
for solubilization and delivery of hydrophobic drugs. For example, MPC100– DPA100 micelle 
system, poly[MPC-co-n-butyl methacrylate (BMA)] (PMB30W)/ PLA micelle system, 
pMPCm-BMAn micelle system[25], cholesterol-end-capped poly(2-methacryloyloxyethyl 
phosphorylcholine) (CMPC) micelle system[26], poly(2-
methacryloyloxyethylphosphorylcholine)-b-poly(butylene succinate)-b-poly(2 
methacryloyloxyethyl phosphorylcholine) (PMPC-b-PBS-b-PMPC) micelle system etc. have 
been studied with the focus on drug delivery system. The research reported yet was a focus on 
the fabrication of MPC based amphiphilic copolymer using conventional or ready-made 
hydrophobic monomer (BMA, Cholesterol). In this study, the MPC based amphiphilic 
copolymer was designed and synthesized by element block concept which comprises a 
synthesis of new element blocks (Polyhedral oligomeric silsesquioxane (POSS)) and 
polymerization of those blocks with MPC (radical polymerization and reversible addition-
fragmentation chain transfer (RAFT) polymerization). This amphiphilic MPC-POSS based 
copolymer having element block POSS as a hydrophobic unit is the first report. The scientific 
and biological evaluation revealed the interesting feature of copolymers. The results indicated 
the thermal and mechanical improvement of the copolymer after incorporation of element 
block POSS. The hydrophobicity of the surface increase and copolymer formed aggregate and 
micelle in an aqueous environment. The hydrophobic domain of aggregate can be applied in 
various field of pharmaceutical science. For example, in the field of drug delivery, it can act as 
a good solubilizer of a poorly water-soluble hydrophobic drug such as Paclitaxel. Stable 
polymeric micelle can encapsulate the hydrophobic drug in the hydrophobic domain and 
deliver to the targeted site. The interface of the biomaterial is important for surface coating and 
micelle nanoparticles as they are in close contact with the circulatory system. In this study 
MPC-POSS, the based copolymer was investigated which contain bioinert phosphorylcholine 
group which helps in preventing nonspecific adsorption. Additionally hydrophobic POSS 
moiety on the water-polymer interface (in the surface coating) help in protein adsorption and 
cell attachment which help in providing bio and hemocompatibility by attracting the 
endothelial progenitor cells from circulatory blood. This thesis describes several novel 
application of the synthesized MPC-POSS based amphiphilic copolymers in the field of 
bioscience.   
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1-2.1. Self-assembling of polymeric biomaterials 
Self-assembling of polymer indicates self-assembly of the mono unit by noncovalent 
interactions has become a topic of increasing interest in recent years. In living organisms, the 
association of various biomolecules such as DNA, polysaccharides and proteins controlled by 
non-covalent interactions such as ionic bonding, hydrogen bonding and hydrophobic 
interaction. Amphiphilic polymers composed of at least one solvophobic moiety and at least 
one solvophilic moiety (hydrophilic and hydrophobic, respectively, if the solvent is water) self-
assemble in selective solvents[27]. The crucial driving force associated with self-assembling is 
based on multiple intermolecular interactions such as hydrogen bonding, p–p stacking, metal-
ligand coordination, hydrophobic interactions and host-guest interactions[28]. The reversible 
and tunable nature of these noncovalent interactions provides important properties of 
reversibility and stimuli-responsiveness. These tuneable natures allow to large physical or 
chemical changes in the response of weak stimulating signal in the environment such as pH, 
temperature, light, redox agents, enzymes, ions, gases, mechanical force, electric and magnetic 
fields. This material as a wide application in the different biomedical field. Self-assembling 
nature of amphiphilic polymer can construct different interesting one-, two- and three-
dimensional morphologies, such as spherical micelles, cylinders, rods and vesicles (Figure 1-
6). These have a wide range application in the fields of bioimaging, drug delivery, sensing and 
electronics[27,29]. 
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Figure 1-6. Self-assembled polymeric biomaterial for different application 
 
The core-corona structure is the distinct feature of polymeric self-assembled particles. 
Both, the core and corona are able to accommodate active substances of appropriate nature and 
to serve as carriers. The core is composed of strongly entangled solvophobic chains, whereas 
the corona is built up of solvophilic chains, which can be nonionic or charged. The careful 
designing the copolymer composition is important to intelligently control the properties and 
the stability of the whole aggregate. 
In this study, we design and synthesize the MPC (hydrophilic) and POSS (hydrophobic) 
based copolymer which formed a self-assembled structure in an aqueous environment. In this 
study, POSS was selected as hydrophobic moiety with the focus of achieving well balance 
stable core-corona structure based polymeric assembly. 
 
1-2.2. Polymeric Micelle and application in drug delivery 
Polymeric micelles are self-assembled core-shell nanostructures of amphiphilic block 
copolymers formed in an aqueous environment. Formation of micelles in aqueous solution 
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happens when the concentration of the block copolymer increases and reached to a certain 
concentration named the critical aggregation concentration (CAC) or critical micelle 
concentration (CMC) (Figure 1-7). At the CAC or CMC, hydrophobic segments start to 
associate to minimize the contact with water molecules which leads to the formation of a 
vesicular or core-shell micellar structure[27,29]. The micelles formation is driven by the decrease 
of free energy. The micelles formation is associated with the removal of hydrophobic fragments 
from the aqueous environment and the re-establishment of the hydrogen bond network in water 
which decreases the free energy of the system. The unique core-shell structure of micelles has 
great potential to deliver the hydrophobic drug. The inner hydrophobic core formed by a 
hydrophobic block of copolymer enables incorporation of poorly water-soluble drugs by 
hydrophobic interaction and improve their stability and bioavailability. Besides, it can also 
form polyion complex (PIC) micelles, hydrogen bonding and metal-ligand coordination 
complex micelles. The outer hydrophilic shell of polymeric micelles plays an important role in 
the in vivo behavior, steric stabilization and ability to interact with the cells.  
 
 
 
Figure 1-7. Polymeric micelles formation and drug encapsulation 
 
The block copolymers can be of two type diblock copolymers or triblock copolymers. A-
B type is the diblock copolymer, commonly used for designing polymeric micelles in which A 
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represents a hydrophilic block and B represents a hydrophobic block. The triblock copolymers 
consist of two types of polymers (A-B-A) or three types of polymers (A-B-C). Most drug 
carrier applications have been studied with A-B or A-B-A type block copolymers[30]. The 
physicochemical characteristics of the building blocks have an influence on the physical and 
biological properties of the polymeric micelles. The choice of hydrophobic core forming 
polymers has a major importance to determine the stability, drug loading capacity, and drug 
release profiles of polymeric micelles. Poly(propylene oxide) (PPO), poly(lactic acid) (PLA), 
hydrophobic poly(amino acids), copolymers of lactic acid and glycolic acids, and 
poly(caprolactone) (PCL) are commonly used core-forming blocks of polymeric micelles. 
These core-forming hydrophilic block will strongly affect the stealth properties and influence 
the circulation kinetics of the micellar assembly. Poly(ethylene glycol) (PEG) is most 
commonly used as the hydrophilic segment of the block copolymers due to its non-toxic nature. 
The poly(N-vinyl-2-pyrrolidone) (PVP) and poly(acrylic acid) (PAA) are also used as an 
alternative of PEG[30]. 
Polymeric micelles can be safely used for parenteral drug administration than 
conventional solubilizing agents such as polyethoxylated Castor oil (Cremophor EL) or 
polysorbate 80. They are kinetically stable, dissociate very slowly and prolonging the 
circulation times in blood. The hydrophobic cores can solubilize hydrophobic drugs. Polymeric 
micelles containing Polyethylene glycol (PEG) provide the “Stealth” effect and help in 
reducing uptake by the macrophages of the reticuloendothelial (RES) system and extend in 
vivo circulation times. In spite of these advantages, micellar delivery has some short-comings 
like the dissociation of the micelle structure after dilution in blood circulation[9,30]. This 
dissociation accelerated when unimeric component bind with the protein. This phenomenon 
can be overcome by stabilizing the micelle core by proper selection and size of the hydrophobic 
block and optimum hydrophobic/hydrophilic ratio.  
In this study, we selected the MPC as a hydrophilic block which is bioinert in nature and 
reduce protein adsorption and cell attachment to overcome the problem associated with the 
stability of the micelles. We selected POSS (modified with different alkyl chain length) as a 
hydrophobic block for the stability of the core, drug loading and controlled release. The 
purpose of this thesis is to design the amphiphilic copolymer and evaluation of their properties 
for the application in the pharmaceutical field. 
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1-2.3. Phospholipid 2-methacryloyloxyethyl phosphorylcholine (MPC) 
Phospholipids draw great attention in the application of biological science as it is one of 
the major components of the lipid bilayer in the cellular membrane (Figure 1-8). Due to the 
biocompatibility of the phosphorylcholine group, the design of synthetic polymers includes 
this moiety to achieve biocompatibility for biomedical applications. One of the representatives 
is 2-(methacryloyloxy)ethyl phosphorylcholine (MPC) polymers which have been developed 
by Ishihara et al. The phosphorylcholine group of 2-(methacryloyloxy)ethyl phosphorylcholine 
(MPC) is one of the components of cell membranes. Phosphorylcholine (PC) group is 
zwitterionic nature which is responsible for its bioinert characteristic. The poly MPC is highly 
water soluble. The hydrophobic main chain of poly MPC does not come in contact with water 
molecules and the phosphorylcholine group has a unique hydration state. The functions and the 
physiochemical properties of MPC for modulating the surface and/or interface properties can 
be controlled by copolymerization with other monomers. Copolymers of MPC and other 
hydrophobic monomers have been widely applied for biomedical applications such as surface 
coating for blood-compatible materials, oxygen sensing membrane and polymeric micelles for 
controlled release of anticancer drugs. K. Ishihara et al. reported that poly[MPC-co-n-butyl 
methacrylate(BMA) (PMB30W)] with 70 mol % of the BMA unit is the most effective polymer 
to dissolve the Paclitaxel. Addition to this, cellular uptake was found to be superior in the case 
of poly MPC-based polymeric micelle than poly(ethylene oxide) (PEO)- and poly(N-(2-
hydroxypropyl)methacrylamide) (PHPMA)-based polymeric micelle which indicates that poly 
MPC shall be advantageous to interact with cell membranes. The hydrophobic part is essential 
to interact with hydrophobic drug paclitaxel and mainly the investigation was conducted with 
hydrophobic BMA moiety. The other hydrophobic monomers have not been investigated yet 
to synthesize MPC based amphiphilic molecules.    
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Figure 1-8. Zwitterionic MPC: component of cell membrane  
 
1-2.4.  Polyhedral oligomeric silsesquioxane (POSS): “element block” 
Polyhedral oligosilsesquioxane (POSS) is an element block whose chemical structure 
follows the basic composition of RnSinO1.5n
[31,32]. In the above-mentioned formula R represent 
the vortex group of POSS cage structure and it can be hydrogen, any alkyl, alkylene, aryl, 
arylene, or organofunctional derivative of alkyl, alkylene, aryl, arylene. With proper designing 
of the R group, the material properties can be controlled relatively as per requirement (Figure 
1-9). The POSS nano-cage structure is 1-3 nm in diameter. The vortex group can the design to 
polymerized with other biocompatible polymers. Incorporation of POSS moiety into polymeric 
material can lead to improving the mechanical property, surface property, thermal property, 
etc. of the polymer. The POSS silica cube is strongly hydrophobic in nature. As a result, it 
strongly interacts with the polymer and increases the local density of POSS core in the 
polymeric matrix. As reported that the introduction of POSS unit in hydrophilic polymer 
enhances the amphiphilicity of the material and increase the encapsulation of guest molecules. 
For example, the introduction of the POSS moiety to the ends of the hydrophilic chain such as 
PEO and poly (ethylene glycol) (PEG), results in the formation of self-assembled micelle and 
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vesicle in solutions and leading to solvent-sensitive self-association behavior.  Kim et al. 
successfully encapsulated insulin inside PEG-POSS nanoparticles for drug delivery and their 
results suggested that the insulin was well protected inside PEG-POSS nanoparticles at gastric 
pH for 2 h. and start releasing at intestine pH 6-7. Yuan et al. synthesized poly(L-glutamic 
acid) dendrimers bearing POSS, conjugated with doxorubicin via pH-sensitive hydrazine bond 
and biotin as a targeting ligand. The hydrophobic nature POSS moiety suitable for application 
as drug carriers as well as artificial molecular chaperones and polymeric capsule for 
photodynamic therapy have been reported.  
 
 
 
Figure 1-9.  Structure of "Element Block": POSS 
 
In this study, element block POSS was selected as hydrophobic moiety to polymerized 
with hydrophilic MPC polymer for the synthesis of the amphiphilic copolymer. The element 
block concept was applied for design and synthesis of element block POSS by modifying its 
R-group with different alkyl chain to fulfill the aim of inducing more hydrophobicity. This 
bottom-up approach (synthesis and design on the basis of functional need) will be a powerful 
tool to develop the advanced biomaterial according to the application. 
 
1-2.5.  Radical polymerization 
Free radical polymerization (FRP) is a common way to synthesize macromolecular 
materials through a radical chain process. The high molecular weight polymer can be achieved 
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even under mild polymerization conditions with the monomer and a radical initiator. These 
features make FRP a very versatile process to obtain several polymer and copolymer 
compounds with peculiar properties. The major problem of FRP is that regulation of the chain 
length distribution and morphology of the resulting polymer not possible. The chain length 
distribution of the final product is associated with radical termination mechanisms which have 
great importance in determining the molecular weight distribution (MWD). The polymer 
microstructure and morphology depend on the network of reaction steps involve a large number 
of different species, including very reactive radicals.  
Most free-radical polymerizations have three basic reaction steps:  
- Initiation         𝐈 → 𝟐?֗? 
-                        ?֗? + 𝐌𝟏 →  𝐌𝟏 ֗ 
- Propagation   𝐌𝒏 +  𝐌𝟏 ֗ →  𝐌𝐧+𝟏 ֗ 
- Termination  𝐌𝒏 ֗ +  𝐌𝒎 ֗ →  𝐌𝐧+𝐦 
                      𝐌𝒏 ֗ +  𝐌𝒎 ֗ →  𝐌𝐧  +  𝐌𝐦 
In random copolymers, different monomeric components of the polymer are randomly 
arranged and the probability of getting a monomer unit at any location on the polymer is 
independent of the nature of the adjacent units (Figure 1-10). The self-assembly behavior of 
random copolymers is largely dependent on their hydrophilic-hydrophobic balance. 
Morphologies of the self-assembled structure greatly vary with the ratio of hydrophilic side 
chains to hydrophobic groups. For example, amphiphilic random copolymers were synthesized 
by hydrophobic dodecyl (C12) chain and hydrophilic L-glutamic acid in which the ratio of co-
monomers can be easily tuned. Vesicles formed when water was added into an ethanol solution 
of these polymers. The reason for the vesicle’s formation is hydrogen bond in the side chains 
and the hydrophobic interactions between the long alkyl chains. The size of vesicles was found 
to be dependent on the hydrophobic alkyl chain. The polymersomes can be achieved from self-
assembly of the amphiphilic random copolymer containing hydrophobic methacrylate and 
hydrophilic methacrylamide repeat units. The amphiphilic random copolymers were 
synthesized by esterification of hydrophilic poly(hydroxyethyl methacrylate) (PHEMA) and 
hydrophobic 2-diazo-1,2-naphthquinone (DNQ) molecules. The spherical assemblies form in 
water were not stable state above water content 35 wt%. It was observed that the relatively high 
molecular weight of poly(DNQMA-co-HEMA) and the suitable hydrophilicity of the polymer 
Chapter 1                                                                                                    General Introduction 
 
27 
 
backbone play an important role in the morphological transition[33]. The amphiphilic random 
copolymers, synthesized with hydrophilic triethylene glycol and hydrophobic alkyl chain 
connected with disulfide bond by free radical polymerization. This copolymer form micelle-
like nano-assemblies in water and able to encapsulate hydrophobic guests inside their core. The 
nano-assemblies can release the encapsulated guest molecules in reducing environment.  
 
 
 
Figure 1-10.  Random copolymerization technique and random copolymer 
 
1-2.6.  Reversible/Addition-Fragmentation Chain Transfer (RAFT) polymerization 
In the free-radical polymerization process, the propagating species is a long-chain free 
radical initiated by the attack of free radicals derived from initiators. The living radical 
polymerization is also a free-radical polymerization containing living characteristic such as the 
process does not terminate or transfer and can be continued by adding more monomers if the 
initial one exhausted (Figure 1-11). The control over molecular weight, molecular weight 
distribution and site-specific functionality can be possible that was impossible to achieve via 
free-radical polymerization. The major LRP techniques include nitroxide-mediated 
polymerization, RAFT polymerization and atom-transfer radical polymerization (ATRP). 
RAFT polymerization is the most versatile process because of its occurrence in a wide 
variety of reaction conditions, functionalities and can be performed in conventional free-radical 
polymerization set-ups. The progress of the RAFT held via degenerative transfer process and 
chain-transfer (RAFT) agents play a major role. The chain-transfer agents are organic 
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compounds containing a thiocarbonylthio moiety. The R group involves in initiating the growth 
of polymeric chains, and the Z group activates the thiocarbonyl bond towards the radical 
addition and stabilization of resultant adduct radical[34]. 
 
 
 
The RAFT polymers have high interest for its biomedical applications such as drug 
delivery via polymeric micelles. PEG and poly(N,N,N-trimethylammonium ethyl 
methacrylate) block copolymers were synthesized via RAFT polymerization method and self-
assembly micelles formation was studied. It was observed that the micelles have the ability to 
encapsulate fatty acid salts. The poly- (2-methacryloyloxyethylphosphorylcholine)-b-
poly(butyl methacrylate) amphiphilic block copolymer was investigated as a micellar carrier 
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of paclitaxel.  its ability to form a micellar carrier for paclitaxel. The cationic polymers were 
investigated as genes and oligonucleotides delivery carrier due to their electrostatic interaction 
with negatively charged groups. Poly(dimethyl amino ethyl) methacrylate synthesized via 
RAFT polymerization was employed as gene delivery carrier. RAFT copolymer of 
poly(acryloyl glucosamine) and NIPAAm results in thermo-responsive micelles which can be 
disintegrated into unimers below the LCST. RAFT polymerization of poly(ethylene 
glycol)acrylate and butylacrylate results in pyridyl disulfide-terminated block copolymer 
which can quantitatively react with thiol-containing compounds such as bovine serum albumin 
(BSA).  
 
 
 
Figure 1-11.  RAFT polymerization technique and di-block copolymer 
 
In this study free radical and RAFT both polymerization technique was performed to 
synthesize the element block POSS-based MPC copolymer for their biomedical application. 
This thesis is composed of eight chapters. 
Chapter 1 is the general introduction describing the background and scope of the current 
research. The concept of the current research and implementation strategies are also elaborately 
described in this chapter.  
Chapter 2 describes the design, synthesis and characterization of the POSS and MPC based 
copolymers. This chapter describe the fundamental characteristics of the designed copolymer 
to extend its application in different field.  
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Chapter 3 describes the new approach of enhancing and tuning of the thermal, mechanical and 
interface wettability of the MPC polymer by POSS moiety to extend it application as surface 
coating material. 
Chapter 4 describes the self-assembled nature of the MPC and R-POSS based random 
copolymer and extend its application in hydrophobic drug solubilization and sustained release. 
This chapter discuss the role of the hydrophobic monomer in hydrophobic drug solubilization 
and release.   
Chapter 5 describe the application of the synthesized MPC and R-POSS based random 
copolymer in formulation of solid doses form for quick dissolution of poorly soluble drug. This 
chapter discuss the role of the copolymer as a solubilizing molecular carrier of hydrophobic 
drug. 
Chapter 6 describes the study about the novel amphiphilic di-block copolymer composed of 
R-POSS and MPC. The copolymer form stable tightly packet micelles in aqueous environment 
and encapsulate the hydrophobic drug inside the core of the micelles. The micelles are highly 
potential for intercellular drug delivery. In this chapter author describes the application and 
novelty of the synthesized copolymer in drug delivery system. 
Chapter 7 describes the important advantages of the random and di-block copolymers for their 
application as a simple modifier of liposome for drug delivery.   
Chapter 8 describes the overall conclusion of the current thesis. 
In this thesis, the author has systemically and strategically design and synthesize the 
polymeric biomaterial focusing its application as surface coating and drug delivery to 
contribute for advancement of the biomedical research.  
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2-1. Introduction 
Phospholipids major components of the lipid bilayer in the cellular membrane, draw 
great attention in biomedical applications. The great biocompatibility of the phosphorylcholine 
group expands its application to the design of synthetic biopolymers.  One of the 
representatives is 2-(methacryloyloxy)ethyl phosphorylcholine (MPC) polymers that have 
been developed by Ishihara et al.[1,2] The zwitterionic nature of this phosphorylcholine (PC) 
group in MPC is responsible for its bioinert nature[3]. The functions and physicochemical 
properties can be controlled by copolymerization of MPC with the other monomers, for 
modulating surface and/or interface properties. The copolymers of MPC polymers with other 
hydrophobic monomers have been widely applied for biomedical applications including 
surface coating for blood compatible materials[4, 5],  a film exhibited the elastic properties with 
high tensile strength[6], oxygen sensing membrane[7], and polymeric micelles for controlled 
release of anticancer drugs[8]. The amphiphilic copolymers of MPC and other hydrophobic 
monomers can be achieved, which can solubilize and deliver paclitaxel (PTX)[9, 10, 11, 12, 13].  
According to the report of K. Ishihara et al., poly[MPC-co-n-butyl methacrylate(BMA) 
(PMB30W)] with 70 mol % of the BMA unit most effectively dissolve the PTX10.  The cellular 
uptake reports revealed that poly MPC-based polymeric micelle showed superior uptake than 
poly(ethylene oxide) (PEO)- and poly(N-(2-hydroxypropyl)methacrylamide) (PHPMA)-based 
polymeric micelle, indicating the advantage of poly MPC to interact with cell membranes14.  
However, the hydrophobic part, which is essential to interact with the hydrophobic molecule, 
has been mainly constructed by BMA, and the other candidates of the hydrophobic monomers 
have not been investigated yet.    
Polyhedral oligomeric silsesquioxane (POSS), the chemical structure follows the basic 
composition of RnSinO1.5n is a well-defined organic/inorganic hybrid material. The small silica-
like cage in POSS shows excellent compatibility with most of the organic polymers via 
blending, graft copolymerization and polymerization [9,15]. It was reported that incorporation of 
POSS moiety provides an enhancement in mechanical, thermal and anti-biodegradable 
property and biocompatibility. Due to the hydrophobic nature of POSS cage, amphiphilic 
copolymers can be synthesized by introducing the POSS moiety to the ends of hydrophilic 
chain. For example poly (ethylene oxide) (PEO) and poly (ethylene glycol) (PEG) [10,11] 
resulted in solvent-sensitive self-assembled micelle and vesicle in aqueous solutions[15].  
Another approach of synthesizing POSS-based amphiphilic copolymers are polymerization 
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with other hydrophilic monomers.  Since the reactivity for POSS monomers is high, various 
kinds of copolymers prepared with methyl methacrylate[12,13], n-butyl acrylate[16] and 
styrene[17,18]. The random POSS copolymers do not induce aggregation and crystallization 
because the POSS moiety can dispersed through the whole polymer matrix. The random POSS 
copolymers are able to decreased rubbery plateau modulus of the polymer with increasing the 
entanglement density[18], which is dependent on the vertex (R) groups of the POSS moiety, for 
example, isobutyl, cyclohexyl, and cyclopentyl groups[19].  Recently, the concept of a new 
concept of “element block” suggested the design and synthesis of new element blocks and 
polymerization of those blocks to create new polymeric materials with improved material 
properties. By considering POSS as an element block, organic-inorganic hybrid at the 
molecular level can be prepared and applied to improve the property of biomaterials. 
The objective of this study is to develop amphiphilic copolymer of element block POSS 
(hydrophobic) and MPC (hydrophilic) polymer. The new approach of designing and synthesis 
will help in enhancing and tuning the properties of MPC-based copolymer. This new material 
with improved thermal and mechanical properties can be applied in the coating of biomaterial 
surface and self-assembling nature of the copolymers in an aqueous environment can 
encapsulate and deliver the hydrophobic drug. In this work, the amphiphilic copolymer was 
synthesized by chemically modifying POSS cage (vertex R-groups modified with ethyl (C2H5), 
hexyl (C6H13), octyl (C8H17)) and polymerization of POSS cage with MPC polymer unit via 
free radical and RAFT polymerization to create POSS-based MPC amphiphilic copolymer. The 
self-assemble behaviour of random copolymers is dependent on hydrophilic-hydrophobic 
balance. Morphologies of the self-assembled structure greatly vary with the ratio of hydrophilic 
side chains to hydrophobic groups. On the other hand, RAFT polymerization allows the design 
and synthesis of copolymers with a well-defined architecture and controlled molecular weight 
(MW) with relatively low polydispersity which forms 3D supramolecular self-assembled 
structures in an aqueous environment when the adequate hydrophilic/ hydrophobic balance is 
reached [20]. The effect of chemical modification (vertex R-groups modified with ethyl (C2H5), 
hexyl (C6H13), octyl (C8H17)) of POSS cage (consider to be effective for hydrophobicity of 
POSS cage) was investigated based on size, surface charge, hydrophobic drug encapsulation, 
drug releasing behaviour. 
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2-2. Experimental Section 
2-2.1. Material 
2-(Methacryloyloxy) ethyl phosphorylcholine (MPC) was kindly supplied by Prof. 
Kazuhiko Ishihara (University of Tokyo, Japan). Poly MPC was prepared by free radical 
polymerization[31]. AIBN was purified by recrystallization from methanol before use. 
Ethyltrimethoxysilane, hexyltrimethoxysilane, and trimethoxyoctylsilane were purchased from 
Tokyo Chemical Industry Co. Inc, (Tokyo Japan.).  3-Methacryloxypropyl trichlorosilane and 
cyanopentanoic acid dithiobenzoate (CPD) were purchased from Sigma-Aldrich (Tokyo, 
Japan).  Those chemicals were used as received without any further purification. Water used 
in all experiment was purified with a Millipore Milli-Q system. Other reagents were used as 
received.  
 
2-2.2. Synthesis of methacrylate POSS and MPC random copolymers by free radical 
polymerization technique 
 
2-2.2.1. Synthesis of silsesquioxane partial cages (1a-c)  
The silsesquioxane partial cages were synthesized according to the previous report[21].   For 
example, in the case of ethyltrimethoxysilane-based silsesquioxane partial cage (Scheme 2-1 
(i); 1a), ethyltrimethoxysilane (0.69 g, 4.6 mmol), THF (5 mL), deionized water (0.106 g, 5.9 
mmol) and sodium hydroxide (0.08 g, 2 mmol) were dissolved and refluxed for 5 h.  After that, 
the reaction mixture was cooled down to room temperature with vigorous stirring for another 
15 h. White solid was recovered by removing the solvent by evaporator (recovery of 59 %). 
Hexyltrimethoxysilane and trimethoxyoctylsilane-based silsesquioxane partial cages (1b and 
1c) were synthesized following the same procedure. 
 
2-2.2.2. Synthesis of polyhedral oligomeric silsesquioxanes (POSS)-based methacrylate 
(MA) (2a-c) 
POSS-MA was synthesized by the following procedure as described below (Scheme 2-1 (ii); 
2a). In brief, 1a (0.24 g, 0.36 mmol) and triethylamine (0.055 ml, 0.4 mmol) were dissolved in 
THF (8 mL) and the system was cool down to 0 ⁰𝐶.  The 3-methacryloxypropyl trichlorosilane 
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(0.105 g, 0.4 mmol) was added to 0.8 ml of THF, and this solution was slowly drop by drop 
added to the mixture. The resulting solution was stirred at 0 ⁰𝐶 for 4 h and then continued 
overnight at room temperature. After removal of insoluble salt by filtration, the solvent THF 
was removed using rotary evaporator. The obtained white solid was then washed with methanol 
for three times and dried in vacuo. Hexyltrimethoxysilane- and trimethoxyoctylsilane-POSS-
based MA (2b and 2c) were synthesized following the same procedure. 
 
2-2.2.3. Synthesis of POSS methacrylate (MA) - MPC random copolymers (R-POSS-MA-
ran-MPC) (3a-c) 
POSS-MA-based MPC copolymers were synthesized considering 1 mol % of 2 (feeding ratio) 
in the copolymer by conventional free radical polymerization technique using AIBN as an 
initiator. In brief, MPC monomer (1.46 g, 4.95 mmol) and 2a (0.037 g, 0.05 mmol) were 
dissolved in dry ethanol (5 mL). After degassing the mixture by N2 bubbling for 15 min, the 
flask was then transferred to the polymerization chamber with the temperature set at 60 ⁰𝐶, and 
sthe tirring process was continued for overnight. The reaction mixture was poured into an 
excess amount of diethyl ether, and the obtained precipitate was dried in vacuo to recover 3a 
(Scheme 2-1 (iii)). The 3b and 3c were synthesized following the same procedure. 
Yield: 3a (~92%), 3b (~97%), and 3c (~95%) 
1H NMR (400 MHz) spectra obtained from CD3OH of 3a-c and poly MPC:  revealed signal δ: 
0.94 [s, -C-CH3], 1.91 [s, -CH2-], 3.28 [s, -N(CH3)3], 4.05-4.3 [m, -OCH2], 3.74 [s, -CH2N], 
0.59 [s, -Si-CH2-]
 (Figure 2-1; (i)).   FT-IR (cm-1): 1725 (C=O Ester), 1249, 1166 and 1089 (-
POCH2-), 966 (-N
+(CH3)3) and 1120 (-Si-O-)
 (Figure 2-1; (ii)). 
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Scheme 2-1. Preparation of R-POSS-MA-ran-MPC copolymers (i) Preparation of 
silsesquioxane partial cages (R-POSS PC; 1a-c). (ii) Preparation of POSS-based methacrylates 
(R-POSS-MA; 2a-c) (iii) Preparation of POSS methacrylate-based MPC copolymers (R-
POSS-MA-ran-MPC; 3a-c) 
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2-2.3. Synthesis of POSS and MPC copolymer by RAFT polymerization technique 
 
2-2.3.1. Preparation of poly(2-(methacryloyloxy)ethyl phosphorylcholine)-based chain 
transfer agent (PMPC61)  
 
MPC (0.01 mol, 2.95 g) monomer was dissolved in dried 10 ml Ethanol. Cyanopentanoic 
acid dithiobenzoate (CPD) (0.0002 mol, 0.0559 g), AIBN (0.00005 mol, 0.0082 g) were added 
to the solution. The mixed solution was deoxygenated by purging N2 gas was for 30 min. It 
was then transferred to the polymerization chamber with the temperature set at 60 ⁰𝐶  and 
continuous stirring process for 24 h (Scheme 2-2 (i)). After cooling, the solution was dialyzed 
against pure water for 3 days. Poly MPC macro-CTA was recovered by freeze-drying. The 
number-average molecular weight (𝑀𝑤(NMR) = 18,275) and degree of polymerization (DP 
= 61) of poly MPC macro-CTA was determined from 1H NMR peak areas observed at 7.3-7.9 
ppm (phenyl, 5H) and 3.7 ppm (N-CH2,2H). 
 
2-2.3.2. Preparation of MPC-block-R-POSS-MA block copolymer (3a'-c') 
Poly MPC macro-CTA (PMPC61) (182.8 mg, Mw = 18,275 (NMR)), C2H5-POSS MA 
(224 mg, 0.3 m mol), C6H13-POSS MA (316 mg, 0.3 m mol) and C8H17-POSS MA (401 mg, 
0.3 m mol) [2a, 2b, 2c respectively from Scheme 2-1 (ii)] and AIBN (0.33 mg, 0.002 m mol) 
were dissolved in 3 ml of ethanol and THF 1:1 mixture. The solution was outgassed and filled 
with N2 by five freeze-pump-thaw cycles. The polymerization was carried out at 60 ⁰𝐶 for 24 
h (Scheme 2-2 (ii)). The reaction mixture was poured into an excess amount of diethyl ether to 
precipitate the polymer. The polymer was purified by reprecipitating it from methanol into a 
large amount of diethyl ether two times.  
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Scheme 2-2. Synthesis route of R-POSS MA-based MPC block copolymer (i) 
Homopolymerization of Poly(2-(methacryloyloxy)ethyl phosphorylcholine)-based chain 
transfer agent [Poly MPC-CTA61 (PMPC61)] by RAFT polymerization using AIBN as initiator 
and CPD as chain transfer agent (ii) Di-block copolymerization of Poly MPC-CTA61 (PMPC61) 
with R-POSS MA in the presence of AIBN as initiator [MPC-block-R-POSS MA]. 
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2-2.4. Characterization of POSS and MPC copolymers synthesized by free radical and 
RAFT polymerization technique 
 
2-2.4.1. Characterization of POSS and MPC copolymers (3a-c) synthesized by free radical 
polymerization technique 
Solubility testing of the prepared copolymers (3a-c) were performed using six different 
solvents; pure water (H2O), methanol (MeOH), ethanol (EtOH), THF, chloroform (CHCl3) and 
Dimethyl sulfoxide (DMSO). The solubility of copolymers was measured at 25 ⁰𝐶  with 
continuous stirring for 24 h (for pure water, methanol and ethanol more than 30 h). The 
solutions were filtered using a 0.45 µm pore size filter to remove the insoluble samples. The 
solvents were removed and the solubility was measured by measuring the weight of the soluble 
solid. The solubility measurements were conducted triplicate. 
GPC measurements were performed by Prof. S. Yusa at University of Hyogo, Japan using 
a Tosoh DP-8020 pump equipped with a Tosoh RI-8020 refractive index detector, and a Shodex 
7.0 μm bead size GF-7 M HQ column (exclusion limit ~107) operated at 25 °C under a flow 
rate of 0.6 mL/min. A phosphate buffer at pH 9 containing 10 vol% acetonitrile was used as 
the eluent. Mn and Mw/Mn were determined using standard sodium polystyrene sulfonate 
samples.  Sample solutions were filtered with a 0.45 µm pore size filter before the GPC 
measurements.  
1H NMR spectra were measured by dissolving the copolymers in d-methanol (CD3OH) 
with a concentration of 5 mg/ml (approximate) using a JEOL JNM-ECZS400FT NMR System.   
The chemical structures of the copolymers were examined by Fourier transform infrared 
(FTIR) spectroscopy (JASCO FT/IR-460plus). KBr was used for the attenuated total 
reflectance crystal. The scanning wave numbers ranged from 4,000 to 400 cm-1. The spectrum 
resolution was 4 cm-1, and the 2 mm/sec scans were accumulated to determine one spectrum. 
 Powder X-ray diffraction was carried out using X-Ray Diffractometer (RINT2000, 
Rigaku Co., Japan) with monochromatic CuKα radiation and the generator working at 40 kV 
and 20 mA. Intensity was measured in the range of 2 < 2θ < 40⁰ with scan steps of 1⁰ min-1.  
The composition of elements was determined by X-ray photoelectron spectroscopy 
(XPS) (Automated XPS Microprobe, PHI X-tool). The samples measurements were performed 
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on the dry powder sample. High-resolution scans for C1s, O1s, N1s, P2p and Si2p were 
acquired at a takeoff angle of 45° for the photoelectrons.  
The thermal analyses of the copolymers were carried out by differential scanning 
calorimetry (DSC) (Seiko Instruments Inc. EXSTAR 6000/DSC6200). The scan rate was 
10 °C/min (1st cooling, 2nd cooling and 1st heating) and 5 °C/min (2nd heating) within the 
temperature range of -50 - 80 °C. The glass transition temperature was obtained at the midpoint 
of change in the baseline of DSC thermograms.  
The thermogravimetric analysis (TGA) of the copolymers were carried out using a 
thermogravimetric analyzer (Rigaku, TG 8121/ Thermo plus EV02) at a heating rate of 20 ⁰𝐶 
/min from 25 to 500 ⁰𝐶 under a continuous nitrogen purge (100 mL/min). Temperature was 
increased from 25 to 120 ⁰𝐶 with holding time for 20 min and then from 120 to 500 ⁰𝐶 and 
with holding time for 10 min [22]. The composition of char yield was determined by XPS 
following the same procedure stated above. 
 
2-2.4.2. Characterization of POSS and MPC di-block copolymers (3a'-c') synthesized by 
RAFT polymerization technique 
1H NMR spectra were measured by dissolving copolymers (3a'-c') in methanol-d3 : 
tetrahydrofuran-d8 (50:50) mixed solvent with a concentration of 3 mg/ml using a JEOL JNM-
ECZS400FT NMR System.  
The chemical structures of the copolymers were examined by FTIR spectroscopy 
(JASCO FT/IR-460plus). The scanning wave numbers ranged from 4000 to 400 cm-1. The 
spectrum resolution was 4 cm-1, and the 2 mm/sec scans were accumulated to determine one 
spectrum. 
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2-3. Results and Discussion: 
 
2-3.1. Synthesis and characterization of R-POSS MA and MPC copolymers (3a-c) 
synthesized by free radical polymerization technique 
Ethyltrimethoxysilane-based POSS-MA (2a), hexyltrimethoxysilane-based POSS-MA (2b) 
and trimethoxyoctylsilane-based POSS-MA (2c) were prepared by using silsesquioxane partial 
cages (1a-c) and 3-methacryloxypropyl trichlorosilane (Scheme 2-1).  The POSS and MPC 
copolymers (3a-c) were prepared by free radical polymerization using AIBN as an initiator. 
The solubility of the copolymers (3a-c) in various solvents were compared to check the 
influence of aliphatic chain length (R-group) in the POSS moiety (Table 2-1). The solubility 
of copolymers 3a, 3b and 3c in water, methanol and ethanol reduced abruptly (compare to Poly 
MPC) after incorporation of R-POSS moiety into the MPC polymeric matrix. Presumably, the 
R-POSS moiety strongly interacted with the phosphorylcholine (PC) group, which is 
responsible for the solubility of the MPC polymer in water and the hydrophobic region (R-
POSS) is exposed on the solid polymer surface even in water [23].  
 
Table 2-1. Solubility of R-POSS and MPC Copolymers (3a-c) 
Sample 
Name 
H2O* 
(mg/ml) 
MeOH* 
(mg/ml) 
EtOH* 
(mg/ml) 
THF 
(mg/ml) 
CHCl3 
(mg/ml) 
DMSO 
(mg/ml) 
Poly MPC 84 ± 0.6 107 ± 4.0 74 ± 6.0 < 0.01 < 0.01 < 0.01 
3a 10 ± 0.1 10 ± 0.1 1 ± 0.02 < 0.01 < 0.01 < 0.01 
3b 5 ± 0.1 19 ± 1.0 10 ± 0.2 < 0.01 < 0.01 < 0.01 
3c 7 ± 0.1 16 ± 0.4 11 ± 0.1 < 0.01 < 0.01 < 0.01 
* Stirring continued for more than 30 h.  
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The molecular weight of the copolymers (3a-c) measured by GPC summarized in Table 2-2. 
The number-average molecular weight (Mn) of all copolymers is in the range of 1 × 104. In case 
of 3a, the molecular weight (Mn) obtained was lower than other two copolymers, suggesting 
the increased copolymerization ratio of 2a, which was calculated from 1H-NMR spectra 
(Figure 2-1; (i) ), affected the propagation and termination steps of radical polymerization.  
 
Table 2-2. Chemical Composition and Thermal Properties of POSS and MPC copolymers (3a-
c) 
Samples 
% Mol 
(Feed) 
% Mol 
1H 
NMR 
Mole. Wt. in a 
phosphate 
buffer/AcCN (9:1) 
Tg 
Char 
Yield 
MPC/ 
R-
POSS 
MPC/   
R-
POSS 
Mn 
×104 
Mw 
× 104 
Mw/ 
Mn 
°C % 
Poly MPC 100 100 5.69 22.49 3.3 3 30 
3a 99/1 98/ 2 2.79 9.81 3.5 11 30 
3b 
①a) 
99/1 99/1 
141 255 1.8 
6 29 ②a) 4.19 14.1 3.3 
Avg. 5.1 58.59 11.5 
3c 99/1 N. D.b) 6.1 41.1 6.8 7 29 
a) Two peaks were observed in GPC charts; b) % Mol. could not be determined from NMR 
spectra 
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Figure 2-1. i) 1H NMR spectra and ii) FT-IR spectra of R-POSS and MPC based copolymer 
(3a-c) 
 
Compositions of POSS and MPC copolymers 3a-c was analyzed by the XPS spectra (Table 2-
3). The peaks of the carbon atom region (C1s) was observed at 285 eV in all the copolymers, 
correspond to neutral carbon. The peak of the phosphorus (P2p) atom region (correspond to the 
phosphate group) was detected at 133 eV and the nitrogen (N1s) atom region correspond to 
protonated ammonium group was detected at 403 eV [24, 25]. The appearance of the Si 2p (101 
eV) and Si 2s (152 eV) were confirmed which indicate the presence of Si. From the results of 
XPS, the successful incorporation of R-POSS moiety in the copolymers 3a-c was confirmed. 
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Table 2-3. XPS Analysis of POSS and MPC copolymer Powder Samples (3a-c) 
Sample 
Atomic Conc. % from XPS 
C1s N1s O1s P2p Si2p 
Poly MPC 59 4 33 4 0 
3a 60 3 31 5 1 
3b 67 1 28 2 2 
3c 71 0 24 1 4 
 
The POSS and MPC copolymers (3a-c)  were characterized by thermal analysis (Table 
2-2). With the incorporation of 1mol. % of R-POSS, the glass transition temperature (Tg)of 3a-
c increased in the order of 3a > 3c ≈ 3b (Figure 2-2; (i)). In the case of 3a, the Tg increased to 
11 ⁰𝐶, which was 8 ⁰𝐶 higher than poly MPC. Since, the thermal property of the polymer is 
primarily associated with their structural orientation, incorporation of R-POSS moiety to the 
MPC chains is likely to hinder the molecular motion of the MPC chain in the polymer matrix. 
This might be the reason of remarkable improvement in Tg 
[26]. In all the three copolymers 3a-
c, 1 mol. % R-POSS was used, and all the three copolymers have shown remarkable 
improvement in Tg. To further investigate the mechanism behind the Tg increase, FTIR 
characterization of the three copolymers 3a-c and poly MPC were carried out (Figure 2-2; (ii)). 
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Figure 2-2. i) DSC thermogram and ii) FT-IR spectra of the regions from 1680 to 1780 cm-1 
of R-POSS and MPC based copolymer (3a-c) 
 
The carbonyl (C=O) and choline (-N+(CH3)3) absorption in poly MPC observed at ~1725 cm
-1 
and 965 cm-1 respectively. In the case of 3a, strong shoulder peak was observed at low 
frequency (1717 cm-1) (Figure 2-2; (ii)) which indicated the existence of new strong dipole-
dipole interaction between the POSS and the carbonyl group of MPC polymer. This dipole-
dipole interaction helps in suppressing the diluting effect of POSS and help in contributing 
positive Tg 
[19,26,27] of 3a. In the case of 3c when R-POSS was incorporated into the MPC 
polymer, a broad absorption shoulder appeared around 1725 cm-1 which indicates the 
interaction between R-POSS and MPC polymer and responsible for increasing Tg of 3c. In the 
case of 3b, after incorporation of R-POSS moiety in MPC polymer the absorption maximum 
shift toward the higher frequency (~1728 cm-1) which indicate that interaction between the R-
POSS and MPC is weaker than the diluent effect of R-POSS to the self-association interaction 
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of MPC. In the case of 3b and 3c, POSS has a small influence on Tg value due to the high 
molecular weight (> 2,00,000 g mol-1) (Table 2-2), as there is a relationship between the high 
molecular weight and topological restriction on chain movement [28].  
TGA thermograms of copolymers 3a-c, indicate the four-step degradations at ~138.9, ~241.1, 
~348.9 and ~396.9 ⁰𝐶  (Figure 2-3).  The temperature of the first degradation (TInitiation) 
observed in poly MPC ~137 ⁰𝐶 to 161 ⁰𝐶 (3a), 144 ⁰𝐶 (3b), 141 ⁰𝐶 (3c) [26] which suggested 
that incorporation of inorganic R-POSS help in increasing the thermal stability of the 
copolymers. XPS analysis of TGA char yield (Table 2-2) was performed, and the result 
indicated no trace of Si in the three copolymers after 500 ⁰𝐶. 
 
 
 
Figure 2-3. TGA thermogram of R-POSS and MPC based copolymer (3a-c) 
 
X-ray diffraction of Poly MPC and 3a-c were performed at room temperature (Figure 2-4). 
The XRD pattern of poly MPC indicated the amorphous broad peak pattern. As a reference, 
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the XRD of 1a (partial cage) was performed, and the main reflections obtained at around 8-11°, 
which correspond to lattice spacing of 11-8 Å, very similar to the recently reported paper [29]. 
In the case of 3a-c, the main reflections attributed to POSS moiety was not observed, and the 
pattern was similar to poly MPC. The results indicated no crystallization of POSS moiety in 
3a-c. Also, the intensity of the peak at 2θ ≈ 20⁰, attributed to the amorphous nature of poly 
MPC was decreased due to the enlargement of interchain correlation distance and inter-side-
group correlation [30].  
 
 
 
Figure 2-4. Powder X-Ray pattern of R-POSS and MPC based copolymer (1a, 3a-c) 
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2-3.2. Synthesis and characterization of R-POSS and MPC di-block copolymers (3a'-c') 
synthesized by RAFT polymerization technique 
The di-block (3a'-c') copolymers were synthesized by RAFT polymerization using PMPC61 as 
the CTA were characterized by 1H NMR and FT-IR measurements (Figure 2-5(i)-(iii) & 
Figure 2-6).  From the 1H NMR spectra, the resonance bands observed at 3.3-4.5 ppm were 
attributed to the phosphorylcholine (PC) moiety. The band observed at 1.7-2.31 ppm are 
attributed to the methylene protons of the main chain. The band observed at 0.8-1.25 ppm are 
attributed to the 𝛼 -methyl proton which split due to the tacticity[6]. The resonance peak 
observed at 0.92, 1.11, 0.62, 1.91 and 4.32 were assigned to methyl and methylene protons of 
POSS moiety in the R-POSS units. The degree of polymerization (DP) was calculated from the 
integral intensity ratio of resonance bands at 3.3 and 0.62 ppm for phosphorylcholine moiety 
and R-POSS moiety, respectively. From the IR spectra, the absorption band appeared at1721 
cm−1 ((C=O)-O-, ester), 1251, 1172, 1089 cm−1 (-P-OCH2-) and 960 cm
−1 (-N+(CH3)3) 
corresponding to the poly MPC block and the absorption band at around 1120 cm−1 (-Si-O-) is 
the characteristic Si-O-Si stretching vibration peak of silsesquioxane cages from R-POSS ( 
Figure 2-6). Accordingly, the degree of polymerization of R-POSS unit was calculated to be 
12-13, which was governed by the same monomer to initiator ratio.  From the results, the 
segment length of three di-block copolymers were determined and abbreviated to MPC61-
block-C2H5-POSS13, MPC61-block-C6H13-POSS13 and MPC61-block-C8H17-POSS12 (3a'-c').  
Thus, the influence of the R-groups of POSS moiety on the micelle formation can be discussed 
the same block length of R-POSS moiety (DP of R-POSS 13/13/12). 
1H NMR (400 MHz) spectra of R-POSS and MPC based block copolymers obtained (Figure 
2-5 (i), (ii), (iii)) from methanol-d3: tetrahydrofuran-d8 (50:50) δ: 0.96 [s, -C-CH3], 1.78-2.24 
[s, -CH2-], 3.29 [s, -N(CH3)3], 4-4.39 [m, -OCH2], 3.77 [s, -CH2N], 0.62 [s, -Si-CH2-], 6.8-7.15 
[phenyl, 5H] 
FT-IR (cm-1): 1721 (C=O Ester), 1250, 1173 and 1089 (-POCH2-), 963 (-N
+(CH3)3) and 1121 
(-Si-O-) (Figure 2-6). 
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Figure 2-5. 1H NMR spectrum of (i) MPC61-block-C2H5- POSS13 (3a'), (ii) MPC61-block-
C6H13- POSS13 (3b') and (iii) MPC61-block-C8H17- POSS12 (3c') in methanol-d3 : 
tetrahydrofuran-d8 (50:50). 
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Figure 2-6. The FT-IR spectra of MPC61-block-C2H5- POSS13 (3a'), MPC61-block-C6H13- 
POSS13(3b'), MPC61-block-C8H17- POSS12 (3c') and polyMPC61 
 
2-4. Conclusion 
The R-POSS and MPC based copolymers were synthesized by two polymerization techniques 
(free radical and RAFT polymerization). The characterization results 1H NMR, FI-IR and XPS 
results indicated the successful synthesis of the copolymers using two polymerization 
technique. The copolymers has been further studied focusing its application in drug delivery 
system. 
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3-1. Introduction 
Hemocompatibility is the major requirement of organic/ inorganic material for those 
application in the preparation and coating of the cardiovascular implant. Nano-composite 
materials have shown unique characteristics for application as blood biomaterial interface. 
Nano-composite polymers can be bi-functionalized with growth-factor through a surface 
modification to attract the endothelial progenitor cells from circulatory blood which could help 
in the enhancement of bio and hemocompatibility of the cardiovascular devices coated by these 
polymers. Recently, the study has been shown that small diameter coronary artery bypass grafts 
composed of POSS-PCU with improved mechanical strength eliminated the apparent 
disadvantages associated with handling and longevity. Guo et al. developed a biodegradable 
drug-eluting stents coating material using POSS-TPU[1]. Their results demonstrated that 
biodegradable PTX loaded POSS-TPU coating allow control drug release with a variation of 
Tg and the degradation rate was tunable by the thickness of the coating under physiological 
conditions [1]. Maeda et al. fabricated the MPC fiber using the electrospinning process and drug 
releasing characteristics from the electro-spun MPC fiber was examined. Their studied 
suggested that MPC-based nanofiber could be a promising candidate as cardiovascular graft 
material with effective control over drug releasing [2].  
POSS and poly MPC have already been studied individually for the application in the 
field of cardiovascular implant fabrication and their coating. Their individual studies have 
demonstrated promising result and their high need in this particular area. In this chapter, R-
POSS-methacrylates (bearing different vertex (R-) groups such as ethyl, hexyl and octyl) and 
MPC-based random copolymers synthesized in chapter 2 has been consider for further study. 
The effect of the R-group in the POSS moiety was evaluated in terms of thermal, mechanical, 
physical and surface properties of synthesized copolymers focusing their application in the 
field of the surface coating. The results showed that thermal and mechanical strengths of 
copolymers have increased by employing only the ethyl (R= C2H5)-POSS. Solubility 
characteristics of the copolymers in various polar and non-polar solvents were evaluated, and 
observation has provided the knowledge about the influence of this R-group in the POSS 
moiety on wettability and hydrophilicity of the copolymer when coating the surface. The 
current study suggested a new approach of enhancing and tuning the properties of MPC, with 
improved thermal and mechanical property for its application as surface coating materials.  
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3-2. Experimental Section 
 
3-2.1. Material 
The R-POSS-MA MPC random copolymers (R = C2H5, C6H13, and C8H17) were 
synthesized as described in Chapter 2 (Scheme 2-1; 3a-c). The mol. % of R-POSS in the 
copolymers were found to be 1-2 mol. %.  Dulbecco's Modified Eagle Medium (DMEM), 
Dulbecco's phosphate-buffered saline (DPBS), 0.25 %-Trypsin/1mM-EDTA solution, 
penicillin-streptomycin mixed solution and sodium carbonate was purchased from Nacalai 
Tesque, Inc. (Kyoto, Japan). Fetal Bovine Serum (FBS) was purchased from Sigma-Aldrich 
Co. LLC. (St. Louis, U.S.A). The other reagents and solvents were used without further 
purification. NIH 3T3 fibroblast cells (kindly supplied by Prof. Tsutomu Tanaka, Kobe 
University) were cultured in DMEM supplemented with 10% FBS and 100 U/mL penicillin-
streptomycin. Cells were grown in a humidified incubator at 37  ℃ under 5% CO2. 
 
3-2.2. Measurements of stress-strain behavior of copolymers (3a-c) 
To prepare the samples for mechanical testing, 3a-c and polyMPC were dissolved in 
methanol (5 w/v %), and the solutions were cast on a molded poly(tetrafluoroethylene) sheet 
(6 cm x 5 cm x 1.5 cm). The samples were kept at 40 ⁰𝐶 inside a dryer for 24 h and then at 
room temperature (25 ℃ ) in a dry condition for 3 days. The dried films were cut into 
rectangular strips (40×5×0.01~0.03 mm) using a razorblade. Stress-strain curves were obtained 
by Autograph AG-XPlus, (Shimadzu Corporation, Japan), considering the gauge length 20 mm 
and crosshead speed 2 mm/min.       
Additionally, compression testing was also performed by Autograph AGS-J, (Shimadzu 
Corporation, Japan). Samples for the measurements were prepared by pressing the dry 
copolymers in steel mold using 10 N force. The size of the sample used for the measurements 
was ~ 10 mm × 10 mm × (2.7 ~ 3.3 mm). The amount of copolymer used for samples 
preparation was 400-500 mg/ sample. The samples were pressed at 0.3 mm/min compression 
rate. Young’s modulus was calculated by measuring the slop in the stress-strain curve over 
10% displacement. Five measurements were recorded for each sample [3]. 
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3-2.3. Film Coating by copolymers (3a-c) 
The copolymers 3a-c were coated by spin coating on an aliphatic polyether-based 
thermoplastic polyurethane film (Tecoflex®) with three different concentration copolymer 
solution (1%, 5% and 10% w/v) using spinning speed of 400 rpm for 10 sec (1st run) and 1200 
rpm for 20 sec (2nd run). The coated films were dried inside the vacuum dryer for 6 h at 40 ⁰𝐶 
[4]. The XPS analysis was performed to determine the composition of elements on the surface 
of the coated film, and the scanning electron microscopy (SEM) (JEOL, JSM-6510) was 
performed to observe the surface morphology. 
 
3-2.4. Water contact angle measurements of the copolymers (3a-c) coated surface 
The wettability of copolymers 3a-c and poly MPC coated surface were evaluated by the 
measurement of the static contact angles by distilled water and 0.1 M PBS (pH 7.4) (4.5 µL 
droplet). The contact angle measurements were conducted by contact angle meter (Kyowa 
Interface Science Co. Ltd., DMs-401) and the measurement was carried out at five different 
positions of each specimen at room temperature. 
 
3-2.5. Protein adsorption on the copolymers (3a-c) coated surface 
The amount of BSA adsorbed on the surface of the copolymers (3a-c) coated and 
uncoated films were quantified by micro-BCA method. The 450 μg/ml BSA in 0.1M phosphate 
buffered saline (PBS) (pH 7.4) solution was used. Before the measurement, the surface of the 
coated film (size of 10 mm × 10 mm) was cleaned by high N2 gas flow. The film surface was 
immersed into 8 ml of BSA solution at 37 ⁰𝐶 for 1 h. The samples were rinsed with 50 ml of 
0.04 M PBS (pH 6.8) at a flow rate of 8 ml/min. The BSA adsorbed on the surface was 
recovered by washing it with 2 ml of 1 wt.% sodium dodecyl sulphate (SDS) solution in 0.1 M 
PBS for 5 min at room temperature [5]. The concentration of protein adsorbed on the surface 
was determined from the BSA standard curve. Stability of the surface coating in PBS for 2 h 
was confirmed by XPS measurement (the composition of elements on the surface of the coated 
film).  
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3-2.6. Cell attachment on the copolymer (3a) coated surface 
To determine the cell attachment on the surface, polystyrene tissue culture dishes were 
coated with 3a using a spin coating technique. NIH 3T3 fibroblast cells were seeded on the 
coated tissue culture dish with a density of 10,000 cells/ dish using DMEM cell medium. After 
incubation for 24 and 48 h at 37 ⁰𝐶 in 5 % CO2 atmosphere, the cell morphology was observed 
under a digital inverted microscope (EVOS FL, Life Technologies). The existence of 3a on 
tissue culture dish after 48 h in the cell culture medium was confirmed by the XPS 
measurements. The culture dish was washed three times with distilled water and dried inside 
the vacuum dryer before the measurement.  
 
3-3. Results and Discussion 
 
3-3.1. Stress-strain behavior of the random copolymers (3a-c) 
In order to assess the bulk properties of 3a-c in relation to the Tg increase, a tensile test 
was performed. The preparation of bulk films of copolymers 3a-c for the measurement of 
mechanical properties was hard.  Figure 3-1 (i)-(ii) represent Young’s modulus and tensile 
strength calculated from the stress-strain curve of the copolymers. The Young’s modulus and 
tensile strength of 3a was observed significantly higher in comparison with the other 
copolymers 3b-c. The compression test results (Figure 3-2 (i)-(ii)) also indicated that 
incorporation of C2H5-POSS help in increasing Young’s modulus of 3a. For the copolymer 3b 
and 3c, the results indicated that incorporation of C6H13 and C8H17-POSS moieties decreased 
the mechanical strength of the copolymers. The tensile strength of 3b could not be measured 
due to weak mechanical strength. The previous study[15] revealed that the mechanical property 
of the copolymer influenced by the degree of dispersion of the R-POSS in the polymer matrix, 
the concentration of R-POSS and type of pendant group. The POSS-POSS and POSS-polymer 
interaction strongly affect the mechanical property of the copolymers. The Figure 3-3 
represented the expanded FT-IR spectra from 1680 to 1780 cm-1. The FT-IR spectra indicated 
that in the case of 3a a strong shoulder peak appeared at low frequency (~1717 cm-1) which 
represented the existence of a new strong dipole-dipole interaction between the C2H5-POSS 
and the carbonyl group of MPC. This strong dipole-dipole interaction might be the reason of 
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increased mechanical strength of 3a. In the case of 3c, a broad absorption shoulder appears 
(~1725 cm-1) which indicates the interaction between C8H17-POSS and MPC polymer. In the 
case of 3b, the absorption maximum tends to shift toward the higher frequency (~1728 cm-1) 
after incorporation of C6H13-POSS which may play an inert diluent role to decrease the self-
association interaction of MPC molecule.  The reason for the improvement of mechanical 
strength of 3a may be (i) the introduction of POSS moiety restricted the mobility of the polymer 
chains due to its strong interaction with MPC polymer, and (ii) evenly distribution of C2H5-
POSS moiety on the polymer matrix in nanometer scale resulting better Young’s modulus [3, 6-
10]. Form these results it can be concluded that long alkyl side chain of R-POSS might not be 
favorable to tangle with MPC polymeric chains in terms of the decreased elasticity of the 
material [7, 11].   
 
 
i) 
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Figure 3-1. Results of Tensile testing of R-POSS and MPC based copolymers (3a-c): i) 
Young’s modulus and tensile strength ii) Tensile stress-strain curves 
 
 
ii) 
i) 
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Figure 3-2. Results of Compression testing of R-POSS and MPC-based random copolymers 
(3a-c): i) Young’s modulus and compression strength at 10 % strain ii) Compression stress-
strain curves 
 
ii) 
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Figure 3-3. FT-IR spectra of the regions from 1680 to 1780 cm-1 of R-POSS and MPC based 
copolymer (3a-c) 
 
3-3.2. Morphology observation and characterization of the random copolymers (3a-c) 
coated surface  
Surface characterization of the copolymer 3a-c coated surfaces were performed using the 
XPS measurements (Table 3-1). Peaks for Si 2p (101 eV) and Si 2s (152 eV) were observed 
for all the copolymers-coated surface. The atomic concentration % analysis showed a higher 
concentration of Si on the surface of 3a coated film which indicates the presence of C2H5-
POSS moiety on the coating surface. Surface morphology of the copolymer 3a-c coated surface 
was observed using SEM measurement. The SEM image showed that when 1% w/v 3a solution 
concentration was used for coating the surface, the smooth wave-like surface appeared, but 
when higher % solution like 10% w/v concentration solution used liner uniform cracked surface 
was observed (Figure 3-4). 
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Table 3-1. XPS Analysis of R-POSS and MPC-based copolymer coated surface (3a-c) 
Sample 
Atomic Conc. % from XPS analysis 
C1s N1s O1s P2p Si2p 
Poly MPC 63.1 4.0 29.9 4.1 0.1 
3a  69.9 4.0 27.0 1.9 3.1 
3b 62.0 4.1 28.9 3.1 2.9 
3c 73.1 0.9 23.1 2.1 1.0 
 
 
 
Figure 3-4. SEM Image of R-POSS and MPC-based copolymers (3a) coated surface. (i) blank 
surface, (ii) poly MPC-coated surface (1% w/v), (iii) poly MPC-coated surface (10 % w/v), 
(iv) 3a-coated surface (1% w/v), and (v) 3a-coated surface (10 % w/v).  
 
3-3.3. Surface property: wettability, protein adsorption and cellar attachment 
The results of the solubility study suggested the presence of C2H5-POSS moiety on the 
surface of 3a which is responsible for the reduction of solubility of the copolymer in water 
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(Table 3-1). So, in the above-mentioned respect, we hypothesized that 3a possess much 
hydrophobic surface due to the restriction of the motion of MPC moiety. The results of static 
contact angle (SCA) measurement (Figure 3-5 (a)1) suggested that the copolymer solution 
concentration for the spin coating should be over 5% w/v, as the SCA value of only poly MPC-
coated surface decreased significantly over 5% w/v. From the results, it can be concluded that 
the copolymer solution concentration over 5% w/v completely covers the whole surface. The 
obtained results suggested that the highest contact angle observed in copolymer 3a coated 
surface supported our hypothesis: The C2H5-POSS moiety was preferably located on the 
surface of the film due to the restricted motion of MPC moiety. The SCA was also measured 
using a PBS solution to evaluate the effect of wettability of copolymer-coated surface in a 
physiological environment. The results (Figure 3-5 (a)2) showed that static contact angle of 
poly MPC was almost same in both water and PBS irrespective of the coating thickness (in this 
study it was considered that increase in the concentration of copolymer solution, deposit more 
copolymer on the surface which increases the thickness of the coating). The results showed 
that the value of the contact angle of 3a coated surface measured using PBS (with 5 % w/v 
solution concentration) was more than the value measured using pure water. The presence of 
inorganic salt in PBS might help in forming the hydrophobic domain (C2H5-POSS moiety) on 
the surface, which helps in increasing the surface hydrophobicity [12]. The value of the contact 
angle was found to be decreased when the coated with 3a with 10 % w/v solution concentration. 
During the time of static contact angle measurement, the increased surface roughness was 
observed, which might be the reason for decreasing the value contact angle. A sudden increase 
in the value of the contact angle was observed in case 3b and 3c-coated surfaces (coated with 
10 % w/v solution concentration). The increased amounts of 3b and 3c copolymers on the 
coated surface increases the presence of C6H13 and C8H17-POSS moieties which forms the 
hydrophobic domain in the presence of inorganic salt in PBS might be the reason for the high 
value of contact angle. 
In order to assess the correlation between the surface wettability and protein adsorption 
on the copolymer 3a-c coated surfaces (with 1 and 5% w/v concentration solutions), protein 
adsorption measurements were conducted, and the adsorption of BSA was quantified. The BSA 
adsorption was only observed in 3a-coated surface and the adsorption was increased with an 
increase in coating thickness (Figure 3-5 (b)). This observation suggested that the hydration 
layer formed surrounding the phosphorylcholine (PC) group of poly MPC in an aqueous 
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medium, which was responsible for the resistance to the protein adsorption, might be disrupted 
by the incorporation of C2H5-POSS moiety at the water-polymer interface 
[11-14]. The results of 
surface wettability and protein adsorption studies suggested the presence of C2H5-POSS moiety 
on the interface of 3a-coated film which was responsible for providing the surface 
hydrophobicity. The current results also strongly correlated with the surface wettability results 
performed using 0.1 M PBS (pH 7.4) solution (Figure 3-5 (a)2). The results of the XPS 
measurements suggested the presence of copolymer on the surface during the protein 
adsorption study. 
 Cell attachment study on the 3a-coated surface was performed using NIH 3T3 cell line, 
in order to investigate the effect of exposed C2H5-POSS moiety on cellular interaction with the 
surface. After 24 and 48 h incubation at 37 ⁰𝐶, the morphology of the NIH 3T3 cells were 
observed under a digital inverted microscope (Figure 3-5 (c)). The observation suggested that 
the number of cells were increased after 24 h although the cells spreading on the surface was 
not observed. After 48 h, the cell spreading with cell membrane extension morphology were 
observed. The observed phenomenon supported that the unique hydration layer of poly MPC 
which resists the protein adsorption and cell adhesion affected by the incorporation of C2H5-
POSS moiety into the polymeric matrix. 
 
 
a) 1. 
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b) 
a) 2. 
Chapter 3           “Element Block” R-POSS and 2-(methacryloyloxy)ethyl phosphorylcholine 
 
71 
 
 
 
Figure 3-5. Surface wettability, protein adsorption and cell attachment on the random 
copolymers 3a-c coated surface. (a) Results of static contact angle (SCA) measurement coated 
with 3a-c with different concentration solutions (1 %, 5 % & 10 % w/v). a) 1. SCA in water & 
a) 2. SCA in PBS,  (b) Results of BSA protein adsorption on the 3a-c coated surface with 
different concentration solution (1 % & 5 % w/v) (c) Image of cell attachment on surface coated 
with copolymer 3a after 24 and 48 h (ii and iv) and cell attachment on polystyrene tissue culture 
plate after 24 and 48 h (i and iii). 
 
3-4. Conclusion 
The C2H5-POSS-based random copolymer in combination with MPC showed unique 
surface and bulk properties. The C2H5-POSS help in increasing the mechanical property of the 
MPC based copolymer. The hydrophobic region (C2H5-POSS moiety) dispersed in the poly 
MPC matrix provides the controlled protein adsorption and cell attachment on the surface. In 
a contest of the investigation, it can be concluded that C2H5-POSS-based MPC copolymer 
c) 
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fulfills all required characteristics needed to develop it for further biomedical application 
especially as coating material of the cardiovascular implant.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 3           “Element Block” R-POSS and 2-(methacryloyloxy)ethyl phosphorylcholine 
 
73 
 
Reference 
1. H. Ghanbari, B. G. Cousins, A. M. Seifalian, Macromol. Rapid Commun. 2011, 32, 1032-
1046. 
2. T. Maeda, K. Hagiwara, S.Yoshida, T. Hasebe, A. Hotta, J. Appl. Polym. Sci. 2014, 131, 
40606. 
3. I. Pramudya, C.G. Rico, C. Lee, H. Chung, Biomacromolecules 2016, 17, 3853-3861. 
4. K. H. Chae, Y. M. Jang, Y.H. Kim, O. Sohn, J. I. Rhee, Sensors and Actuators B 2007, 
124, 153-160. 
5. J. Sibarani, M. Takai, K. Ishihara, Colloids and Surfaces B: Biointerfaces 2007, 54, 88-93. 
6. W. Sirithep, Y. Narita, Y. Nagase, Trans. Mat. Res. Soc. Japan 2013, 38, 473-476. 
7. S. Kuo, F. Chang, Prog. Polm. Sci. 2011, 36, 1649-1696. 
8. Y. Du, M. Yu, X. Chen, P. X. Ma, B. Lei, ACS Appl. Mater. Interfaces 2016, 8, 3079−3091. 
9. Md. Rabby, S. Jeelani, V. K. Rangari, J. Nanomat. 2015, Art. ID 894856, 13. 
10.  R. Drake, A. W. Vogl, A. W. M. Mitchell, Gray's Anatomy E-Book: The Anatomical 
Basis of Clinical Practice, Nerve Biomechanics, 3 rd ed., Churchill Livingstone, 2014.  
11. K. Tanaka, S. Adachi, Y. Chujo, J. Polym. Sci.: Part A: Polym. Chem. 2009, 47, 5690–
5697. 
12. K. Ishihara, M. Mu, T. Konno, Y. Inoue, K. Fukazawa, J. Biomater. Sci. Polym. Ed. 2017, 
28, 884-899. 
13. Y. Inoue, Y. Onodera, K. Ishihara, Colloids and Surfaces B: Biointerfaces 2016, 141, 507–
512. 
14. Y. Inoue, T. Nakanishi, K. Ishihara, React. & Funct. Polym. 2011, 71, 350–355. 
15. S. Chatterjee, T. Matsumoto, T. Nishino, T. Ooya, Macromol Chem Phys 2018, 219 (8), 
doi: 10.1002/macp.201700572. 
 
Chapter 4                  R-POSS and 2-(methacryloyloxy)ethyl phosphorylcholine-based random 
 
74 
 
Chapter 4 
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copolymers as a hydrophobic drug solubilizer in drug delivery 
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4-1. Introduction 
Paclitaxel (PTX) is a hydrophobic, poorly water-soluble anti-cancer drug for the 
treatment of breast, ovarian and lung cancers. Because of poor water solubility of PTX, special 
solvents are required to solubilize it in water like 50:50 v/v mixture of polyoxyethylated castor 
oil, dehydrated ethanol[1] etc. The use of the solvents often results in serious hypersensitivity 
reaction, and also the solvent causes erythema and swelling at the injection sites. So, the 
alternative dosage form is essential to reduce the side effects. The applications of liposomes[2], 
[3] , polymeric assemblies[4], and cyclodextrin complexes[5] mediated delivery of PTX have 
been reported, but there is no report yet of clinically effective delivery. The water-soluble 
polymers have been extensively studied for the effective therapeutic use of the poorly water-
soluble drug. Among them, a zwitterionic water-soluble polymer like 2-methacryloyloxyethyl 
phosphorylcholine (MPC) polymer (poly MPC) has been used extensively studied for its 
application in blood-contacting medical devices because of its high level of biocompatibility 
and resistance to protein adsorption [6,7]. The MPC monomer can be easily copolymerized with 
different hydrophobic monomers and the obtained amphiphilic copolymers can be effectively 
used for the solubilization and delivery of PTX[8-12].  According to the report by K. Ishihara et 
al., the most effective copolymer to dissolve the paclitaxel was poly[MPC-co-n-butyl 
methacrylate(BMA) (PMB30W)] containing 70 mol % of the hydrophobic BMA unit[9].  In 
addition, cellular uptake of a poly MPC-based polymeric micelle was found to be superior to 
poly(ethylene oxide) (PEO) and poly(N-(2-hydroxypropyl)methacrylamide) (PHPMA)-based 
polymeric micelle system because of the interaction of poly MPC with cellular membrane[13].  
However, the hydrophobic part thus is essential for the interaction with the hydrophobic drug 
molecule like PTX has been mainly constructed by hydrophobic BMA unit. The other 
hydrophobic monomer in combination with MPC has not elaborately investigated yet.    
Polyhedral oligomeric silsesquioxane (POSS) is an organic/inorganic hybrid molecule. 
It is soluble in many solvents and is highly compatible with various polymeric materials due to 
the synergy between inorganic core and organic side groups. The hydrophobic nature of POSS 
can generate an amphiphilic molecule when incorporated in the hydrophilic polymer chain. 
The aggregation and order stacking nature of hydrophobic POSS cage are responsible for the 
generation of self-assembled amphiphilic molecules. The various studies related to the 
synthesis of POSS-containing hybrid polymers and characterization of their self-assembly 
behavior in selective solvents have been reported recently. The studies have revealed some 
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novel interesting self-assemble morphologies of POSS-containing polymers like ellipsoidal 
aggregates, giant capsules, complex spheres, dendritic cylinders etc. The introduction of POSS 
moiety at the ends of PEO and poly (ethylene glycol) (PEG) hydrophilic chain resulted in the 
formation of self-assembled micelle and vesicle in solutions and solvent-sensitive self-
association behavior have been observed[13].   Kim et al. reported the successful encapsulation 
of insulin by PEG-POSS for delivery. They observed that insulin was well protected inside 
PEG-POSS nanoparticles at gastric pH for 2 h and start releasing at intestine pH 6-7[15]. Yuan 
et al. reported the successful synthesis of poly(L-glutamic acid) dendrimers bearing POSS 
nanocubic-core conjugated with doxorubicin (via pH-sensitive hydrazine bond) and biotin used 
as a targeting ligand[16]. Thus, the hydrophobic nature of POSS moiety suitable for its 
application as drug carriers as well as artificial molecular chaperones[17]  and polymeric capsule 
for photodynamic therapy[18].   
R-POSS and MPC based random copolymers (where R-groups are modified with ethyl 
(C2H5), hexyl (C6H13), octyl (C8H17) alkyl group) were designed, synthesized and subsequent 
mechanical, thermal and surface properties were studied (see Chapter 2 and Chapter 3). It 
has been observed that incorporation of only the C2H5-POSS moiety increases the 
hydrophobicity at water polymer interface in poly MPC matrix. This study is the first report of 
synthesis and biomedical application of element block (see Chapter 2 and Chapter 3) R-
POSS-based MPC copolymer. Therefore, the study has been extended towards the application 
of the amphiphilic nature of R-POSS-based MPC random copolymers for solubilization of 
hydrophobic anti-cancer drugs like PTX and their delivery as a carrier molecule.  
In this chapter, the self-assembled nature of different copolymer is characterized by 
fluorescence spectroscopy using pyrene as a fluorescence probe to determine critical 
association concentration (CAC), dynamic light scattering (DLS) measurements and 
transmission electron microscopy (TEM) observation.  Among the different copolymer, only 
C2H5-POSS-based MPC copolymer (3a) (see Chapter 2, Scheme 2-1 (iii)) has increased the 
solubility of paclitaxel which was related to the formation of the assembled structure. The 
relationship between the C2H5-POSS and MPC-based copolymer concentration and PTX 
solubility was discussed. The cytotoxicity, cellular uptake of the copolymer using a 
fluorescein-4-isothiocyanate (FITC)-labelled PTX was evaluated using the HeLa cell line. The 
release of PTX from C2H5-POSS and MPC based copolymer assembly was demonstrated to 
discuss the role of C2H5-POSS moiety as a hydrophobic monomer.  
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4-2. Experimental Section 
 
4-2.1. Material 
The R-POSS and MPC based copolymers (R = C2H5, C6H13, and C8H17) are synthesized 
as mentioned in Chapter 2 (Scheme 2-1; 3a-c). The mol. % of R-POSS in the synthesized 
copolymers were found to be 1-2 mol. %.  The PTX was purchased from FUJIFILM Wako 
Pure Chemical Corporation, Japan. Dulbecco's Modified Eagle Medium (DMEM), Dulbecco's 
phosphate-buffered saline (DPBS), 0.25 %-Trypsin/1mM-EDTA solution, penicillin-
streptomycin mixed solution and sodium carbonate was purchased from Nacalai Tesque, Inc. 
(Kyoto, Japan). Fetal Bovine Serum (FBS) was purchased from Sigma-Aldrich Co. LLC. (St. 
Louis, U.S.A). The other reagents and solvents were used without any further purification. The 
HeLa cells (Health Science Research Resources Bank, Osaka, Japan) were cultured in media 
DMEM supplemented with 10% FBS and 100 U/mL penicillin-streptomycin. The HeLa cells 
were grown in a humidified incubator at 37 ℃ under 5% CO2. 
 
4-2.2 Measurements 
The critical association concentration (CAC) measurement was performed by fluorescent 
spectroscopy using a hydrophobic fluorescent probe pyrene[19-20]. The pyrene stock solution 
was prepared (15 μM) in acetone and added to the aqueous solution of copolymers (3a-c) with 
different concentrations (ranging from 0.0001 to 50 mg/ml) to get final samples containing 6.0 
× 10-7 M pyrene. As the C2H5-POSS and MPC based copolymer was partially soluble in water, 
the aqueous solution was prepared by first dissolving it in methanol, followed by the addition 
of water along with stirring the solution. The methanol was completely removed by rotary 
evaporator and subsequently keeping the solution inside the vacuum dryer for 1 h at 40 ℃. The 
solution was diluted with water to prepare the required concentration.   The samples were kept 
overnight in dark at room temperature to allow complete evaporation of acetone.  Fluorescence 
spectra were recorded at room temperature using a fluorescence spectrophotometer (JASCO 
Spectrofluorometer FP-8200). The CAC was determined by measuring the excitation spectra 
of pyrene in different concentration solution.  The emission wavelength was at 390 nm.  
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Dynamic light scattering (DLS) measurements were carried out using a light scattering 
instrument (Malvern, Zetasizer Nano ZS) with 90⁰ as scattering angle. The measurement was 
performed at 25 ℃ in pure water with the copolymer (3a-c) concentration varying between 1 
and 100 mg/ml.  
Transmission electron microscopy (TEM) images were collected using JEOL JEM-1230 
at an accelerating voltage of 100 kV. Samples were prepared using 200 mesh copper grids. 
Before the measurements, the samples were vacuum dried and kept overnight in vacuo.  An 
energy-dispersive X-ray analysis (EDS) attached to the scanning TEM-high angle annular dark 
field (STEM-HAADF) was performed with JEOL JEM-ARM200F at 200 kV.     
 
4-2.3 Cytotoxicity of the copolymers (3a-c) 
The cytotoxicity of the copolymers (3a-c) was determined by cell counting kit-8 (CCK-
8). The copolymer (1 mg) was dissolved in 1 ml of 0.1 M phosphate buffer saline (pH 7.4). 
The copolymer 3a (high concentration range 5, 10, 50, and 100 mg/ml), was considered to 
evaluate the concentration-dependent cytotoxicity. The copolymers were purified by dialysis 
process (MWCO: 1,000) against ultra-purified water before cytotoxicity measurements. 
During the dialysis process, no visible precipitation of copolymers was observed.  The HeLa 
cells were seeded in 96-well plate with volumes of 90 µl (5000 cells/ well in DMEM media, 
supplemented with 10% FBS) and incubated overnight at 37 ℃. The copolymer 3a-c solutions 
were sterilized for 30 min under UV light.  The 10 µl of sample 3a-c solution were added to 
each well and incubated for 24 h at 37 ℃. Only media and only cell were considered as blank 
(BL) and positive control (C), respectively. The 10 µl of CCK-8 reagent was added to each 
well and incubated for 2 h at 37 ℃. The absorbance was measured using Corona Grationg 
Microplate Reader SH-9000 Series (Corona Electric Co., Ltd, Japan) at 450 nm. The cell 
viability (%) was calculated by the following formula:  
Cell viability (%) = (I450
S – I450BL) / (I450C - I450BL) × 100…(1)             
where I450
S, I450
BL and I450
C represent the absorbance of the copolymer samples (S), blank 
(BL) and positive control (C) respectively. 
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4-2.4 Determination of paclitaxel solubility in copolymers (3a-c) solution 
One mg of PTX was dissolved in 1 ml of methanol. Three different concentrations 
copolymers (3a-c) solutions were prepared in water (5, 10 and 50 mg/ml). The 100 µl of PTX 
solution (in methanol) was added to 900 µl of 3a-c aqueous solution, followed by vortexing. 
Methanol was removed from the solution by keeping it under reduced pressure. The PTX 
crystal appeared in all concentration poly MPC solution, but for other copolymers (3a-c), the 
crystal appeared only in 5 mg/ ml concentration solution. The solid PTX crystal phase was 
separated by centrifugation (3000 rpm) for 15 min. All the samples were filtered before HPLC 
measurement[21] using 0.45 µm pore size filter. HPLC measurements were performed using 
GILSON HPLC system (UV-vis detector : Gilson 119 UV/VIS Detector, Autosampler : 
GILSON 231XL, Pump : GILSON 805 Manometric Module, GILSON 811c dynamic mixer 
and GILSON 306 Pump, Injector : GILSON DILTOR401)  with a COSMOSIL 5C18-MS-II (Φ 
4.6 nm × 150 mm) column (Nacalai Tesque Inc., Japan) as stationary phase at room 
temperature. The detection was performed at a wavelength of 227 nm. The mixture of 
acetonitrile (60 %) and water (40 %) was used as mobile phase with a flow rate of 1 ml/min. 
The PTX concentration in 3a-c solution was calculated by comparing the peak area with the 
standard curve. Since the PTX solubility in 3a; solution was found to be higher than the other, 
the solubility was further measured by increasing the concentration to 100 mg/ml. 
 
4-2.5 Preparation of PTX-loaded R-POSS and MPC-based random copolymers assembly 
(3a-c) 
The 3a-c; copolymers (20 mg) and PTX (1 mg) were dissolved in 1ml of methanol and 
the solution was drop by drop added into 10 ml water with vigorous stirring for overnight. The 
mixture was dialyzed against water (MWCO = 6,000-8,000) for 24 h to eliminate the methanol. 
The inner phase was collected after centrifugation (4000 rpm) for 30 min, and the supernatant 
was filtered by 0.45 µm filter. The solution was used for further characterization and stability 
study.   The 3a-c copolymer blank micelles (without PTX-loading) was also prepared following 
the similar procedure. 
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4-2.6 Characterization of the R-POSS and MPC-based copolymer assembly 
The morphology of 3a-c copolymer assembly structure in the dry state was observed in 
day 1 and 4 by transmission electron microscopy (TEM) measurements using JEOL JEM-1230 
at an accelerating voltage of 100 kV. Samples were prepared using 200 mesh copper grids. 
Before the measurements, the samples were dried and kept overnight in vacuo. In addition, an 
energy-dispersive X-ray analysis (EDS) attached to the scanning TEM-high angle annular dark 
field (STEM-HAADF) was performed with JEOL JEM-ARM200F at 200 kV (at JAIST, 
Japan).     
Dynamic light scattering (DLS) measurements were carried out to determine the average 
hydrodynamic diameter and size distribution of both with or without PTX-loaded 3a-c. The 
measurement was performed using a light scattering instrument (Malvern, EXSTER DSC600) 
with 90° as a scattering angle. The stability measurement was performed after standing the 
sample at room temperature for 4 days. The DLS measurement was performed at 25 ℃ in the 
water of 1 mg/ml concentration sample. The sample was filtered using a 0.45 µm-pore size 
filter before measurements and every sample was measured three times to analyse the mean 
diameter.   
 
4-2.7 Cell viability measurements of PTX-solubilized 3a copolymer 
PTX (1 mg/ml in ethanol) and 3a (100 mg/ml) aqueous solution was prepared following 
the same procedure as solubility measurement (see Chapter 2). This 3a copolymer and PTX 
mixed solution were divided into three parts: one for solubility measurement by HPLC, second 
for preparing pH 7 neutral copolymer solution and third for preparing pH 5 solution using 0.5 
M HCl. The PTX (1 mg) was dissolved in 1 ml ethanol to use as a control. The HeLa cells were 
seeded into 96-well plate considering the volumes of 90 µl (5000 cells/ well in DMEM media 
supplemented with 10% FBS) and incubated overnight at 37 ℃. The 3a copolymer solution 
was sterilized under UV light for 30 min before the measurement.  The 10 µl of solutions were 
added to the well plate and incubated for 24 and 48 h at 37℃ to measure the cell viability (the 
final concentration of PTX in the copolymer solution and control was 7.6 and 100 µg/ml 
respectively). Only media and cell were considered as blank and positive control respectively. 
10 µl of CCK-8 reagent was added after 24 and 48 h and incubated for 2 h at 37 ℃. The 
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absorbance at a wavelength of 450 nm was measured using a microplate reader. The cell 
viability (%) was calculated using the Eq. (1). 
 
 
4-2.8 Cellular uptake of FITC-PTX solubilized copolymer (3a) 
The visualization of cellular uptake of PTX solubilized 3a was performed by FITC-
labelled PTX (FITC labelled PTX; Scheme 4-1; 4) which was synthesized according to the 
literature [22, 23] with some modifications (Scheme 4-1).  The FITC-labelled PTX has 
encapsulated inside the 3a by dialysis approach. The HeLa Cells were seeded into a 4-well 
slide and chamber plate (Watson Bio Lab, Kobe, Japan) with a cell density of 12,750 cells/ 
well in 0.8 ml DMEM media supplemented with 10% of FBS and incubated overnight at 37 ℃. 
After 24 h incubation, the media was removed and the cells were treated with serum-free 
medium containing FITC-labelled PTX solubilized 3a (concentration of FITC-labelled PTX: 
2 µg/ml) solution.  As a control, only FITC-labelled PTX (2 µg/ml) was used.  After incubation 
for 2, 5 and 24 h, the medium was removed and 3 times washed with D-PBS. The cells were 
fixed with cold acetone and washed 3 times with D-PBS.   The cells were imaged by confocal 
laser scanning electron microscope (CLSM) Fluo ViewTM FV1000 Confocal Microscope 
(Olympus Co., Tokyo, Japan). 
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Scheme 4-1. Synthetic route of synthesis of FITC labelled paclitaxel (FITC labelled PTX, 4) 
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4-2.9 In vitro release of PTX from copolymer assembly (3a) 
The PTX-solubilized copolymer (3a) assembly (2.4 mg of lyophilized solid powder) was 
dissolved in 1 ml of D-PBS (pH 7.4).  The mixture was then poured into a dialysis tube with a 
molecular cut-off of 6,000 – 8,000 Da, followed by introducing it in the vial containing 25 ml 
of D-PBS (pH 7.4) and 1 % Tween 80 mixed solution. The system was kept in a shaking bed 
with shaking speed of 100 rpm at 37 ℃. One ml of the release medium was collected at the 
predetermined interval for concentration measurement and an equal volume was replaced with 
of D-PBS (pH 7.4) plus 1 % Tween 80 mixed solution to keep the volume of the release 
medium constant. The concentration of PTX release was monitored by HPLC measurements 
(GLISON HPLC system, see section 2.4) at a detection wavelength at 228 nm. The sample was 
diluted with an equal volume of acetonitrile and filtered with 0.45 µm pore-size filter before 
measurement. A mixture of acetonitrile (60%) and water (40%) was used as the mobile phase 
with a flow rate of 1 ml/min. The concentration of PTX was determined by comparing the peak 
area with the PTX standard curve prepared under the same measurement conditions. The 
amount of PTX remaining in the assembly was also measured after collecting the inner phase 
of the dialysis tube following a similar procedure.  
 
4-2.10 Statistical analysis 
Statistical analysis was performed applying the one-way analysis of variance (ANOVA) 
followed by Fischer's test as post-hoc comparison at a significance level set at p<0.05. 
 
 
4-3. Results and Discussion 
 
4-3.1 Characterization of R-POSS and MPC based random copolymers (3a-c) 
As discussed in Chapter 2, the number-average molecular weight (Mn) of copolymers 
3a-c was in the range of 104 and the copolymers are soluble in water. Characterization of 3a-c 
copolymers was performed by 1H NMR and FT-IR measurements and was discussed in 
Chapter 2. The effect of R-POSS domain in terms of hydrophobicity was determined by 
fluorescence technique using pyrene as a hydrophobic probe. The critical association 
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concentration (CAC) was calculated from the fluorescence excitation spectra of pyrene, 
participate between aqueous and micellar environment. A shift in excitation spectra of pyrene 
was observed with increase in the concentration of 3a-c in an aqueous medium. The intensity 
ratio (I339/I334) vs. logarithmic value of concentration (Log C) was plotted (Figure 4-1). The 
curves were flat at the low concentration of 3a-c, but started decreasing at high concentration 
except in the case of poly MPC.  The phenomenon indicated the association formation in water. 
The CAC values of 3a-c were determined by drawing the intersection of two straight lines. The 
calculated value of CAC of 3a-c were 4.8 × 10-2 mg/ml, 6.3 × 10-2 mg/ml and 8.1 × 10-2 mg/ml 
respectively. The results indicated that the CAC value of the 3a-c increased with increasing the 
aliphatic chain in the R groups (C2H5, C6H13, C8H17) of POSS moiety. As mentioned in 
Chapter 3, C2H5-POSS moiety was responsible for increasing the hydrophobicity in poly MPC 
matrix at water-polymer interface. Due to the increased hydrophobicity, the CAC value at 3a 
was found to be lower than the other copolymers 3b and 3c. The other factors affecting the 
CAC values were the molecular weight (Mn).  The Mn of the 3a-c were in the order of 3a (Mn 
= 9.8 × 104) < 3c (Mn = 4.1 × 10
5) < 3b (Mn = 5.9 × 10
5). Since the hydrophobic part (R-POSS 
moiety) of the copolymers was the same (~1-2 mol. %), the hydrophilic chain length was 
responsible for increasing the molecular weight (Mn).  The increased hydrophilic chain length 
of 3b and 3c decreased the association tendency of the hydrophobic R-POSS segment. 
Additionally, the appropriate balance between hydrophilic (MPC chain) and hydrophobic (R-
POSS) segment required to achieve lower CAC value[24,25].   
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Figure 4-1. Intensity ratio (I339/I334) in pyrene excitation spectra in the presence of poly MPC 
and the 3a-c copolymers as a function of logarithmic concentration (Log C). The emission 
wavelength was 390 nm. 
 
The z-average sizes of 3a-c copolymers were estimated by DLS measurements (Figure 
4-2). The z-average diameter of the 3a-c copolymers was in the range 65 – 80 nm (solution 
concentration 1 mg/ml) and showed a wide size distribution. In 3a copolymer, two peaks were 
observed at around 10 and 100 nm. The peak observed around 10 nm likely to be unimolecular 
assembly. Since the R-POSS moiety in the 3a copolymer matrix was only 1-2 mol. %, the 
random incorporation of R-POSS moieties induced the association states. The z-average 
diameter after 4 days was found similar in the case of 3a which indicate the stability of the 
assembled structure in water (Figure 4-2). The similar phenomenon was observed in the case 
of 3b and 3c.  ζ-Potentials of 3a-c were measured in water and the values found in the range of 
- 0.5 to – 4 mV (Figure 4-2). The slightly anionic charge which was observed in the current 
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study was considered to be beneficial for acquiring good blood compatibility as reported by 
the researcher in case of MPC-based nanoparticles[26].  
 
 
 
Figure 4-2. Particle size (Z-average diameter (nm)) (day 1 & 4) and ζ-potential (mV) of 3a-c  
 
Morphology of 3a-c assembly (concentration of solution 1 mg/ml) was investigated by 
TEM observation (Figure 4-3 (D)) after 4 days. The shapes of the 3a-c assembly were found 
to be spherical and the size was consistent with the size found in DLS measurements. After 4 
days, the morphology and size found similar in the case of 3a and 3b (Figure 4-3 (D)). The 
distribution of R-POSS moiety in the assemble structure (at 1st day) was determined by high-
resolution dark field STEM/EDS observation[27] (Figures 4-3 (A)-(C)). The dark phase 
represents the region with lower electron density, so the copolymer assemblies are likely to be 
located in the bright phase.  From the elemental map of nitrogen (N), oxygen (O), phosphorous 
(P) and silicon (Si), the R-POSS and MPC molecule are likely to be located in the assemblies, 
and all the elements were found homogeneously distributed in the matrix. The results suggested 
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that the randomly incorporated R-POSS moiety help in the formation of stable (4 days) 
assemble structure in water.   
 
 
 
A) 
B) 
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Figure 4-3. STEM images of (3a-c) copolymer A) 3a, B) 3b and C) 3c at day 1:  i) dark-field 
STEM image and elemental map of ii) nitrogen (N) iii) oxygen (O) iv) phosphorous (P) v) 
silicon (Si) vi) composite map of all elements (N= yellow, O= red, P= blue, Si= green) D) TEM 
images of i) 3a (30K) ii) 3b (120K) iii) 3c (100K) iv) 3a (150K) and v) 3b (250K) after 4 days 
(Stability study). 
C) 
D) 
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The cytotoxicity of 3a-c assemblies (concentration of 1 mg/ml) after 24 h incubation was 
determined by CCK-8 assay. The cell viability was observed ~ 100 % and in some case more 
than 100 % (Figure 4-4).   
 
 
Figure 4-4. The cell cytotoxicity of  3a-c assemblies (1 mg/ml) at pH 7.   Each of the copolymer 
solution (10 µl) was added to HeLa cells seeded on the well plate (90 µl) and incubated for 24 
h at 37 ⁰𝐶 to measure the cell viability. Values are mean ± s.d. (n = 6).  Cell viability was 
determined using the CCK-8 Kits and the absorbance was detected at 450 nm. 
 
4-3.2 Characterization of PTX-solubilized copolymer (3a-c) assembly 
The PTX can be loaded in 3a-c copolymer assemble structure which helps in increasing 
the solubility of PTX. After the PTX loading, the z-average diameter was measured by DLS 
(Figure 4-5). The z-average diameter of both 3a and 3b decreased after the PTX loading 
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(Figure 4-5). The strong hydrophobic interaction between PTX and the R-POSS moiety leads 
to the shrinkage in hydrodynamic diameter. After 4 days, PTX loaded 3a and 3c copolymer 
maintained its original hydrodynamic size, while 3b copolymer showed an increase in size due 
to aggregation.  The results suggested that 3a copolymer association structure are stable in 
water after 4 days. 
 
 
 
Figure 4-5. Particle size (Z-average diameter (nm)) and ζ-potential of PTX-solubilized 3a-c 
assemblies in the water at 25 ̊𝐶 at the concentration of 1 mg/ml. The particle size was measured 
after 1 day and 4 days.   
 
4-3.3 Solubility of PTX in copolymers (3a-c) solution 
The solubility of PTX solubility in 3a-c copolymers and poly MPC different 
concentration solutions (5, 10 and 50 mg/ml) were evaluated by HPLC measurements (Figure 
4-6 (a)). The solubility of PTX in poly MPC aqueous solution was found less than the 
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detectable range (considered to be around 0 µg/ml). The 3a-c enhanced the solubility of PTX 
in an aqueous environment, especially at concentration 50 mg/ml. The PTX solubility was 
found in the order of C2H5 > C6H13 > C8H17, which indicates that shorter alkyl chain (R-group 
in POSS moiety) enhanced the hydrophobic interaction of copolymer with PTX. The results 
were also consistent with the CAC value observed in the study.   The solubility of PTX in 100 
mg/ ml concentration aqueous solution of 3a was also measured to evaluate the concentration-
dependent solubility (Figure 4-6 (b)).  The solubility of PTX at 100 mg/ml (3a copolymer 
solution) was found to be 75.5 ± 8.8 µg/ml. From the results, 3a copolymer was selected for 
further study and cell viability study.   
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Figure 4-6 (a) PTX solubility of in the presence of 3a-c and poly MPC in 5, 10, and 50 mg/ml 
concentration solution (b) 3a concentration-dependent (5, 10, 50 and 100 mg/ml concentration 
solution) PTX solubility. Initial PTX concentration was 1 mg/ml.  Values are mean ± S.D. (n 
= 3).   
 
4-3.4 Cell viability study of PTX solubilized copolymer (3a) 
The cell viability in PTX solubilized 3a copolymer aqueous solution of two different pH 
(pH 7 and pH 5) was measured and compared with free PTX as control (Figure 4-7). The final 
concentration of PTX dissolved in 3a was ~ 7.6 μg/ml and the free PTX was 100 μg/ml. The 
cell viability in free PTX was observed 38 ± 18 and 17 ± 10 % after 24 and 48 h respectively. 
Xu et al reported that HeLa cell viability in the presence of free PTX (concentration 10 μg/ml) 
after 24 and 48 h was about 50 and 30 % respectively[28].  According to that, the cell viability 
observed in free PTX with a concentration of 100 mg/ml in this study was identical.  The cell 
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On the other hand, cell viability in free PTX was found significantly low.  This indicates that 
the PTX solubilized in 3a was strongly bounded inside the copolymer association until 24 h. 
After 48 h, a significant decrease in cell viability was observed at 21 ± 5 %. The result 
suggested that PTX bounded with the 3a copolymer association was released in the cellular 
medium after 24 h.  The similar phenomena were also observed when solution pH was adjusted 
to 5 (Figure 4-7) which suggested the release of PTX from the copolymer association facilitate 
under the intracellular pH condition. The cellular uptake study of the 3a was performed to 
understand the mechanism of cytotoxicity due to the release of PTX. 
 
 
 
Figure 4-7. The cytotoxicity results of free PTX (initial conc.: 1 mg/ml) and PTX solubilized 
3a copolymer solution (100 mg/ml) at two different pH (pH 7 and pH 5).   Each of the solutions 
(10 µl) were added to HeLa cells seeded on a well plate (90 µl) and incubated for 24 and 48 h 
at 37 ⁰𝐶 to measure the cell viability. The final concentration of PTX in 3a solution and control 
was 7.6 and 100 µg/ml, respectively.  Values are Mean ± S.D. (n = 6) (*: P < 0.05 #: P < 0.05 
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vs control, one-way ANOVA, Fischer's test).  Cell viability was determined using the CCK-8 
Kits and the absorbance was detected at 450 nm. 
 
4-3.5 Cellular uptake of FITC labelled PTX solubilized copolymer (3a) 
The cellular uptake of PTX-solubilized 3a copolymer was observed by FITC-labelled 
PTX (4) which was synthesized and confirmed by 1H NMR and ECI-MS spectroscopy.  FITC 
labelled PTX was solubilized in the 3a solution following the same procedure as PTX. The 
green fluorescence intensity inside the cells was observed in Figure 4-8 (i) after 2 h incubation 
with 4 solubilized 3a. The cells treated with only 4 did not show any fluorescence color after 
the same incubation time.  After 24 h incubation, the green fluorescence color was observed 
inside the cells treated with both free 4 and 4 solubilized 3a, although most of the cells were 
found died due to the cytotoxicity of 4 (Figure 4-8 (ii)). The results suggested that 4 solubilized 
3a was internalized by the HeLa cells through cellular uptake mechanism within 2 h incubation.  
Therefore, from the results, it can be concluded that 3a assembly plays a major role in rapid 
cellular uptake process, followed by the release of paclitaxel in the targeted cells.  
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Figure 4-8. The CLSM images of HeLa cells i) control without FITC-PTX (upper), with free 
FITC-PTX (middle) and solubilized 3a (bottom) after 2 h incubation ii) free 4 and 4 solubilized 
3a after 5 and 24 h incubation. 
ii) 
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4-3.6 In vitro release of PTX from the copolymers (3a-c) assemblies 
In vitro release profile of PTX from the PTX solubilized 3a-c copolymers was studied 
using D-PBS (pH 7.4) and 1 % Tween 80 mixed solution as dissolution medium.  Figure 4-9 
indicated different release pattern of three PTX solubilized 3a-c copolymer. The initial burst 
release was not observed in case of all the PTX solubilized 3a-c copolymer which confirmed 
the absence of free PTX on the surface of the copolymer association.  The cumulative release 
of PTX from the PTX solubilized 3a copolymer assembly was reached to 30 %, while that from 
the other 3a and 3c copolymer was over 40 % at 47 h.  According to the STEM/EDS results 
(Figures 4-3 (A)-(C)), the R-POSS seem to be homogeneously distributed in the copolymer 
association. The slow release of PTX might be the effect of strong hydrophobic interaction 
between the hydrophobic region in the 3a copolymer association and PTX. From the results, it 
can be concluded that C2H5-POSS moiety in 3a copolymer effectively controlled the slow 
release of PTX. The results were also supported by the results of DLS (Figure 4-2 and Figure 
4-5) where the size of 3a copolymer association (~ 80 nm) was observed to be decreased after 
the PTX solubilization (~ 62 nm) and the structure remain stable for 4 days.   
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Figure 4-9. Released of PTX from PTX solubilized 3a-c copolymer vs. time curves of (square) 
PTX solubilized 3a, (circle) PTX solubilized 3b and (triangle) PTX solubilized 3c.  Values are 
mean ± S.D. (n = 3).   
The in vitro PTX release profile during the first 7 h was fitted in different mathematical 
models, and was interpreted from the graphical representation as shown in Figure 4-10. The 
highest degree of correlation coefficient (r2) represent the suitability of the mathematical model 
for drug release kinetics.   The PTX release from 3a follows the zero-order model (r2 = 0.9749) 
and 3c follows the first-order model (r2 = 0.9596) (Table 4-1). The Korsmeyer-Peppas model 
(eq 1) states the type of diffusion which can be evaluated by the value of n[29]. 
𝑀𝑡
𝑀∞
= 𝑘 ∙  𝑡𝑛      (eq. 1) 
 Where 
𝑀𝑡
𝑀∞
⁄  is the fraction of drug released at time t, k is the rate constant and n is the 
release exponent.   In case of 3a, the value of n was calculated to be 0.49.  Since the n value of 
the Higuchi model is approximated to 0.5, the calculated n value for 3a implies that the PTX 
release from the system follows Fickian diffusion. The drug release profile of 3a micelle system 
indicated the release of PTX followed the zero order and Higuchi model (r2 = 0.9094) which 
implies the controlled drug diffusion. The drug release profile and kinetics indicates controlled 
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and sustained drug release from 3a. The n = 0.53 in 3c implies that the PTX release follow the 
non-Fickian transport[29]. The 3c follows first-order kinetic model and did not maintain constant 
release rate. The release behavior of 3c implies rapid-to-slow release of PTX. The PTX release 
profile of 3b does not match with any mathematical model (Table 4-1) considered in the 
current study.  These mathematical models play an important role in the prediction of 
mechanism of drug release, drug release rate and diffusion behavior from the system.  
 
Table 4-1. The results of different model in terms of r2, slop and intercept 
Model 
Name 
3a 3b 3c 
r2 Slope Intercept r2 Slope Intercept r2 Slope Intercept 
Zero-order 
model 
0.9749 2.15 14.41 -0.1254 0.18 43.49 0.9132 7.53 27.22 
First-order 
model 
0.8555 0.04 92.76 0.4046 0.06 75.97 0.9596 0.17 86.87 
Higuchi 
model 
0.9094 18.09 0.00 -50.61 36.26 0.00 0.8258 39.87 0.00 
Korsmeyer-
Peppas 
model 
-19.10 0.49 31.44 -181.67 0.018 45.05 -25.78 0.53 76.75 
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Figure 4-10. Interpretation of PTX release profile with various mathematical models: (A) Zero 
order model (B) First order model (C) Higuchi model (D) Korsmeyer-Peppas model   
 
4-4. Conclusion 
The R-POSS and MPC based random copolymers (R-groups in POSS moiety modified 
with alkyl chain ethyl (C2H5), hexyl (C6H13), octyl (C8H17)) were evaluated as a solubilizing 
biocompatible carrier molecule of hydrophobic drug paclitaxel.   Among the series of R-POSS 
molecule consider in the current study, C2H5-POSS based MPC copolymer have shown 
promising contribution in terms of enhancement of paclitaxel solubility in an aqueous 
environment with high cellular uptake and release of paclitaxel at the intracellular environment. 
The hydrophobic C2H5-POSS moiety strongly interacted with paclitaxel controlled the release 
rate in an aqueous environment.  Based on the findings of the current investigation it can be 
concluded that C2H5-POSS and MPC based copolymer possess promising characteristics to be 
considered as polymeric biomaterials for enhancing the solubility of poorly water-soluble 
component like a drug, imaging prob, etc.   
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5-1. Introduction 
Paclitaxel (PTX) is known as one of the excellent regimens for the treatment of different 
types of cancer such as breast, ovary, stomach, lung, etc. The major limitation of the application 
of paclitaxel is its low aqueous solubility (~0.4 μg/mL) due to its hydrophobic nature. The 
mixture of Cremophor EL (polyoxyethylated castor oil) and dehydrated ethanol need to be used 
for intravenous administration to solubilized paclitaxel in the circulatory system. The solvents 
often are the reasons for a serious hypersensitivity reaction [1].  In order to avoid the problem, 
various formulation of paclitaxel (use of biocompatible materials, polymer) and different mode 
of administration has been investigated.  The various study on solid dispersion technology 
using biocompatible materials has been reported for the improvement of the solubility and 
dissolution of poorly water-soluble drugs like PTX [2,3].  For example, the incorporation of PTX 
into poly(ϵ-caprolactone)-based film [4].  The liposome delivery system was investigated to 
improve the aqueous solubility, stability and clinical efficacy of paclitaxel [5,6].  The 
nanoparticles (Abraxane®) and micelles (Genexol®, Nanoxel® and Paclical®) nanoplatforms 
have been investigated for clinical studies [7,8]. The cyclodextrin complexes system as a 
formulation to increase the water solubility has been reported [9,10],  which has observed a 
decrease in toxicity.  The promising clinical effects have not achieved yet. 
Oral administration of PTX is one of the important methods for successful 
implementation of low-dose metronomic (LDM) chemotherapy. The LDM chemotherapy 
focus on low doses frequent administration of the drug with no drug-free periods in the system. 
For successful implementation of this LDM chemotherapy oral doses form of PTX is important 
in term of patient convenience and compliance. The major limitation of the oral administration 
of paclitaxel is its poor aqueous solubility which leading to reduce the bioavailability [11]. The 
recent studies reported that glycyrrhizic acid (GA) micelle encapsulate the PTX and help in 
improving the oral bioavailability [12]. So, to develop the solid dispersion suitable polymer need 
to be designed depending on nature and chemical structure of the poorly water-soluble drug. 
For example, 2-methacryloyloxyethyl phosphorylcholine (MPC) and butyl methacrylate 
(BMA) based copolymer poly[MPC-co-BMA] has been synthesized [13], which could 
solubilize the PTX by encapsulating it (hydrophobic paclitaxel) in the hydrophobic domain and 
form a micelle-like structure in an aqueous environment [14].  The poly[MPC-co-BMA] was 
also applied for the preparation of solid dispersion of tranilast, [N-(3,4-dimethoxycinnamoyl) 
anthranilic acid], an anti-allergic BSC class II drug [15]. The study suggested that poly[MPC-
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co-BMA] improved the dissolution rate by the interaction between the polymer and tranilast.  
The polyvinylpyrrolidone (PVP) has been extensively studied for solid dispersions study to 
improve the dissolution rate poorly water-soluble drug without recrystallization [16].  The solid 
dispersion formulation containing PVP, sodium lauryl sulfate (SLS) and paclitaxel (PTX) have 
been studied and shown to increase the solubility and dissolution rate of PTX and the solid 
dispersion formulation was the first clinical trial of oral LDM chemotherapy [11].  From the 
literature review, it can be inferred that the design of water-soluble polymers which will interact 
and keep the paclitaxel in an amorphous state is one of the crucial factors for improving the 
solubility and dissolution rate of paclitaxel [17].  
Based on the literature review, focus was given on MPC as a hydrophilic monomer and 
R-POSS hydrophobic monomers as the BMA segment in poly[MPC-co-BMA] which as 
mentioned above was not optimized for the interaction and controlled release of PTX.   In the 
current study, a random copolymer of MPC (hydrophilic unit) and ethyl (C2H5) group-modified 
polyhedral oligomeric silsesquioxane (POSS) (hydrophobic unit) was synthesized (Chapter 2, 
Scheme 2-1).  The obtained copolymer 3a was observed to be non-cytotoxic [18], and form 
hydrophobic domain in water through hydrophobic interaction. Additionally, the copolymer 
solubilizes the paclitaxel and the strong interaction between the C2H5-POSS and paclitaxel 
strongly correlated with the slow release of PTX from a micelle-like association (Chapter 4) 
This finding encourages for further application of the copolymer 3a toward the preparation of 
homogeneous PTX solid formulation. The current study suggested that 3a is a potential carrier 
of PTX in the formulation of drug/polymer mixture.  The solid formulation of 3a and PTX was 
prepared by simple evaporation technique.  The hydrophilic carrier PVP was added to the 
formulation to evaluate the role of PVP in the 3a copolymer matrix.   The solid states of PTX 
in the PVP and 3a polymeric matrix was characterized by X-ray diffraction (XRD), Fourier 
transforms infrared spectroscopy (FT-IR), and differential scanning calorimetry (DSC).   The 
dissolution behavior of paclitaxel from the formulation of 3a copolymer/ PVP/PTX was 
investigated and the effect of the 3a copolymer on the dissolution of PTX was also discussed 
in this study.  The enhancement in PTX dissolution without any precipitation was observed, 
which can be correlated with the amorphous state of PTX in the copolymer / PVP matrix. 
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5-2. Experimental Section 
 
5-2.1 Materials 
The 2-(Methacryloyloxy) ethyl phosphorylcholine (MPC) was purchased from NOF 
Corporation (Tokyo, Japan). The 3a copolymer was synthesized in the laboratory as described 
in the Chapter 2. The mol. % of C2H5-POSS in the 3a copolymer was calculated by the 
1H 
NMR spectrum and value found to be 2 mol. %. The PTX was purchased from FUJIFILM 
Wako Pure Chemical Corporation, Japan. The PVP K30 (Mn = 50,000) was purchased from 
Sigma-Aldrich Co. LLC. (St. Louis, U.S.A). The other reagents and solvents were used without 
any further purification. 
 
5-2.2 Paclitaxel solid formulation preparation using 3a copolymer and PVP  
The solid formulation was prepared by the solvent method. The 3a copolymer, PTX and 
PVP were dissolved in dehydrated ethanol with a ratio of 3a : PVP : PTX = 44 : 44 : 12 wt. % 
and mixed with continuous stirring. The solvent was removed under reduced pressure inside 
vacuum dryer at 25 ℃. The 3a/PTX (3a : PTX = 88 : 12 wt. %) and PTX/PVP (PVP : PTX = 
88 : 12 wt. %)  formulations were also prepared following the same procedure.   
 
5-2.3 Dissolution study 
The dissolution of the solid formulation was studied following the European 
Pharmacopoeia, using a type 2 (paddle) dissolution apparatus (NTR-6100A, Toyama Sangyo 
Co., Ltd., Japan). The dissolution study was conducted in a 500 ml dissolution medium 
containing 2nd Fluid mixed with 1 % Tween 80 mixed solution. The 1 % Tween 80 maintained 
the sink condition and acted as solubilizing agent of drug. The temperature 37 ⁰C and a stirring 
speed of 100 rpm were maintained during the study. The 10 mg solid formulation was 
considered for dissolution study containing 1.1 mg equivalent of PTX.  The 25 ml sample 
solutions were collected in the different time interval (5, 10, 20, 30, 40, 50, 60, 90, 120 and 180 
min) and an equivalent amount of fresh media was added to keep the volume constant. The 
dissolution of PTX was determined by measurement of concentration of PTX in dissolution 
medium using HPLC equipped with UV-vis detector (Gilson 119 UV/VIS Detector), two 
pumps (GILSON 805 Manometric Module and 306 Pump), a mixer (GILSON 811c dynamic 
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mixer), a column (TSKgel ODS-100S (Φ 4.6 nm × 150 mm) (TOSOH Co., Japan)). All the 
samples were filtered by 0.45 µm pore size PVDF membrane filters before each measurement. 
The mixed solution of methanol and water (with a ratio of 70:30 v/v) was used as the mobile 
phase and the flow rate of 1 ml/min was maintained during the measurement. The wavelength 
of 227 nm was fixed for the detection of PTX peak. The PTX dissolution was calculated using 
the PTX standard curve. The PTX standard curve was prepared by plotting the area under the 
peak vs. different concentration (considering the different concentration 100, 50, 10, 1, 0.1 
µg/ml in methanol). The resulting standard curve was linear with 𝑅2 = 0.9949.  All the 
dissolution experiments were conducted triplicate. 
 
5-2.4 X-ray diffraction (XRD)  
Powder X-ray diffraction was carried out using an X-Ray Diffractometer (RINT2000, 
Rigaku Co., Japan) with monochromatic CuKα radiation and the generator working at 40 kV 
and 20 mA. Scattering intensity was measured in the range of 2 < 2θ < 60⁰ with scan steps 1⁰ 
min-1. 
 
5-2.5 Fourier transform infrared spectroscopy (FT-IR)  
The chemical bonds of the solid formulation were characterized by Fourier transform 
infrared spectroscopy (FT-IR) using apparatus (JASCO FT/IR-460plus). The scanning wave 
numbers ranged from 4,000 to 400 cm-1. The KBr was used for the attenuated total reflectance 
crystal. The spectra were recorded from KBr pellets, prepared by mixing the solid formulation 
with KBr at room temperature. The spectrum resolution was 4 cm-1, and the 2 mm sec-1 scans 
were accumulated to determine one spectrum. 
 
5-2.6 Differential scanning calorimetry (DSC)  
Thermal analyses of the solid formulation were carried out by differential scanning 
calorimetry (DSC) using apparatus (EXSTAR 6000/DSC6200, Seiko Instruments Inc., Japan). 
The scan rate was considered 10 °C min-1 (1st cooling, 2nd cooling, 1st heating and 2nd heating) 
within the temperature range between 20 and 185 °C. The glass transition temperature (Tg) was 
obtained at the midpoint of change in the baseline of DSC thermograms of 2nd heating. The 
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𝑇𝑔 𝑚𝑖𝑥  of the solid formulation (blend) 
[11] of amorphous  polymer blend was calculated by 
using the Fox-equation, 
1 𝑇𝑔 𝑚𝑖𝑥⁄  = ∑ 𝑤𝑖 𝑇𝑔 𝑖⁄𝑖    ..... (1) 
where 𝑤𝑖 is the weight fraction of the i
th pure component and 𝑇𝑔 𝑖 is the glass transition 
temperature (in Kelvin) of the ith pure component.  
 
5-3. Results and Discussion 
 
5-3.1 Characterization of the solid formulation (3a/PVP/PTX) 
In the current study, three different solid formulations were prepared considering the 
PTX weight % same:  3a : PVP : PTX = 44 : 44 : 12 wt. % (3a/PVP/PTX),  3a : PTX = 88 : 12 
wt. % (3a/PTX) and PVP : PTX = 88 : 12 wt. % (PV/PTX).  The crystalline and amorphous 
states of PTX and polymers were characterized by XRD, DSC and FT-IR measurement. 
XRD spectra of the 3a, PVP, PTX, and the three different solid formulations were 
represented in Figure 5-1 (i). The PTX showed semi-crystalline diffraction peaks at 5.5°, 8.7° 
and 12.6° (Figure 5-1 (i)-C). The observed peaks were consistent with the previous report [20].  
The characteristic peaks of PTX as observed in Figure 5-1 (i)-C were not seen in solid 
formulations of 3a/PTX, PVP/PTX, and 3a/PVP/PTX (Figure 5-1 (i)-D, E & F), suggesting 
the amorphous state of PTX in the formulation [4]. From the results, it can be concluded that 
PTX was homogeneously distributed over the 3a/PVP/PTX formulation [11, 19]. 
The Tg of the solid formulations and constituent polymers (3a and PVP) were calculated 
from DSC thermograms (Figure 5-1 (ii)), which supported the results observed in XRD. The 
Tg of 3a, PVP and PTX were observed at 69.9 ⁰C (~343 K), 156.1 ⁰C (~429 K) and 105.9 ⁰C 
(~379 K), respectively (Figure 5-1 (ii)-A, B and C). The Tg obtained in case of PVP was 
consistent with the previous report [20]. From this observation, it can be stated that the 
calculation of Tg values from the 2
nd heating curves in case of PVP was reliable. It is known 
that paclitaxel exhibits a melting point around 213-217 ⁰C as a semi-crystal phase [21] and also 
bears a Tg value as an amorphous phase 
[22].  In the solid formulation of 3a/PVP/PTX single Tg 
was observed at 91.1 ⁰C (~364 K) (Figure 5-1 (ii)-F).  
According to the Fox-equation (1), Tg mix of the 3a/PVP/PTX was calculated to be 98.1 
⁰C (~381 K), approximately. The Fox-equation (1) only applicable to the prediction of the 
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properties of pure components. The contribution of asymmetric entropic and enthalpic does not 
reflected in this equation. Also, the Fox-equation (1) does not reflect the strength of 
intercomponent and intracomponent interaction, entropic effect, structural heterogeneity term 
and composition dependent energetic contribution from hetero-contact. The limitations of the 
Fox-equation (1) has been considered in the study which suggested that Tg and Tg mix are not 
directly comparable. 
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Figure 5-1. X-ray diffraction (XRD) spectra (i), DSC thermogram (ii), FT-IR spectra 
(iii) of A: 3a; B: PVP; C: PTX; D: 3a/PTX; E: PVP/PTX; F: 3a/PVP/PTX and FT-IR 
spectra (iv) of A: PTX; B: 3a/PTX physical mixture; C: PVP/PTX physical mixture; D: 
3a/PTX /PVP/PTX physical mixture. 
 
In amorphous binary systems, the glass transition temperature and microstructure are 
closely related. The microstructural characteristics are evident of miscibility in binary polymer 
and drug/polymer mixture ( 3a/PVP/PTX system) [25, 26]. The analytical equation proposed by 
Brostow et. al. (Brostow, Chiu, Kalogeras and Vassilikou-Dova (BCKV) equation) for the 
prediction of glass transition temperature (Tg) that characterizes the binary systems of polymer 
blends or copolymers depending on their composition [24]: 
 
𝑇𝑔 = ∆𝑇𝑔 + 𝑥1𝑇𝑔1 + (1−𝑥1)𝑇𝑔2 …….. (2) 
∆𝑇𝑔 = 𝑥1(1 − 𝑥1)[𝑎0 + 𝑎1(2𝑥1 − 1) + 𝑎2(2𝑥1 − 1)
2] ……… (3) 
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where ∆𝑇𝑔 the term is the deviation from the linear function (additional term in FOX equation), 
xi is the mass fraction of component i, ai is the parameters of the polynomial (a quadratic 
polynomial for binary systems). In the above equations (2) and (3), 𝑎𝑖 parameters need to be 
determined to correlate with the experimental data and it highlight the complexity of the binary 
systems [24].  The higher deviation observed from the experimental and predicted Tg values 
calculated from the Fox equation (1) represent the increased system complexity. The 
parameters 𝑎𝑖  in the equation reflected the strength of intercomponent and intracomponent 
interactions, entropic effects, structural heterogeneities, composition-dependent energetic 
contributions from hetero-contacts [23]. The BCKV equation has been used to correlate the 
experimental data of drug plus polymer mixture (poly(vinyl pyrrolidone‐co‐vinyl acetate) ) and 
the results indicated that the results from the equation was a good agreement with the 
experimental data[25].   
 The ∆𝑇𝑔  which represent the system complexity in the BCKV equation to the 
formulation of 3a/PVP/PTX was determined. The TgDSC was determined from the DSC 
thermogram (Figure 5-1 (ii)) and Tg mix was calculated using the FOX equation.  The difference 
between TgDSC and Tg mix represent the ∆𝑇𝑔 which was calculated -14, -45 and -17 K for 3a/PTX, 
PVP/PTX and 3a/PVP/PTX respectively (Table 5-1).  According to the equation (3), the ∆𝑇𝑔 
values include a0-a2 parameters (in the case of 3a/PVP/PTX, a0-a3 due to the trinary systems). 
Since the parameters ai indicate the interaction energies and structural heterogeneities, the 
energetic term related to the interaction between 3a, PVP and PTX in solid formulations will 
exhibit in this value. The smaller ∆𝑇𝑔 values of the 3a/PTX and 3a/PVP/PTX than PVP/PTX 
solid formulation suggested that 3a copolymer has some contribution toward increasing the 
miscibility of PTX.    
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Table 5-1 The TgDSC ,  Tg mix and ∆𝑇𝑔 values of the solid formulations, 3a copolymers and PTX 
Sample 𝑻𝒈𝑫𝑺𝑪
a) (K) 𝑻𝒈𝒎𝒊𝒙
b) (K) 
∆𝑻𝒈 
(= 𝑻𝒈𝑫𝑺𝑪-𝑻𝒈𝒎𝒊𝒙)  (K) 
3a 343 - - 
PVP 429 - - 
PTX 379 - - 
3a/PTX 333 347 -14 
PVP/PTX 377 422 -45 
3a/PVP/PTX 364 381 -17 
a) Experimental Tg values from DSC thermogram 
b) Calculated from FOX equation (1) 
 
The Tg value is dependent on the mass fraction in case of binary polymer and 
drug/polymer mixture. In the current study single Tg at 91 ⁰C was observed and it was higher 
than the Tg of 3a copolymer (69.9 ⁰C). The observation is similar to the conventional miscible 
organic blends [23].  It can be stated that the presence of single Tg value represents the miscibility 
and strong interaction between PTX, PVP and 3a copolymers in single homogeneous phase 
[11]. Additionally, the increased Tg value of 3a copolymer from 70 ⁰C to 91 ⁰C suggests the 
increased stability of PTX due to strong interaction in 3a/PVP/PTX homogeneous formulation 
[22].  
The FT-IR spectrum of PTX (Figure 5-1 (iii)-C) represented strong carbonyl bands 
around 1714 cm-1 (C=O, ketone),1735 cm-1 ((C=O)-O-, ester), 1643 cm-1 (aromatics), 1071 cm-
1 (C-O-C).  In case of  3a copolymer, the corresponding ester bonds appeared at 1724 cm-1 
((C=O)-O-, ester) and 1080 cm-1 (P-O) from MPC segment [26] (Figure 5-1 (iii)-A).  In 3a/PTX 
(Figure 5-1 (iii)-D), the similar spectrum of 3a was observed which suggested that 
incorporation of PTX in the 3a copolymer matrix was difficult to confirm from the IR 
spectrum. The FT-IR spectrum of 3a/PTX was governed by the 3a copolymer. When PVP was 
incorporated in the formulation (3a/PVP/PTX), many jagged peaks around 1705-1740 cm-1 
were appeared (Figure 5-1 (iii)-F). This observation suggested the restricted molecular 
interaction between individual components. This result was consistent with the DSC data which 
indicated high 𝑇𝑔 𝑚𝑖𝑥  of the solid formulation.  This result also indicated the contribution of 
PVP toward the reduction of crystallinity in the solid formulation.  FT-IR measurements of the 
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physical mixtures of 3a/PTX, PVP/PTX and the 3a/PVP/PTX were performed to confirm the 
detection of 12 wt. % PTX in FT-IR spectra (carbonyl bands at 1714 cm-1 (C=O, ketone) and 
1735 cm-1 ((C=O)-O-, ester) in addition to 1643 cm-1 (aromatics) and, 1071 cm-1 (C-O-C)) 
(Figure 5-1 (iv)). The FT-IR spectra of the physical mixture of the component were observed 
to be the summation of the spectra of an individual component. This result suggested the 
negligible interactions between the components in the physical mixture. In case of the 
formulation, PTX was found more homogeneously distributed over the 3a and PVP matrix than 
physical mixture [11]. Considering all the results (XRD, DSC and FT-IR spectra) it can be 
concluded that PTX exist as an amorphous state in the homogeneous single-phase formulation. 
 
5-3.2 Dissolution profile of solid formulation (3a/PVP/PTX) 
The dissolution profile of PTX from the solid formulation of 3a/PVP/PTX, 3a/PTX and 
PVP/PTX was studied by in vitro dissolution tests.  Figure 5-2 indicate that the dissolution 
rate of PTX from 3a/PVP/PTX was higher than the 3a/PTX and PVP/PTX solid formulation 
in the first 10 min. Here, the dissolution rate was considered as the slope of the first liner curve 
section between 0 and 10 min.  The cumulative release amount of PTX from 3a/PVP/PTX was 
saturated until 20 min and then the dissolution was observed to be accelerated. The accelerated 
dissolution rate dissolved ~90% PTX at 40 min.  As the similar complicated dissolution 
behavior was not observed in the case of the 3a/PTX and the PVP/PTX, the first stage of the 
dissolution (until 20 min) might be due to the synergistic effects of the 3a and PVP in the solid 
formulation. In the second stage (from 20 min to 40 min) the dissolution might be governed by 
the 3a as the apparent dissolution behavior observed to be similar to the 3a/PTX.   The 
maximum dissolution of PTX from 3a/PVP/PTX was around 2 µg ml-1 (almost complete 
dissolution of PTX) during 40 min. The similar phenomenon was also observed in the 3a/PTX, 
where the solubility of PTX was observed around 1.5 µg/ml in 40 min. After reaching the 
maximum dissolution %, the dissolved concentration % was observed to be decreased. The 
decreased in PTX concentration was due to the rise of crystal nucleation rate of PTX which 
represent the ratio of the supersaturated solubility to the solubility of the crystal [27]. This is the 
general phenomenon observed in the case of the homogeneous solid formulation.  
The in-vitro drug release profile (first 0 to 0.5 h time) was fitted in different mathematical 
model. The highest degree of correlation coefficient (r2) represent the suitability of the 
mathematical model for drug release kinetics.   The PTX release from 3a/PVP/PTX follows 
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the Higuchi square root model (r2 = 0.96996) and 3a/PTX  (r2 = 0.96008) and PVP/PTX (r2 = 
0.94711) follows the zero-order model. In case of 3a/PVP/PTX and 3a/PTX  the release 
exponent n is lower than 0.5 which indicate that the drug release from the system follow Fickian 
diffusion. In case of PVP/PTX the value of the n = 0.52 which indicate that the drug release 
follow the non-Fickian transport. 
 
 
Figure 5-2. Dissolution profiles of PTX from solid formulations in mixed solution of 2nd 
fluid and 1 % Tween 80 at 37 ⁰C; (■):  3a / PVP / PTX; (●):  3a/ PTX; and (▲)): PVP / 
PTX.  Values are Mean ± S.D. (n = 3).   
 
The higher apparent dissolution of PTX from 3a/PVP/PTX was caused by various factors 
like i) the amorphous state of PTX in the formulations (Figure 5-1 (i)-F & D), ii) enhanced 
solubilizing effect of 3a (solubility of PTX 75.5 ± 8.8 µg in 3a 100 mg mL-1 solution) [19], iii) 
inhibition of recrystallization of amorphous PTX by PVP. The amphiphilic nature 3a [19] 
prevent the immediate recrystallization of amorphous PTX at the water interface and reduce 
the interfacial tension between PTX and water [28].  The amount of PTX dissolution was 
observed to be lower in case of PVP/PTX than 3a/PVP/PTX and 3a/PTX which suggested that 
hydrophilic PVP matrix (absence of hydrophobic moiety) induced the recrystallization of PTX. 
Thus, from the results, it can be concluded that incorporation of the 3a in the solid formulation 
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plays a crucial role in modulation of the dissolution behavior of PTX which help in providing 
PTX supersaturation around the media [29].  
 
5-4. Conclusions 
The 3a amphiphilic copolymer was used to prepare the solid formulation of PTX and 
PVP.  The 3a/PVP/PTX solid formulation formed a single phase homogeneous formulation 
and enhance the dissolution rate of PTX. The improved wettability and amphiphilic nature of 
3a copolymer facilitated the rapid and complete release of paclitaxel (~ 90% within 40 min.). 
The interaction between PTX and 3a copolymeric matrix in 3a/PVP/PTX solid formulation 
reduced the mobility of amorphous PTX, which help in the enhancement of PTX dissolution. 
Therefore, it can be concluded that the formulation of 3a/PVP/PTX would be a promising 
combination to enhance the physicochemical nature of PTX. 
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6-1. Introduction 
The nanoparticle-mediated drug delivery has revealed great progress in the field of cancer 
therapy where the side effects of chemotherapeutic drugs can be reduced by nanoparticle-
mediated delivery into tumors site. The appropriate size of the nanoparticle can deliver the drug 
to the specific tumor tissues via passive enhanced permeability with negligible toxicity to the 
other organs. The appropriate size also can help the nanoparticles (NPS) to escape the 
macrophage phagocytosis and rapid clearance from the blood circulation system. The micellar 
nanoparticle system, which formed by the self-assembling of amphiphilic copolymers, have 
been extensively studied for their great role in the enhancement of the solubility of hydrophobic 
anticancer drugs (poorly soluble in water). This nanoparticle (micelles) contain a lipophilic 
core which solubilizes hydrophobic drugs and a hydrophilic shell which help in solubilizing 
the entire micelle system in water. The small dimensions of polymeric micelles (> 200 nm) 
advantageous for escaping the renal excretion and also for avoiding the recognition of the 
reticular endothelial system (RES) [1, 2]. 
The amphiphilic di-block copolymers containing a hydrophilic and hydrophobic segment 
form a micellar structure in an aqueous environment. The hydrophobic drug can be easily 
entrapped into the hydrophobic core of micelle using various techniques like 
solution/precipitation etc. The amphiphilic di-block copolymers composed of poly(ethylene 
glycol) (PEG), polyacrylamide, dextran, polyvinyl alcohol, polyvinylpyrrolidone, PEG-based 
hydrogels, etc. have been widely studied as a hydrophilic chain. Among them, PEG is 
commonly used as a hydrophilic chain. The study has reported that low molecular weight (> 
3000) PEG is cytotoxic to the body [2]. The phosphorylcholine (PC) group has reported being 
a promising replacement of PEG as it possesses biomimetic biocompatibility, which was come 
from its mimicking nature with phospholipid membrane bilayers. Principally the presence of 
PC group reduces the protein adsorption and cell activation, which help in avoiding 
macrophage-mediated RES removal [3]. The 2-methacryloyloxyethyl phosphorylcholine 
(MPC) has a polar phosphorylcholine (PC) group, which help in providing the excellent 
biocompatibility in copolymer containing MPC and another hydrophobic unit. The amphiphilic 
di-block copolymers  micelle system of MPC (as a hydrophilic chain) have been widely studied 
such as poly(2-methacryloyloxyethyl phosphorylcholine)-b-poly(2-(diisopropylamino)ethyl 
methacrylate (MPC100– DPA100) have been shown to possess biomimetic and pH-responsive 
properties [4], poly[MPC-co-n-butyl methacrylate (BMA)] (PMB30W)/ PLA nanoparticles 
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have been shown to possess high dispersive stability which restrained the adsorption of blood 
components [5], pMPCm-BMAn micelle have been shown to increase the water solubility of 
PTX [6], cholesterol-end-capped poly(2-methacryloyloxyethyl phosphorylcholine) (CMPC) 
micelle have been shown to reduce in size (less than 200 nm) after drug loading with no 
cytotoxicity [2]. The copolymers of poly(2-methacryloyloxyethylphosphorylcholine)-b-
poly(butylene succinate)-b-poly(2 methacryloyloxyethyl phosphorylcholine) (PMPC-b-PBS-
b-PMPC) formed micelles with sizes ranging from 108 to 170 nm. The DOX-loaded micelles 
showed high cytotoxicity to and internalized by HeLa cells. The PMPC-b-PBS-b-PMPC 
micelles minimized the clearance of the reticuloendothelial system and prolonged the 
circulation time [3]. The PMPC40-b-PDPA70 assemblies were internalized by the cells more than 
PEO122-b-PDPA43 or PHPMA64-b-PDPA72 system. The assemblies were internalized by cancer 
(HeLa) more, compared to the healthy (Telo-RF) cells due to the stronger binding of PMPC to 
cell membranes [7]. 
The amphiphilic di-block copolymer, PHEMA-POSS-b-P(DMAEMA-co-CMA), 
synthesized via reversible addition-fragmentation chain transfer (RAFT) polymerization, form 
spherical micelles in an aqueous environment with POSS core and stimuli-responsive shell [8]. 
The tetraphenylporphyrin tetrasulfonic acid hydrate (TPPS)-loaded polymeric capsules 
containing light illumination produced cytotoxic singlet oxygen to kill the tumor cells. The 
MePEG-b-P(MAPOSS-co-DPA) was synthesized by atom transfer radical polymerization 
(ATRP), which produced spherical micelles with core-shell structure and possess a pH-
responsive property [9]. The poly(L-glutamic acid) dendrimers containing POSS nanocubic 
core conjugated with doxorubicin was prepared via pH-sensitive hydrazine bond and biotin 
used as targeting ligand. The faster release of doxorubicin at pH 5.0 (than at pH 7.0) was 
observed due to the acid cleavage of the hydrazine bonds [10]. The poly (ethylene glycol) (PEG)-
polyhedral oligosilsesquioxane (POSS) nanostructured core-shell nanoparticles were 
synthesized and insulin was encapsulated in the core. The study found that insulin was 
protected at gastric pH for 2 h and released at intestinal pH 6 - 7 where the absorption and 
activation of insulin are necessary [11]. Thus, POSS-containing inert vertex groups attached to 
the silicon-oxygen cage promote the formation of a well-patterned micelle structure for its 
hydrophobic nature and controlled the drug release. The aggregation of POSS- moiety forms 
regular stable hydrophobic micelle core that encapsulates the hydrophobic drug. 
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The objective of this chapter is to develop amphiphilic copolymer which can form 
micelle in an aqueous environment and has an important implication in encapsulation of 
hydrophobic drug molecules inside and can be internalized by the cells. In this work, 
amphiphilic di-block copolymers were synthesized by chemically modifying POSS cage 
(vertex R-groups modified with ethyl (C2H5), hexyl (C6H13), octyl (C8H17)) and polymerization 
of POSS cage with MPC polymer unit via RAFT polymerization to create POSS-based MPC 
amphiphilic block copolymers.  RAFT polymerization process was selected as it needs a lower 
temperature (70 ℃) for polymerization and does not need any metal complex. Also, RAFT 
polymerization allows the design and synthesis of polymers with a well-defined architecture 
and controlled molecular weight (Mw) with relatively low polydispersity which forms 3D 
supramolecular self-assembly structures in an aqueous environment when the adequate 
hydrophilic/ hydrophobic balance is reached [6]. The effect of chemical modification (vertex R-
groups modified with ethyl (C2H5), hexyl (C6H13), octyl (C8H17)) of POSS cage (keeping the 
hydrophilic chain length same) was investigated based on size, surface charge, hydrophobic 
drug encapsulation, drug releasing behavior. The cellular uptake and intracellular distribution 
of FITC-PT- loaded polymeric association in HeLa cell line were investigated by fluorescence 
microscopy and flow cytometry analysis. The encapsulation and releasing behavior of α −
Tocopherol (α-TP) (Figure 6-1) were additionally studied (along with PTX) to understand the 
interaction between hydrophobic drugs and the hydrophobic domain (POSS cage with different 
vertex R-group) of copolymers. The combination of DLS (particle size 20-50 nm), fluorescence 
microscopy and flow cytometry results suggested that R-POSS-based MPC copolymer could 
be a promising candidate for hydrophobic drug encapsulation and intracellular drug delivery. 
From the viewpoint of literature review, R-POSS based MPC block copolymer micelle system 
with the potential for application in intracellular hydrophobic drug delivery has not been 
investigated earlier. 
 
 
Figure 6-1. Chemical structure of α − Tocopherol (α-TP)  
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6-2. Experimental Section 
 
6-2.1 Materials 
The block copolymers 3a'-c'were synthesized in the laboratory as described in the 
previous Chapter 2, Scheme 2-2 (ii). The molecular weight ( 𝑀𝑛 ) of copolymers were 
calculated by the 1H NMR spectrum and the values summarized in the tabular form.  The 
Dulbecco's Modified Eagle Medium (DMEM), Dulbecco's phosphate-buffered saline (DPBS), 
0.25 %-Trypsin/1mM-EDTA solution, penicillin-streptomycin mixed solution and sodium 
carbonate were purchased from Nacalai Tesque, Inc. (Kyoto, Japan). The Fetal Bovine Serum 
(FBS) was purchased from Sigma-Aldrich Co. LLC. (St. Louis, U.S.A). The water used in all 
experiments was purified with a Millipore Milli-Q system. The other reagents and solvents 
were used without any further purification. The HeLa cells (Health Science Research 
Resources Bank, Osaka, Japan) were cultured in DMEM supplemented with 10% FBS and 100 
U/mL penicillin-streptomycin mixed solution. The cells were cultured in a humidified 
incubator at 37 ⁰C under 5% CO2 atmosphere. 
 
6-2.2 Measurements 
 
6-2.2.1 Dynamic light scattering (DLS) 
Dynamic light scattering (DLS) measurements of nanoparticles were carried out using a 
light scattering instrument (Zetasizer Nano ZS, Malvern Instruments, UK). The measurement 
was performed at 25 ̊C in water with the 3a'-c' copolymer concentration of 1 mg/ml. Samples 
were filtered by 0.45 µm pore size filter before measurements. The hydrodynamic radius (RH) 
of the copolymer was determined by using the Stokes-Einstein relation Eq. (1) with 𝐷 =
 𝜏−1𝑞−2 : 
𝑅𝐻 =  
𝑘𝐵𝑇𝑞
2
6𝜋𝜂
𝜏 … . (1) 
Where 𝑘𝐵 is Boltzmann constant, T is the absolute temperature, q is the scattering vector, 
𝜂 is the viscosity of the solvent and 𝜏is the mean relaxation time. The polydispersity indexes 
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were determined using cumulant analysis of the autocorrelation functions monitored at 90o as 
Eq. (2) 
ln 𝑔1(𝑡) = ln 𝐶 −  Γt +  
𝜇2
2
𝑡2 … . (2) 
Where C is the amplitude of autocorrelation function and Γ is the relaxation frequency 
(𝜏−1). The parameter 𝜇2 (the second order cumulant) was used to calculate the polydispersity 
index of the samples (PDI = 𝜇2/Γ
2). 
CAC was measured using DLS to the aqueous 3a'-c' copolymer solutions of 
concentration varying from 0.0001 to 1 mg/ml. Above the CMC, the intensity of scattering 
light increases due to the presence of micelles and the intercepts obtained in the correlation 
functions are much higher. 
 
6-2.2.2 Static light scattering (SLS) 
Static light scattering (SLS) measurements were performed using Otsuka Electronic 
Photal (Osaka, Japan) DLS-7000 at 20 °C. A He–Ne laser (10.0 mW at 632.8 nm) was used as 
a light source. Each (3a'-c') copolymer was dissolved in a 10 mM PBS (pH 7.4) with polymer 
concentration (Cp) = 0.5 g/L and stirred overnight and then filtered using a membrane filter of 
0.45 μm pore size. The 3a' copolymer was stirred overnight at 60 °C, but it wasn’t soluble 
completely. The difference between the Rayleigh ratio (Rθ) of the solution and that of the 
solvent due to the angular dependence can lead to the estimation of the weight-average 
molecular weight (Mw) and z-average radius of gyration (Rg) from the following relationship 
Eq. (3): 






+= 2
2
g
w
p
3
1
1
1
qR
MR
KC
 …. (3) 
where K is the optical constant and q is the magnitude of the scattering vector. The K 
value was calculated using K = 4π2n2(dn/dCp)2/NAλ4, where n is the reflective index of the 
solvent, dn/dCp is the refractive index increment against Cp, NA is Avogadro’s number, and λ 
is the wavelength of the light source. The q value was calculated using q = (4πn/λ)sin(θ/2), 
where θ is the scattering angle. Values of dn/dCp at 633 nm were determined using an Otsuka 
Electronics Photal DRM-3000 at 20 °C. 
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6-2.2.3 Electrophoretic light scattering (ELS) 
The electrophoretic light scattering (ELS) measurements were performed using a 
Zetasizer Nano ZS instrument (Malvern Instruments, UK). The measurement was performed 
at 25 ̊C in water with the 3a'-c' copolymer concentration of 1 mg/ml. Samples were filtered by 
0.45 µm pore size filter before measurements. The value of electrophoretic mobility (𝑈𝐸) were 
converted to the value of 𝜁-potential (mV) through Henry’s equation (4): 
𝑈𝐸 =  
2𝜀𝜁𝑓(𝑘𝑎)
3𝜂
… . (4) 
Where 𝜀 is the dielectric constant of the medium and 𝜂 is the viscosity. The Henry’s 
function 𝑓(𝑘𝑎) was calculated through the Smoluchowski approximation 𝑓(𝑘𝑎) = 1.5.  
 
6-2.2.4 Transmission electron microscopy (TEM) 
Transmission electron microscopy (TEM) images were collected using a TEM apparatus 
(JEOL JEM-1230, JEOL, Japan) at an accelerating voltage of 100 kV. Samples were prepared 
on 200 mesh copper grids. Before the measurements, the 3a'-c' samples were vacuum dried 
and kept overnight in vacuo. 
 
6-2.2.5 Preparation of micelles and drug-loaded micelles  
Polymeric micelles were prepared by dialysis approach. 10 mg of 3a'-c' copolymers were 
dissolved in 1 ml ethanol using ultrasonication for 30 min. The solutions were dropped by drop 
added into 10 ml of pure water with vigorous stirring for 24 h. The mixture was then transferred 
into a dialysis tube (MWCO = 2,000) and dialyzed against water for 24 h to eliminate organic 
solvent. The inside phase of the dialysis tube was filtered by 0.45 𝜇𝑚 pore size filter. The 
copolymeric micelle solutions were then used for stability study by DLS and 𝜁 -potential 
measurements (0, 5, 8, 11, 12 days keeping at 25 ⁰C). 
 PTX and α − Tocopherol (α-TP)-loaded polymeric micelles were prepared following 
the method mentioned above. The 3a'-c' to drug weight ratio was considered 10:1. One part of 
drug-loaded polymeric micelle solution was then used for stability study by DLS and 𝜁 -
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potential measurements (0, 2, 5 days keeping at 25 ⁰C) and another part was lyophilized for 
drug release study. 
Drug loading content (DLC) and Drug loading efficiency (DLE) was measured using 
HPLC (acetonitrile : water (60 : 40) (PTX)/ methanol : water (70 : 30) (α − Tp) mobile phase, 
flow rate of 1 ml/min) by dissolving the drug (PTX and α − Tp)-loaded polymer into methanol. 
DLC and DLE % were calculated according to the following equations (5) & (6): 
DLC (%) =
Mass of drug in micelle
Mass of drug − loaded micelle
 × 100 … . (5) 
DLE (%) =
Mass of drug in micelle
Mass of drug in feeding
 × 100 … . (6) 
 
6-2.2.6 In vitro drug release studies  
The PTX-loaded copolymer (3a'-c') micelles (3 mg of lyophilized solid powder) were 
dissolved in 1 ml of D-PBS (pH 7.4).  The solutions were then placed into a dialysis membrane 
bag with a molecular cut-off of 6,000 – 8,000 Da. The dialysis membrane bag was then placed 
in a vial containing 25 ml of D-PBS (pH 7.4) and 1 % Tween 80 mixed solution. The vials 
were placed in shaking bed maintaining the temperature 37 ̊C with the shaking speed of 100 
rpm. At predetermined time interval, 1 ml of the release medium was withdrawn for 
concentration measurement and an equal volume of fresh D-PBS (pH 7.4) and 1 % Tween 80 
mixed solution was added to keep the volume constant. The concentration of paclitaxel release 
in the releasing medium and end PTX-loaded micelle sample (unreleased PTX inside dialysis 
tube) was monitored by HPLC measurement (GLISON HPLC system, see section 2.4) at a 
detection wavelength of 228 nm. Before measurement, the sample was filtered with a 0.45 µm 
pore-size filter. Mixture of acetonitrile (60%) and water (40%) were used as the mobile phase 
with a flow rate of 1 ml/min.  In vitro α − Tocopherol  release study was additionally 
performed following the same procedure for better understanding of the drug release profile 
and hydrophobic drug-copolymer interaction.  
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6-2.2.7 Biological Assays 
 
6-2.2.7.1 Cell Viability 
The biocompatibility of the (3a'-c') copolymer samples and cell viability of drug-loaded 
polymeric micelles were determined using Cell Counting Kit-8. The cells (HeLa) were seeded 
into 96-well plate in volumes of 90 µl (5000 cells/ well in DMEM media supplemented with 
10% FBS) and incubated overnight at 37 ⁰C. The drug-loaded copolymer (3a'-c') was dissolved 
in 1 ml of D-PBS solution (pH 7.4) using ultrasonication (for 10 mins). 10 µl of drug-loaded 
copolymer micelles solutions were added to each well to give a final concentration of Paclitaxel 
2 µg/ ml and α-Tocopherol 108 µg/ml (paclitaxel and α-Tocopherol concentration in copolymer 
micelles were calculated from DLC %) and incubated for 24 & 48 h at 37 ⁰C. The 
biocompatibility of the copolymer (without drug loaded) was measured following the same 
procedure mentioned above and the final concentration of copolymer was considered the same 
as PTX-loaded copolymer micelle concentration used in cell viability study. Only media and 
only cell in the well were considered as blank (bl) and positive control (c+) respectively in this 
experiment. 10 µl of CCK-8 reagent was added to each well and incubated for 2 h at 37 ⁰C. 
The absorbance of each well was measured using microplate reader (Microplate Reader SH-
9000 Lab, Corona Electric Co., Ltd, Japan) at a wavelength of 450 nm. The % Cell viability 
was calculated using the Eq. 7. Where I450
s, I450
bl and I450
c+ represents the absorbance of 
copolymer Samples, Blank and Positive Control respectively. 
% Cell Viability =  
I 450
        s − I 450
        bl
I 450
        c+ −  I 450
        bl
 × 100 … . (7) 
 
6-2.2.7.2 Cellular Uptake  
FITC labelled paclitaxel (FITC-PTX) was encapsulated inside the copolymeric micelle 
(by dialysis approach) to visualize the cellular uptake. FITC-PTX was synthesized according 
to the literature [12]. The HeLa cells were seeded into a 24-well plate with a cell density of 
20,000 cells/ well in 1 ml DMEM media supplemented with 10% FBS and incubated overnight 
at 37 ̊C before the experiment. After 24 h incubation, the growth media removed and the cells 
were treated with serum free medium containing free FITC- PTX (2 µg/ml) and FITC-PTX 
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loaded copolymeric (3a'-c') micelles (equivalent FITC-PTX= 2 µg/ml) for 2, 6 h. The media 
were removed and washed with D-PBS for 3 times. The cellular uptake was observed and 
imaged immediately (each well containing 0.5 ml D-PBS) using a fluorescence inverted 
microscope (EVOS Digital Inverted Microscope, Life Technologies, Carlsbad, CA, USA). 
 
6-2.2.7.3 Flow cytometry  
Cellular uptake of FITC labelled PTX loaded (3a'-c') copolymers were further quantified 
by flow cytometry using BD FACS Canto II flow cytometer (CA, U.S.A.). The experimental 
procedure was similar to cellular uptake experiment except that after 2 h of incubation the cells 
were collected, washed three times with D-PBS and resuspended in D-PBS for the 
measurement. 10,000 events were collected for each experiment and acquisitions were perform 
in triplicate. 
 
6-3. Results and Discussion 
 
6-3.1 Characterization of di-block (3a'-c') micelles 
The di-block (3a'-c') copolymers were synthesized by RAFT polymerization using 
PMPC61 as the CTA were characterized by 
1H NMR and FT-IR measurements (Chapter 2, 
Figure 2-5(i)-(iii)).  The results of SLS and DLS were summarized in the Table 6-1. The CMC 
values of all the copolymers (3a'-c') were found in the range of 49-92 μg/ml, so that the SLS 
and DLS measurements of the copolymers were conducted at a concentration of 0.5 mg/ml.  
Since the copolymers are di-block copolymers, the copolymer above CMC are likely to form a 
core-shell type micelle structure with hydrophobic R-POSS blocks forming the cores and 
hydrophilic poly(MPC) blocks forming the shells. The aggregation number (Nagg) was 
calculated from the ratio of the apparent molecular mass of the micelle (Mw (SLS)) and the 
number-average molecular weight (Mn (NMR)) of the unimer (Table 6-1). The values of Nagg 
for 3a', 3b'and 3c' were 41, 4.1 and 1.5, respectively (Table 6-1). These results suggested that 
the aggregation ability of the copolymers decreased with increasing the long alkyl chain length 
of R-POSS in the copolymer. Our previous study also supported this phenomenon: the C2H5-
POSS part in a random copolymer enhanced the hydrophobicity of a copolymer coated film 
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interface in the presence of water[13].  In order to evaluate how the alkyl chain length, affect the 
compaction of micelle formation, the Rg and Rh values of those copolymers were estimated 
(Table).  The Rg values of 3a', 3b'and 3c' were 44.9, 50.4 and 32.6, respectively. Also, the Rh 
values of 3a', 3b'and 3c' were 36.1, 43.0 and 26.1, respectively. These results suggest that 3b' 
exhibited somewhat expanded states, because both Rg and Rh values showed the highest ones 
although the Nagg value was just 4.1.  Since the Rg/Rh values provide the shape of molecular 
aggregates, the Rg/Rh values of the copolymers were compared with each other.  The Rg/Rh 
values of 3a', 3b'and 3c' were 1.24, 1.17 and 1.25, respectively. It is known that the ideal Rg/Rh 
value of hard spherical particle is 0.778.  If the packing state of the aggregates decreases or the 
polydispersity of the aggregates increases, then the Rg/Rh value increases around 1.5−1.7 for 
flexible linear chains in a good solvent[14].  Therefore, the polymeric micelles of 3a', 3b'and 
3c' were close to a spherical shape with somewhat polydisperse in size.  The polydisperse states 
of the micelles could be confirmed by the size distribution data obtained by DLS measurements 
(Figure 6-2).  Since the size distribution of 3a' was extremely small (Figure 6-2), 3a' forms 
tightly packed association in conjunction with the high Nagg value (Table 6-1).   On the other 
hand, 3b' and 3c' exhibited relatively broad two peaks representing the micelles and/or 
oligomers (Figure 6-2).  Considering the low Nagg values of 3b' and 3c', longer alkyl chains of 
C6H13- and C8H17- on the POSS part induced loosely packed association to form the micelle.    
Transmission electron microscopy (TEM) images also supported the packing states 
(Figure 6-3). From the TEM images of 3a', 3b'and 3c', spherically shaped images were 
observed, while they are quite polydisperse in size. Especially, the TEM image of 3b' (Figure 
6-3) showed that the clear and monodispersed particles (diameters 30-50nm) were uniformly 
distributed in a broadly distributed large aggregate. Thus, the size of the copolymers found in 
the TEM images was found to be consistent with the size that was obtained from DLS results.   
ζ-Potentials of 3a', 3b'and 3c' were - 0.12, -7.5 and -0.91 mV, respectively.  Only the 
3b' micelles showed the highest negative values: the loosely packed association and the 
polydisperse states of 3b', as seen in Figure 6-2 and Figure 6-3, might disrupt the 
intermolecular interaction. 
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Table 6-1. Dynamic and static light scattering (DLS & SLS) results of 3a'-c' copolymer in 10 
mM PBS (pH 7.4) 
Sample 
Mwa × 10
5 
(g/mol) 
Mn × 10
5 
(NMR) 
(g/mol) 
Naggc 
Rga 
(nm) 
Rhb
 
(nm) 
Rg/Rh 
dn/dCp 
(mL/g) 
ξ-Potential 
(mV) 
CMC 
(DLS) 
(μg/ml) 
MPC61-block-
C2H5-POSS13 
(3a') 
10.7 0.261 41 44.9 36.1 1.24 0.0141 -0.12±0.26 49.1 
MPC61-block-
C6H13-POSS13 
(3b') 
1.29 0.312 4.1 50.4 43.0 1.17 0.1889 -7.5±0.60 24.5 
MPC61-block-
C8H17-POSS12 
(3a') 
0.497 0.325 1.5 32.6 26.1 1.25 0.1269 -0.91±0.29 91.8 
a Estimated by SLS in PBS buffer. b Estimated by DLS in PBS. c Aggregation number of a polymer 
micelle calculated from Mw of the micelle determined by SLS and Mw of the corresponding unimers 
determined by Mn(NMR). 
d Estimated by DLS measurements. 
  
 
 
Figure 6-2. Size distribution of 3a' (MPC61-block-C2H5-POSS13), 3b' (MPC61-block-C6H13-
POSS13) and 3c' (MPC61-block-C8H17-POSS12) copolymer in 10 mM PBS (pH 7.4). 
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Figure 6-3. The TEM image of 3a' (MPC61-block-C2H5-POSS13), 3b' (MPC61-block-C6H13-
POSS13) and 3c' (MPC61-block-C8H17-POSS12) copolymer  
 
The stability of the obtained 3a'-c' copolymer micelles was determined by DLS 
measurements (Figure 6-4). After standing up to 12 days at 25 ⁰C, the hydrodynamic diameter 
of 3a' (Figure 6-4 (A)) and 3c' (Figure 6-4 (C)) did not increase. The spherical micelles 
formed in aqueous environments by the C2H5-POSS13 –based tightly packed association 
contributed to the good stability.  In case of the 3c', even though the formation of the micelle 
was loosely packed manner but hydrophobic interaction due to the C8H17 alkyl chain 
maintained the micelle formation. Besides, 3b' (Figure 6-4 (B)) showed growth in size after 5 
days, suggesting that the C6H13- moiety is thermodynamically unfavourable for the micelle 
formation.   
 
(3a') (3c') 
100 nm  200 nm  200 nm  
(3b') 
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Figure 6-4 Particle size (Z-average diameter) change of (A) 3a', (B) 3b' and (C) 3c' copolymer 
micelles in water at 25 ̊C at the concentration of 1 mg/ml. The solutions were measured at 
different time interval 0, 5, 8, 11 and 12 days.   
 
6-3.2 Characterization of drug-loaded di-block (3a'-c') copolymers micelles  
As described in section 6-3.1, 3a', 3b'and 3c' formed polymeric micelles, but the 
association states were governed by the R-groups in POSS moiety.   In order to evaluate how 
the polymeric micelle formation, affect poorly soluble drugs, we performed encapsulation of 
PTX and α-TP into the micelles.  
Table 6-2 summarized the Z-average size (nm) change of polymeric micelles with or 
without PTX loading.  The diameter of 3a' was found to decrease after loading of PTX (day 0), 
indicating the strong interaction between PTX and C2H5- POSS moiety, which leads to the 
shrinkage and well consistent with our previous data[12].  In the case of 3c', the diameter was 
not changed after PTX loading: the long alkyl chain (C8H17) induced the hydrophobic 
interaction with PTX. This phenomenon also indicates that the PTX was encapsulated in the 
core of the micelle. On the contrary, the hydrodynamic diameter was observed to increase for 
3b' micelle after PTX loading, which suggests that the huge aggregation was induced by the 
PTX encapsulation. Considering the unstable state of 3b'as seen in Figure 6-2 (DLS) and 
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Figure 6-3 (TEM), the micelle-like formation was rearranged by the interaction with PTX. The 
PTX-loaded 3a' and 3c' micelles were found to be stable after 5 days at 25 ⁰C. After 5 days, 
3b' showed an increase in hydrodynamic size due to the enhanced aggregation formation. 
 
Table 6-2. Z-average size (nm) change of PTX-loaded 3a'-c' copolymer micelles in distilled 
water at 25 ̊C  
Sample a 
Without PTX-loaded b PTX-loaded b 
Day 0 Day 5 Day 0 Day 5 
MPC61-block-C2H5-POSS13 
(3a') 
53 ± 9.1 21 ± 1.5* 24 ± 0.9 25 ± 1.8 
MPC61-block-C6H13- POSS13 
(3b') 
35 ± 0.2 64 ± 0.5* 106 ± 2.7 198 ± 14.8* 
MPC61-block-C8H17- POSS12 
(3c') 
21 ± 0.3 19 ± 0.5* 21 ± 4.4 16 ± 1.1 
a  The concentration was 1 mg/ml.   b Z-average diameter (nm) (Mean ± SEM) (n = 3) 
 (*) indicates significantly different (p<0.05) from day 0 (Student t-test) 
 
Similar experiments were performed using α-TP (Table 6-3). The diameter of all the α-
TP loaded copolymers (3a'-c') were in the range of 49-52 nm, and those were found to be stable 
after 5 days. Abrupt reduction of polydispersity index (0.09 - 0.15) was observed after α-TP 
loading, indicating the uniform size distribution. This observation indicates that α-TP 
molecules were encapsulated inside the micelle core, presumably due to the preferable 
intermolecular interaction between the aliphatic carbon chain in α-TP and the peripheral alkyl 
groups of POSS moiety in the micelle core and help in forming stable micelle structure[15]. 
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Table 6-3. Z-average size (nm) change of α-tocopherol (α-TP) loaded 3a'-c' copolymeric 
micelles in distilled water at 25 ̊C  
Sample a 
Without α-TP-loaded b α-TP-loaded b 
Day 0 Day 5 Day 0 Day 5 
MPC61-block-C2H5-POSS13 
(3a') 
53 ± 9.1 21 ± 1.5* 51 ± 0.7 54 ± 0.6* 
MPC61-block-C6H13- POSS13 
(3b') 
35 ± 0.2 64 ± 0.5* 49 ± 0.7 54 ± 0.3* 
MPC61-block-C8H17- POSS12 
(3c') 
21 ± 0.3 19 ± 0.5* 52 ± 0.5 58 ± 0.8* 
a  The concentration was 1 mg/ml.   b Z-average diameter (nm) (Mean ± SEM) (n = 3) 
 (*) indicates significantly different (p<0.05) from day 0 (Student t-test) 
 
DLC and DLE of PTX loaded micelle were calculated using Eq. (5) and (6), respectively. 
The DLC of PTX for 3a', 3b'and 3c' were found to be 0.033 %, 0.024 % and 0.031 % 
respectively, while DLE of them were 0.44 %, 0.30 % and 0.20 %. The DLC and DLE were 
found to be relatively low in this case. Generally, the DLC and DLE depend not only on 
hydrophobicity and core size of the amphiphilic molecules but also the chemical structure of 
the drug.  Since PTX does not bear normal aliphatic chains, the peripheral alkyl chains of the 
POSS moiety in the micelle core are not likely to fit the PTX chemical structure due to the 
enhancement of the intermolecular interaction.  Additionally, DLC and DLE of α-TP were also 
investigated to gain a better understanding of the phenomenon. It was observed that DLC of α-
TP for 3a', 3b'and 3c' were 3.6 %, 5.6 % and 3.6 %, respectively. Similarly, DLE of α-TP for 
each copolymer was 35 %, 53 % and 35 %, respectively. Since α-TP contains 4,8,12-
trimethyltridecyl chain, the long aliphatic chain has the potential to provide good compatibility 
with the aliphatic core region of the polymeric micelles via hydrophobic interactions, resulting 
in high DLC and DLE values. Thus, loading capacity and efficiency of the 3a'-c' copolymeric 
micelles were influenced by the selection of drug molecules.  
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6-3.3 In vitro drug release from (3a'-c') copolymers micelles  
PTX release from the 3a', 3b'and 3c' copolymer micelles was monitored by a dialysis 
method for 52 h.  However, the PTX concentration in the outer medium at each sampling time 
could not be determined because the PTX concentration was below the detection limit of the 
HPLC measurements. This indicates the strong interaction between PTX and micelle inside the 
core, which leads to a negligible level of PTX release from the 3a', 3b'and 3c' copolymer 
micelles. Additionally, the α-TP release was also investigated to compare the PTX release 
(Figure 6-5). It was found that even after 61 h, the α-TP release from 3a', 3b'and 3c' copolymer 
micelles was 37 %, 12 % and 20 %, respectively. Because of higher DLC and DLE of α-TP 
than those of PTX, the amount of α-TP released slowly to the outer medium was determined.  
Both the phenomena can be explained that, once the drugs were encapsulated to the micelle 
core, most of the drugs were maintained in the copolymer micelles.    
 
 
 
Figure 6-5. α-TP release from α-TP -loaded 3a'-c' copolymer micelles: vs. time curves (A) (●) 
3a' (MPC61-block-C2H5-POSS13), (B) (▼) 3b' (MPC61-block-C6H13-POSS13) and (C) (◄) 3c' 
(MPC61-block-C8H17-POSS12) micelles.  Values are mean ± S.D. (n = 3).   
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6-3.4 Cell viability (in (3a'-c') copolymers micelles) 
Cell viability of the 3a'-c' copolymers were evaluated using HeLa cells. All the 
copolymers showed excellent cell viability after 24 and 48 h (Figure 6-6). The cytotoxic 
activity of PTX-loaded copolymeric micelles was evaluated (initial PTX concentration: 2 
μg/ml) (Figure 6-7). After 24 h, the cell viability was almost 90 % in all the PTX-loaded 
copolymers and free PTX. After 48 h, the cell viability reduced to around 50 % in all the 
copolymers and free PTX. This means that, if the efficacy of cellular uptake of the copolymers 
was assumed to be similar to the free PTX, those copolymers can release PTX in the 
intracellular environments rapidly, or the PTX-loaded micelles themselves acted as the 
anticancer compounds. Xu et al reported that HeLa cell viability of free PTX at 10 μg/ml was 
about 50 and 30 %, for 24 and 48 h of incubation respectively[16]. In our case, PTX 
concentration was 2 μg/ml, which is much less than the reported concentration to decrease the 
cell viability after 24 h. This is why it took 48 h to decrease cell viability.  However, it is 
difficult to understand why there was no difference between the free PTX and the PTX-loaded 
micelles, and therefore, cellular uptake study was performed. 
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Figure 6-6. The cell viability of (A) 3a' (MPC61-block-C2H5-POSS13), (B) 3b' (MPC61-block-
C6H13-POSS13) and (C) 3c' (MPC61-block-C8H17-POSS12) (~11 mg/ml in cell-seeded plate).   
Each of the solutions (10 µl) were added to HeLa cells seeded well plate (90 µl) and incubated 
for 24 h and 48 h at 37⁰C to measure the cell viability. Values are mean ± s.d. (n = 6).  Cell 
viability was determined using the CCK-8 Kits and the absorbance was detected at 450 nm. 
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Figure 6-7. The cell viability % in presence of PTX-loaded copolymer micelle: (A) 3a' 
(MPC61-block-C2H5-POSS13), (B) 3b' (MPC61-block-C6H13-POSS13) and (C) 3c' (MPC61-
block-C8H17-POSS12) (each micelle contains PTX concentration 2 μg/ml seeded cell plate ).   
Each of the solutions (10 µl) were added to HeLa cells seeded well plate (90 µl) and incubated 
for 24 h and 48 h at 37 ⁰C to measure the cell viability. Values are mean ± s.d. (n = 6).  Cell 
viability was determined using the CCK-8 Kits and the absorbance was detected at 450 nm. (#) 
indicate significantly different (p<0.05) from the control sample (Two sample t-Test). 
 
6-3.5 Cellular uptake of (3a'-c') copolymers micelles 
Cellular uptake of the copolymers and its intracellular localization were investigated by 
using FITC-PTX-loaded copolymer[12,17]. FITC-PTX (Figure 6-8) was used as a green 
fluorescent probe, and the green fluorescent intensity was considered to be attributed by the 
FITC-PTX that was loaded in the copolymer micelles. Figure 6-9 (a) shows the fluorescent 
microscope images of HeLa cells after 2 h incubation with free FITC-PTX and FITC-PTX-
loaded micelles. The fluorescent intensity of free FITC-PTX in the cells is likely to increase as 
compared to control.  Similarly, the green fluorescent colour of the FITC-PTX-loaded 3a' and 
3b' was found inside the cells after 2 h.  It is to note that the intensity of FITC-PTX-loaded 3c' 
seemed to be enhanced as compared with the other two copolymers.   The fluorescent intensity 
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of FITC-PTX in the cells increased with incubation time (6 h) Figure 6-9 (b)). These results 
suggest that the 3c' might modulate the cellular uptake.  However, since this hypothesis is just 
based on the qualitative observation, we conducted FACS measurements of the same sample 
series after 2 h incubation.    
 
 
 
Figure 6-8. Structure of FITC-PTX 
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Figure 6-9. The Fluorescence microscopy images of HeLa cells treated with medium without 
a fluorescent prob, free FITC-PTX and FITC-PTX-loaded copolymer micelles 3a', 3b'and 3c' 
(each micelle contains paclitaxel concentration 2 μg/ml seeded cell plate) after (a) 2 h and (b) 
6 h incubation. 
 
6-3.6 Quantitative assessment of cellular uptake of (3a'-c') copolymers: Flow cytometry  
The flow cytometry results were summarized in Figure 6-10.  As shown in Figure 6-10 
(i), both the free FITC-PTX and the FITC-PTX-loaded copolymers increased the intensity level 
as compared to control, indicating the cellular uptake of both the free FITC-PTX and the FITC-
PTX-loaded copolymers after 2 h.  In order to quantitatively discuss the cellular uptake, mean 
fluorescence intensity (MFI) was calculated and summarized in Figure 6-10 (ii).  The MFI of 
the FITC-PTX-loaded 3b'and 3c' micelles were found to no different from free FITC-PTX, 
while only the MFI of FITC-PTX-loaded 3a' micelle was significantly smaller than that of the 
free FITC-PTX.  Considering the tightly packed association state of 3a' micelle (Table 6-1 
and Figure 6-2), it can be considered that the relatively harder morphology of 3a' micelle 
might reduce the cellular uptake.  Among the copolymer micelles, the cellular uptake of the 
FITC-PTX-loaded 3b' was higher than that of the 3a' and 3c'. Previous reports suggest that the 
particle size and the distribution play an important role in cellular uptake which achieves a 
maximum in the size range of ~25-35 nm. Cellular uptake goes down for larger particles. The 
cellular uptake also depends on the surface charge (negative zeta potential caused electrostatic 
repulsion and hamper particle membrane interaction), hydrophobic nature of the core of the 
particle. It is noted that the size of PTX-loaded 3b' was around 106 nm (Table 6-2: higher than 
the other copolymers), and the zeta potential was -10 mV (the highest negative charge among 
the copolymers) after PTX loading. Taking the unstable micelle formation of 3b' into account 
(Table 6-2), the amphiphilic unimer or oligomers of 3b' might disrupt cellular membrane to 
enhance the uptake.  Overall, cellular uptake level of FITC-PTX-loaded copolymer micelles 
was similar to the free FITC-PTX, suggesting the PMPC shell of the micelles did not disturb 
the cellular uptake.  Recently, de Castro et al. reported that PMPC has a strong affinity towards 
specific receptors that are expressed by most of the cells due to the phosphorylcholine group[7]. 
Therefore, the PMPC shells of the copolymers are likely to enhance the uptake similar to the 
free FITC-PTX, although the mechanism of uptake was independent. 
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Figure 6-10. Flow cytometry data of (i) histograms (count vs fluorescence intensity) and the 
(ii) mean fluorescent intensity for FITC-PTX-loaded copolymer micelles (A) 3a', (B) 3b' and 
(C) 3c' (each micelle contains FITC-PTX concentration 2 μg/ml seeded cell plate) in HeLa 
cells after 2 h incubation. The mean fluorescence intensity was calculated by total 10000 
events. (*) Statistically significant different compared to free FITC-PTX and (#) statistically 
significantly different compared to control. 
 
6-4. Conclusion 
In this chapter, amphiphilic di-block copolymers of 2-(methacryloyloxy)ethyl 
phosphorylcholine (MPC) and methacrylate R-POSS (vertex R-groups of POSS cage modified 
with ethyl (C2H5), hexyl (C6H13), octyl (C8H17) alkyl chain) were synthesized via RAFT 
polymerization.  All the di-block copolymers formed spherical micelles in an aqueous 
environment within the range of 26-43 nm. By changing the alkyl chain length of R-POSS 
block, solution properties of the polymeric micelles were modulated: C2H5 induced tightly 
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packed association, in which ca. 41 3a' (MPC61-block-C2H5-POSS13) molecules were 
aggregated.  By changing the R-groups to C6H13 and C8H17, they induced loosely packed 
association, in which ca. 2-4 di-block copolymer molecules were aggregated.  We found that 
only 3b' (MPC61-block-C6H13-POSS13) micelle was unstable due to the polydisperse nature.   
All the micelles were able to encapsulate hydrophobic drugs inside the core, the stability of 
which was dependent on the chemical structure of the drugs: poorly soluble drugs bearing long 
alkyl chains such as α-TP were suitable for the R-POSS core.  Cellular uptake of PTX-loaded 
micelles was governed by the PMPC-related cellular uptake phenomena. Therefore, the 
amphiphilic copolymers of MPC and R-POSS prepared by RAFT polymerization could be a 
promising candidate for controlled micelle formation and the selective hydrophobic drug 
encapsulation and potential as a carrier for drug delivery.  
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7-1. Introduction 
Liposome has high potential as a carrier of bioactive molecules due to its 
biocompatibility, low toxicity, low antigenicity[1,2]. Liposomes can carry both hydrophilic and 
hydrophobic drug and protect them from the surrounding environment. The major limitations 
of its wide application are lack of mechanical and chemical stability. The instability of the 
liposome leads to leakage of bioactive molecules entrapped in the inner water phase[2]. 
Different approach has been investigated to improve the stability of liposome such as 
polymerization of phospholipid with diene or acrylate moiety[3-5], combination with polymer[6-
9], ionic complexation with natural polyelectrolyte[6], introduction of hydrophobic group in 
water soluble polymer as anchor[7-9] etc. A poly(ethylene glycol)-modified liposome was 
investigated to achieve the long term circulation in the body[7]. It was assumed that PEG on the 
liposome surface attract the water shell which provide a steric barrier against the recognition 
by the cells of mononuclear phagocyte system. The major limitation PEGylated liposomes 
systems are that second dose of PEGylated liposomes intravenous injection causes extensively 
accumulate in liver. This phenomenon is known as “accelerated blood clearance (ABC) 
phenomenon”[10]. Different liposomal surface coating approach has been reported to improve 
its stability. The polysaccharide having cholesterol moiety has been reported for liposome 
coating. The cholesterol moiety act as anchor for fixation of polysaccharide on the liposomal 
surface which improve the stability and cell-specific targeting[9]. The hydroxyapatite (HA) has 
been used for liposome coating which helps in reducing the release rate of hydrophobic drug 
indomethacin[11]. Hyaluronic acid coated liposomal formulation has been studied for paclitaxel 
delivery. The study showed that hyaluronic acid electrostatically attracted to the liposome 
surface and provide better antitumor efficacy[12]. Poly(MPC-co-BMA) has been studied for 
coating the liposome surface. The results of the study indicated that MPC molecules interact 
with the liposome surface and enhanced its stability in physiological environment [2]. 
Interpenetration of hydrophobic group in liposomal membrane induced instability in some 
cases.  
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Random and di-block copolymers using MPC and alkylated POSS, which were 
synthesized in Chapter 2 (Figure 7-1),  have shown excellent biocompatibility and form 
highly stable micelle in aqueous environment. The R-group of hydrophobic POSS moiety was 
located on the surface and induced surface hydrophobicity. The micelles composed of the 
copolymers, uptake by the cell due to the affinity of the MPC molecule toward specific receptor 
located in cell membrane. The study revealed that amount of phospholipid adsorption increases 
with increase in MPC molecules on MPC-based polymer surface. Based on the fact that MPC 
polymers have an affinity for phospholipid, MPC and POSS copolymers were subjected for 
investigating of stabilization of liposomes. This hypothesis in this study was that the alkylated 
POSS moieties act as an anchor to liposomal membrane for fixation of the copolymers on the 
surface of liposome. Also, the hydrophilic MPC will remain on the surface and provide stability, 
bio- and hemocompatibility. The DSPE-PEG-2000 modified liposome was parallelly 
investigated as a control sample to compare the results.   
 
                    
 
Figure 7-1. Structure of MPC and R-POSS based copolymers i) random copolymer (3a-c) ii) 
di-block copolymer (3a'-c') 
 
7-2. Experimental Section 
 
7-2.1 Liposome preparation 
Liposomes consisting of L- 𝛼 -phosphatidylcholine (HSPC) and cholesterol were 
prepared by thin-film hydration method. HSPC (228 mg, 300 𝜇mol) and cholesterol (77.3 mg, 
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200 𝜇mol) were dissolved in chloroform (10 ml) and transferred in an eggplant flask. The 
solvent was removed under reduced pressure using rotary evaporator. Equal amount of D-PBS 
was added and sonicated for 30 min. The extrusion was performed using Avanti Lipid 
miniextruder (100 nm polycarbonate membrane filter, 21 times) to prepare liposome with 
narrow size distribution.  
To entrap the doxorubicin, 255 mM (pH 5.25, 9.5 ml) (NH4)2SO4 was added instead of 
D-PBS and hydrated at 65 ℃ for 30 min. This is followed by same extrusion process and then 
the solvent was replaced to D-PBS by passing through the column. Unmodified liposome 
suspension (14 ml) and DOX (13.88 mg) aqueous solution (1 ml) (solvent- D-PBS) were mixed 
and incubated at 65 ℃ for 1 h. The unencapsulated DOX was removed by gel filtration column 
chromatography.   
To prepare the coated liposome equal volumes of liposomal suspension and 1 % w/v 
concentration copolymer solution (in D-PBS) were slowly added. The mixtures were stirred 
for 1 h at room temperature. The surface modification of liposome by DSPE-PEG-2000 was 
carried out following the similar procedure except stirring at 65 ℃. The modified liposomes 
(liposome containing DOX coated with copolymer and DSPE-PEG-2000) was separated by 
passing through the chromatographic column.  
 
7-2.2 Transmission electron microscopy (TEM) 
Transmission electron microscopy (TEM) images were collected using JEOL JEM-
ARM200F at an accelerating voltage of 200 kV. Samples were prepared using 200 mesh copper 
grids. Before the measurements, the samples were vacuum dried and kept overnight in vacuo.  
An energy-dispersive X-ray analysis (EDS) attached to the scanning TEM-high angle annular 
dark field (STEM-HAADF) was performed.  
 
7-2.3 Particle size and zeta potential measurement 
Dynamic light scattering (DLS) measurements were carried out to determine the average 
hydrodynamic diameter and size distribution of both with or without DOX-loaded copolymers 
and DSPE-PEG-2000 modified liposome. The zeta potential of both with or without DOX-
loaded copolymers and DSPE-PEG-2000 modified liposome were also measured in D-PBS 
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and 1 : 1 D-PBS and FBS  mixed solution. The measurement was performed using a light 
scattering instrument (Malvern, EXSTER DSC600) with 90° as a scattering angle. The stability 
measurement was performed after standing the sample at 37 ℃  for 0, 1, 3 and 8 days 
(copolymer-modified DOX encapsulated liposomes). The DLS measurement was performed 
at 25 ℃ in the water of 1 mg/ml concentration sample. Every samples were measured three 
times to analyse the mean diameter and zeta potential.   
 
7-2.4 Differential scanning calorimetry 
The phase transition temperature (Tc) of liposomal bilayer membranes represents the 
rippled gel-liquid crystalline phase transition and can be measured using DSC apparatus 
(EXSTAR 6000/DSC6200, Seiko Instruments Inc., Japan).  The 6-7 mg lipid samples were 
weighted in aluminium pan and 20 μl of 2.5 mg/ml copolymers and DSPE-PEG-2000 aqueous 
solution was added. The pan was then hermetically sealed. The scan rate was considered 5 °C 
min-1 (1st cooling, 2nd cooling, 1st heating and 2nd heating) within the temperature range between 
20 and 80 °C. The Tc was evaluated from DSC thermograms of 2
nd heating cycle. The empty 
aluminium pan was used as reference[1].  
 
7-2.5 Cellular Uptake  
HeLa cells were seeded into a 24-well plate with a cell density of 10,000 cells/ well in 
1 ml DMEM media supplemented with 10% FBS and incubated overnight at 37 ̊C before the 
experiment. After 24 h incubation, the growth media removed and the cells were treated with 
serum free medium containing unmodified liposome, copolymers modified liposome and 
DSPE-PEG-2000 modified liposome (DOX concentration 10 µg/ml) for 2, 6 h. The media were 
removed and washed with D-PBS for 3 times. The cellular uptake was observed and imaged 
immediately (each well containing 0.5 ml D-PBS) using a fluorescence inverted microscope 
(EVOS Digital Inverted Microscope, Life Technologies, Carlsbad, CA, USA). 
 
7-2.6 Flow cytometry  
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Cellular uptake of modified liposomes was further quantified by flow cytometry using 
BD FACS Canto II flow cytometer (CA, U.S.A.). The experimental procedure was similar to 
cellular uptake experiment except that after 2 and 6 h of incubation the cells were collected, 
washed three times with D-PBS and resuspended in D-PBS for the measurement. 10,000 events 
were collected for each experiment and acquisitions were perform in triplicate. 
 
7-3. Results and discussion 
 
7-3.1 Characterization of liposomes 
The particle size of copolymer-modified liposome was measured by DLS in D-PBS 
(pH7.4) at 25 ̊C, and the z-average diameters were 230-270 nm with PDI of 0.40-0.57 in D-PBS 
(Figure 7-2 (i)). The results represented that modified liposome had little bigger size (3a, 3c, 
3a' and 3b') in comparison with non-mollified liposome (241 nm). The MPC is a hydrophilic 
molecule which uptake water and swell in aqueous environment. Zeta potential is known as a 
factor of surface electrostatic charge of particles. After modification with copolymers the 
surface of liposomes showed little increase in negative charge (non-modified liposome ζ-
potential= -2, modified liposome ζ-potential= -3).  
TEM images of the obtained liposomes were subjected to investigate the morphology 
of the liposomes (Figure 7-2 (ii)). The images represented that the modified liposomes were 
spherical in shape with aggregation. After modification with 3a, 3b, 3a' and 3b' smooth and 
more compact surface morphology was observed. The size of particles observed from TEM 
image was less than the hydrodynamic size observed from DLS measurements. This 
inconsistency might be due to the TEM image taken in dry state whereas the DLS measurement 
was taken in aqueous solution of D-PBS. The swelling may be the reason for higher size being 
observed in DLS measurement.   
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Figure 7-2 (i) Particle size (Z-average diameter) of the modified liposomes in D-PBS (pH7.4) 
at 25 ̊C (ii) TEM images of copolymer-modified liposomes 
 
The distribution of copolymers on DOX encapsulated liposome surface in dry state was 
determined by high-resolution dark field STEM/EDS observation (Figure 7-3). In case of 3b 
and 3c', the element analysis results indicated that the surface was mainly covered by the 
phosphorous (P) molecule in dry state. In the case of 3a, 3c, 3a' and 3b', the carbon (C), oxygen 
(O) and phosphorous (P) are observed. These oxygen and carbon might have come from the 
copolymer.  
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Figure 7-3. STEM images and component analysis results (by EDS measurement) of modified 
liposome surface  
 
7-3.2 Stability of liposomes 
The stability of copolymer coated liposomes (DOX encapsulated and without DOX) 
and uncoated liposomes (DOX encapsulated and without DOX) were investigated using 
particle size and  −potential measurement after keeping the samples at 37 ℃ for  3 and 6 days 
(1, 3 and 8 days for DOX encapsulated liposomes) in 1:1 D-PBS and serum mixed solution 
(Figure 7-4). The particle size of copolymer 3a, 3b and 3c-coated liposomes (without DOX) 
showed very little change after 3 and 6 days (not significantly different from the day 0) in 1:1 
D-PBS and serum mixed solution, suggesting that the coating enhances the stability of the 
liposomes. In the case of 3a' and 3c' coated liposomes, the particle size decreased after 6 days, 
indicating closely packed structure (Figure 7-4 (i)). This close packing reduces the tendency 
of aggregation. In the case of the copolymer-coated DOX encapsulated liposome the particle 
size increased slowly (135 to 168 nm) over 8 days (Figure 7-4 (iii)). 
The zeta potential of the copolymer-coated liposomes (DOX encapsulated and without 
DOX) and uncoated liposomes (DOX encapsulated and without DOX) were monitored (Figure 
7-4 (ii) & (iv)). The zeta potential of the coated liposomes was increased after 1 days (DOX 
encapsulated) (Figure 7-4 (iv)) and 3 days (without DOX encapsulated) (Figure 7-4 (ii)). The 
adsorption of copolymers on the surface of the liposomes might increases the zeta potential. 
The zeta potential value was observed to be stable after 3 days in case of 3a' and 3b' indicating 
the equilibrium state of adsorption (Figure 7-4 (ii)). 
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Figure 7-4. Results of stability measurement- (i) particle size (z-average value), (ii) - potential 
of copolymer modified liposomes (without DOX) after 0, 3 and 6 days, (iii) particle size (z-
average value), (iv) - potential of copolymer-modified DOX encapsulated liposomes after 0, 
1, 3 and 8 days keeping at 37 ℃ in 1: 1 D-PBS and serum mixed solution. (*) Statistically 
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significant different compared to Day 0 and (#) statistically significantly different compared to 
Day 3 [only in case of Fig. (ii)]. 
 
7-3.3 Effect of copolymers on the phase transition temperature of liposome membrane 
The endothermic peak at about 53.3 °C corresponds to the gel-liquid crystalline phase 
transition temperature of HSPC[1] (Figure 7-5 (i)). After the addition of copolymers 3a-c, the 
phase transition temperature shifted upward, indicating the liposome membrane become 
thermostable. The shift of the main phase transition temperature (53.3 °C) to a higher 
temperature side indicates miscibility and cooperative interaction between the liposome 
(HSPC) and the copolymers. The addition of 3c' with liposomal system reduces the enthalpy 
(5.03 to 3.89 mJ/mg) of the phase transition. This phenomenon indicates that 3c' limit the 
cooperativity of phospholipid structure in liposome. The 3c' might act as membrane sealer and 
stabilize the membrane (low permeability). Addition of 3c' helps in enhancing the stability 
against leakage of encapsulated molecules[1]. 
The 3c' copolymer addition to the liposome decreases the ∆𝐻 but sharp endotherm 
appeared (Figure 7-5 (ii)). This abnormal behaviour might be due to the following reasons, a) 
3c' form copolymer rich micro-domain (which are although not detectable in endotherm) at 
water-lipid interface, b) the copolymer form micelle (not detectable under DSC) with 
phospholipid of the lipid bilayer, c) the accumulation of copolymer at bilayer surface 
(undetectable by DSC) disrupt the hydrogen bonding at the surface between the lipid molecule 
by diminishing the intermolecular interaction. In case of the other copolymer-coated liposomes 
(3a, 3b, 3c, 3a' and 3b'), the increase in ∆𝐻 might be due to an ordering effect of copolymer 
in forcing part of the molecule to align into the bilayer interior[13]. 
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Figure 7-5. Results of liposome membrane stability measurement (i) DSC thermogram and (ii) 
∆ 𝐻 value of the copolymer-modified liposomes (without DOX) 
 
7-3.4 Uptake study 
7-3.4.1 Qualitative uptake study 
The in vitro intracellular localization of modified (coated with copolymers) DOX 
encapsulated liposomes in comparison to free DOX and blank (DOX encapsulated liposomes) 
was studied in HeLa cell line after 2 and 6 h incubation (Figure 7-6 (i) & (ii)). The red 
fluorescence intensity (red fluorescence signal) correspond to the free DOX. After 2 h, all the 
modified liposome (copolymer coated and DSPE-PEG-2000 modified liposome) samples 
showed weak fluorescent signal (Figure 7-6 (i)). The free DOX-treated liposome showed 
strong fluorescent intensity inside the cell. This phenomenon can be described by different cell 
penetration mechanism of free DOX. The free DOX molecule are hydrophobic and penetrate 
into the cell by slow and simple diffusion after dissolution in cell membrane. Diffusion is a 
kind of concentration gradient which mainly depends on the difference of free DOX 
concentration in and outside of cell membrane[12]. The modified liposome penetrates the cell 
by endocytosis mechanism. After six hours, the fluorescent intensity inside the cell was 
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observed to increase which indicates the increase in concentration of DOX inside the cell 
(copolymer 3b, 3a', 3b' and 3c' modified liposome) (Figure 7-6 (ii)). 
 
i. 
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Figure 7-6. The Fluorescence microscopy images of HeLa cells treated with medium without 
a fluorescent probe containing liposome, free DOX and copolymer modified DOX 
encapsulated liposomes (DOX concentration 10 μg/ml seeded cell plate) after (i) 2 h and (ii) 
6 h incubation. 
 
7-3.4.2 Quantitative uptake study 
The flow cytometry analysis was performed to measure the cellular uptake of modified 
(coated with copolymers) DOX encapsulated liposomes (Figure 7-7). The flow cytometry 
results are consistent with the visualization results. The free DOX showed strong fluorescent 
intensity than the modified liposomes due to different uptake mechanisms. Cellular uptake goes 
down for larger particles. The size of the liposomes was in the range of 230 to 270 nm. This 
might be the reasons for overall reduction of the cellular uptake of liposomes. Among the 
modified (coated with copolymers) DOX encapsulated liposomes, 3c, 3a', 3b' and 3c' 
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copolymer-modified liposomes showed a little bit greater cellular uptake than DSPE-PEG-
2000-modified liposome after 6 h, but there were no significantly different  (Figure 7-7 (iii)). 
The copolymer contains MPC molecules, which have some affinity towards specific receptors 
expressed by most of the cells due to the phosphorylcholine group. Therefore, MPC molecules 
present on the surface of modified liposomes might contribute to the cellular uptake.  However, 
the extent of the effect of MPC molecules on the liposomes seems to be not so strong.  
 
       
i. ii. 
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Figure 7-7. Flow cytometry data of (i) histograms (count vs fluorescence intensity) results of 
2 h (ii) histograms (count vs fluorescence intensity) results of 6 h and (iii) mean fluorescent 
intensity for DOX encapsulated modified liposome (DOX concentration 10 μg/ml seeded cell 
plate) in HeLa cells after 6 h incubation. The mean fluorescence intensity was calculated by 
total 10000 events.  
 
7-4. Conclusion 
In this study, the HSPC/cholesterol liposome surface was modified by amphiphilic 
random and di-block copolymers containing MPC and POSS which was synthesized in 
Chapter 2. The liposomes modified with 3a, 3a' and 3c' copolymers increased the stability of 
liposome for 6 days in 1:1 D-PBS and serum mixed solutions. The copolymer 3a-c increased 
the thermal stability of the liposomes, and 3c' helps in enhancing the stability against leakage 
of encapsulated molecules. The cellular uptake after 6 h was observed to be more in case of 3c, 
3a', 3b' and 3c' copolymer modified liposome than DSPE-PEG-2000 modified liposome. The 
MPC and POSS based random and di-block copolymers could be a good amphiphilic surface 
modifier of liposome for advancement of liposomal drug delivery, and further study can be 
done to investigate the potential as a replacement of DSPE-PEG-2000 modified liposome in 
future.   
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Chapter 8 
 
General Conclusion 
 
The purpose of this study is to design and develop amphiphilic copolymer with element 
block R-POSS methacrylate as stable hydrophobic domain and zwitterionic MPC molecule as 
a hydrophilic domain with improved thermal and mechanical properties which can be applied 
in the coating of biomaterial surface and enhancement of the encapsulation and delivery of the 
hydrophobic drug molecules. The new approach of designing and synthesis of element block 
(R-POSS) as hydrophobic domain, help in enhancing and tuning the properties of MPC based 
copolymers and extend their range of biomedical applications. The scientific and biological 
evaluation of R-POSS and MPC-based copolymers revealed the interesting feature which is 
highly motivating requisite for its application in various field of pharmaceutical science.  
In Chapter 2, the results of the study indicated the successful design and synthesis of R-
POSS and MPC based copolymer following free radical and RAFT polymerization techniques 
to obtain random and di-block copolymer respectively. The solubility of random copolymers 
in a polar solvent (water, methanol and ethanol) reduced abruptly due to the strong interaction 
of R-POSS moiety with phosphorylcholine (PC) group which is responsible for water solubility. 
All three random copolymers have shown remarkable improvement in Tg and thermal stability. 
The results also indicated no crystallization phase of R-POSS moiety in the randon copolymer. 
The RAFT polymerization could lead to controlling the sequence of R-POSS and MPC. The 
degree of polymerization of the di-block copolymer was calculated to be 12-13 (R-POSS), 
which was governed by the same monomer/initiator ratio. The molecular weight of copolymers 
(random) is in the range of 105 whereas in case of the di-block copolymer (RAFT) it is in 104 
range. The control over the molecular weight, molecular weight distribution and site-specific 
functionality was the advantage of RAFT polymerization technique over the free radical 
polymerization. The successful design, synthesis and investigation of the properties of R-POSS 
and MPC-based copolymer (synthesized following two different polymerization technique) 
help in understanding the contribution of hydrophobic moiety R-POSS in the copolymer for it 
various field of application. 
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In Chapter 3, the synthesized random copolymer was studied focusing their application 
in the field of polymeric material for coating of cardiovascular implant fabrication and their 
coating. The promising results confirmed their high need in this particular area. The mechanical 
strength of the copolymer composed of C2H5-POSS improved due to the even distribution of 
C2H5-POSS moiety on polymer matrix and restricted mobility of the polymer chain. The 
hydrophobic C2H5-POSS moiety restricted the mobility of MPC molecule and increased the 
surface hydrophobicity at water polymer interface. The C2H5-POSS moiety disrupted the 
hydration layer surrounding the phosphorylcholine (PC) group which was responsible for 
resistance to the protein adsorption and cell adhesion on the surface. The hydrophobic C2H5-
POSS moiety uniformly dispersed in MPC polymer matrix and support controlled protein 
adsorption, cell attachment and cell spreading on the surface. Therefore, the C2H5-POSS and 
MPC random copolymer fulfill all requisite characteristics for its application especially as 
coating material of the cardiovascular implant.   
In Chapter 4, the synthesized random copolymer was studied focusing its application 
for solubilization of hydrophobic anti-cancer drugs like paclitaxel and their delivery as a carrier 
molecule due to its amphiphilic nature. The R-POSS and MPC random copolymers could form 
a stable association structure (size 65 – 80 nm) in the aqueous environment due to hydrophobic 
interaction of R-POSS moiety. The C2H5-POSS and MPC random copolymer observed highly 
biocompatible and effectively solubilized the poorly water-soluble drug paclitaxel forming a 
stable association. The paclitaxel solubility was concentration dependence and found in the 
order of C2H5 > C6H13 > C8H17.  The hydrophobic C2H5-POSS moiety strongly interacted with 
paclitaxel and controlled its release rate in an aqueous environment. The results obtained from 
the cell viability study in presence of paclitaxel solubilized C2H5-POSS based MPC random 
copolymer and in vitro paclitaxel release (from paclitaxel solubilized C2H5-POSS based MPC 
random copolymer association) study supported the phenomenon. The cell viability was 
observed 87 ± 24 % after 24 h incubation at pH 7 and in vitro paclitaxel release was observed 
around 30% in 24 h. The C2H5-POSS based MPC random copolymer was internalized by the 
cells through cellular uptake mechanism. Therefore, C2H5-POSS and MPC based copolymer 
possess promising characteristics as polymeric biomaterials for enhancing the solubility and 
delivery of poorly water-soluble component like a drug, imaging probs etc. 
In Chapter 5, the solid formulation of paclitaxel was prepared using C2H5-POSS and 
MPC based random copolymer as amphiphilic solubilizer and PVP as hydrophilic carrier 
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molecule of paclitaxel. The solid formulation containing C2H5-POSS and MPC based random 
copolymer formed single phase homogeneous formulation and enhance the dissolution rate of 
paclitaxel. The C2H5-POSS and MPC based random copolymer improved wettability and 
facilitated the rapid and complete release of paclitaxel (~ 90%) within 40 min. The C2H5-POSS 
and MPC based random copolymer interacted with PTX and reduced the mobility of 
amorphous PTX, which help in the enhancement of the dissolution. Therefore, C2H5-POSS and 
MPC based random copolymer could be a promising amphiphilic solubilizing material to 
enhance the dissolution of the poorly water-soluble drug from the solid formulation.   
In Chapter 6, the synthesized di-block copolymer was studied focusing its application 
in delivery and encapsulation of poorly soluble drug forming stable micelle system. The R-
POSS and MPC based di-block copolymer formed micelles (size 26-43 nm) in an aqueous 
environment and the aggregation ability in the order of C2H5 > C6H13 > C8H17. The size 
distribution of C2H5-POSS based di-block copolymer was extremely small and the results 
indicated the formation of the tightly packed association. The C2H5-POSS and C8H17-POSS 
based di-block copolymer were highly stable even after drug loading. The drug loading 
capacity and efficiency of the polymeric micelles were highly dependent on the structure of 
drug molecules. The drug-containing long aliphatic chain compatible with aliphatic core region 
of the polymeric micelles due to strong hydrophobic interactions. The strong interaction 
between the drug molecule and polymeric micelles leads to the negligible release of drug as 
most of the drug remains inside the micelles. The cell viability was almost 90 % in all the PTX-
loaded di-block copolymers after 24 h, and around 50 % after 48 h of incubation. These results 
supported the phenomenon of negligible drug release. The cellular uptake of C2H5-POSS based 
di-block copolymer was significantly smaller than C6H13-POSS, C8H17-POSS and free drug 
due to its tightly packed association state and relatively harder morphology. The cellular uptake 
of R-POSS and MPC based di-block copolymer was governed by the strong affinity of MPC 
molecules towards specific cell membrane receptors. Therefore, the R-POSS and MPC based 
di-block copolymer could be a promising candidate for controlled stable micelle formation and 
selective hydrophobic drug encapsulation and drug delivery.  
In Chapter 7, study on stability enhancement of liposome by surface modification using 
synthesized random and di-block copolymers was performed. The obtained results suggested 
the enhancement in the stability of liposome by maintaining the size for 6 days and also stability 
against leakage of encapsulated molecules. Overall, the random copolymers were preferable 
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for the liposome coating in terms of the stability.  The cellular uptake of copolymer modified 
liposome was observed to be comparable with that of DSPE-PEG-2000 modified liposome 
after 6 h. The cellular uptake was governed by the affinity of MPC molecule towards cellular 
membrane. Therefore, the modification of liposome using POSS-MPC-based random and di-
block copolymer could be a promising approach for enhancing the stability of liposome. 
Overall, the effect of the alkyl chain length of the vertex R-groups [ethyl (C2H5), hexyl 
(C6H13), octyl (C8H17)] of R-POSS methacrylate in both types of the R-POSS and MPC-based 
copolymer (random and di-block) were systemically studied. The molecular weight and 
association behavior of R-POSS and MPC based di-block copolymer was found to be 
controlled in a better way by controlling the degree of polymerization than that in R-POSS and 
MPC-based random copolymer where the control over the molecular weight and also the 
association behavior is difficult. This control on molecular weight and association behavior 
leads to formation of micelles from di-block copolymer in an aqueous environment with size 
range of 26-43 nm which is maintained even after drug loading. Thus, higher cellular uptake 
could be obtained from R-POSS and MPC based di-block copolymer which additionally 
showed encapsulation of the hydrophobic drug in the core of the tightly packed associated 
micelle leading to negligible drug release. The application of the copolymers can be extended 
for the stabilization of liposome by surface modification. This can be considered as a good 
alternative for DSPE-PEG-2000 modified liposome which has shown limitations in the clinical 
applications.  
The innovative biomaterial for the advancement of medical treatment and diagnosis is 
the urgent need in the medical and pharmaceutical field. The advancement of medical diagnosis 
and treatment will improve the quality of human life. The systemic study in this thesis revealed 
that element block R-POSS as a hydrophobic domain is highly promising to improve bulk and 
solution properties of polymeric material. The proper selection and modification of R-group in 
the POSS cage could develop the biomaterial for advanced application. The element block R-
POSS in combination with MPC has the potential to develop new polymeric biomaterial which 
will improve the quality of the medical and pharmaceutical system. The author firmly believes 
that R-POSS and MPC-based polymeric biomaterial will be explored more for the development 
of advanced biomaterial in the future.  
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